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Erratum: Quantification of Radiation-induced DNA Damage following intracellular Auger-
Cascades 
 PhD. Thesis by Pil Møntegaard Fredericia, June 2017 
 
1. The following sentence has been added to the preface page 1. 
“The work is partially funded by the MATHIAS project (European Union Seventh Framework 
Programme FP7/2007-2013 under Grant 602820).” 
 
2. SC(N←C) has been renamed to SC(N←CM). Corrections have been made on page 4, 9, 10, 
12, 83, 86 (figure 3.8), 106 &157. 
SC(C←N) has been corrected to SC(N←CM) on page 11, 112, 121 & 177. 
 
3. SC-values for 29 HeLa nuclei, and not 30 HeLa nuclei were calculated. Corrected on page 86, 
110,111 & 160 
 
4. Due to a mistake in the calculation of the volumes of the HeLa and V79 cell nuclei, the 
stated mean ± sd. volumes are 4/3 too small.  
These values have been changed from 0.630 pL ± 0.217 to 0.84 pL ± 0.295 for HeLa nuclei 
and from 0.400 pL ± 0.182 to 0.53 pL ± 0.243 for V79 nuclei. The changes are made on page 
110, 111, 112, 118, 119 & 160 
 
Likewise have figure 4.10 B and figure 4.11 B (page 111), plus figure 4.14 A and 4.15 A 
(page 118 & 119) also been changed to show the right volumes. 
 
As stated on page 117 the nuclei volume ranged from 0.178 pL to 1.163 pL for HeLa and 
from 0.080 pL to 1.080 pL for V79. The correct number should be from 0.238 pL to 1.55 pL 
for HeLa and from 0.107 to 1.440 for V79.  
 
These mistakes had no influence on the SC-value calculations or absorbed dose calculations 
as these were performed using the correct nuclei volumes.   
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Preface 
 
This thesis is the result of 3 years graduate work carried out carried at the Hevesy Laboratory, part of 
the Center for Nuclear Technologies, at the Technical University of Denmark, under the supervision of 
Dr. Torsten Groesser and Prof. Mikael Jensen. The work is partially funded by the MATHIAS project 
(European Union Seventh Framework Programme FP7/2007-2013 under Grant 602820). 
 
The work has focused on investigating the biological response following intracellular Auger emitter 
decays and comparing these results with external reference radiation. 131Cs has been developed as a 
new model for use in cell studies of radiation damage following Auger-emitter decays. This 
radionuclide is gamma-silent, has no nuclear beta emissions, has a good Auger cascade and 
internalises into cells by a natural process. Special attention has been given to the experimental 
design to establish a reliable calculation of the absorbed dose and dose rate from internalised 131Cs.  
In order to obtain valid RBE-values, care has been taken to deliver the reference radiation at dose 
rates comparable to that of the internal 131Cs test radiation.  
 
The work is presented as fulfillment of the requirements for obtaining a PhD at the Technical 
University. It is composed as a monograph and divided into chapters comprising: Introduction, 
background overview, materials and methods, results, discussion, conclusions and outlook.     
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Abstract 
 
Purpose: The aim my PhD study and the topic of this thesis is to investigate the radiotoxicity and the 
Relative Biological effectiveness (RBE) of intracellular Auger cascades. A special focus is kept on 
obtaining reliable absorbed dose calculations and using matched dose rate profiles for the Auger 
exposed cells and cells exposed to the reference radiation.  
In order to accomplish this, a new experimental model was developed. The Auger cascades were 
induced by intracellular decays of the electron-capture radionuclide 131Cs. The use of radiocaesium 
allowed me to develop new version of the cellular S-values (SC-values). 
 The work can be divided into three steps; Examination of the bio-kinetics of the Auger emitter 131Cs 
used in the study, calculations of the SC-values and finally the measurement of the RBE of intracellular 
131Cs decays, through ƴH2AX and clonogenic cell survival assay.  
Methods: A series of experiments examining the cellular uptake, release rate and cellular 
accumulations of 131Cs in HeLa and V79 cell cultures were performed. The intracellular 131Cs activity 
was measured using liquid scintillation counting.  The geometry used for the SC-values calculations 
were a confluent cellular monolayer, with the nuclei dispersed within. The height of this cellular 
monolayer and the size and shape of the nuclei were determined by confocal microscopy for both 
HeLa and V79 cell cultures. SC-values values were obtained for whole cell to nucleus, SC(N←CM), with 
131Cs distributed homogeneously throughout the entire cellular monolayer. Monoenergetic electron 
emission dose kernels for a point source were calculated using the method applied by MIRD for 
cellular S-values and using Cole´s pseudo stopping power for electrons in water. K- and L-Auger 
electron energies and intensities (24.6 keV (9.3 %) and 3.43 keV (79.7 %) respectively) with an 
intensity normalisation factor of 1.17 were used as input for the SC value calculation. To measure the 
RBE of intracellular 131Cs decays, confluent cellular monolayers of HeLa and V79 cells were incubated 
with 131Cs containing medium. Using the obtained results of the 131Cs bio-kinetics, and the SC-values, 
dose rate profiles and absorbed doses for the 131Cs exposed cells could be calculated. HeLa and V79 
cell cultures were then exposed to matched dose rate profiles using 137Cs ƴ-rays as the reference 
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radiation. The biological effects of the two exposures were evaluated using ƴH2AX and clonogenic cell 
survival.  
Results:  131Cs was taken up, accumulated and then released by both cell lines. The uptake and release 
could be described by exponential equations (A =  A0 ∗ (1 − e
−t∗kc) and A = A0 ∗ e
−t∗kout) with kc 
and kout having values of 1/283 min
-1 (HeLa), 1/204 min-1 (V79) and 1/339 min-1 (HeLa) , 1/256 min-1 
(V79) respectively. The cellular uptake of 131Cs was found to be mediated by the Na+/K+-ATPase, 
supporting the hypothesis of a homogenous, intracellular distribution of 131Cs. The SC-values for 29 
and 50 different sized nuclei were found to range from 7.78*10-4 to 7.83*10-4 Gy/(Bq*Sec)/pL for 
HeLa nuclei and from 7.45*10-4 to 7.63 *10-4 Gy/(Bq*Sec)/pL for V79 nuclei. The SC-values were 
shown to be were very robust and almost independent of cellular and nuclear size. A RBE value of 1 
was obtained for HeLa cells using ƴH2AX assays. RBE values of 4.5 ± 0.5 and 3.8 ± 0.8 were obtained 
for HeLa and V79 cells respectively, using clonogenic cell survival. The RBE values obtained in this 
study are higher than expected for Auger emitters located intracellularly but not directly intercalated 
to the DNA. 
Conclusions: The implication of this study is two-fold. The obtained RBE values give further hope for 
the development of future Auger therapy, as the Auger emitters might not be needed to bind to the 
DNA in order to achieve high radiotoxicity. At the same time these RBE values should raise concerns 
about in the ignorance of Auger electrons in dosimetry of diagnostic nuclear medicine procedures, as 
the risk associated with these might be underestimated. The RBE of Auger emitter decays clearly need 
to be further investigated. My new experimental method with the robust absorbed dose calculations, 
the new concept of SC-values, and the applicability to most cells types and all Auger emitters with 
homogeneous intracellular distribution, could be a valuable tool for such investigations. 
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Resume (in Danish)                           
 
Formål: Formålet med mit PhD studie og emnet for denne afhandling er en undersøgelse af 
radiotoksiciteten og den Relative Biologiske Effektivitet (RBE) af intracellulære Auger-kaskader. Særlig 
fokus har været rettet mod at opnå pålidelige beregninger af absorberet dosis og brugen af 
sammenlignelige dosishastigheder for både de celler, der blev bestrålet med Auger elektroner og de 
celler der blev bestrålet med reference strålingen.  For at kunne opnå dette har jeg udviklet en ny 
eksperimental metode. Den radioaktive isotop 131Cs, der henfalder via elektron indfangning, blev 
brugt til at frembringe disse Auger-kaskader. Brugen af 131Cs tillod mig at udvikle en ny version af de 
cellulære S-værdier. Arbejdet kan inddeles i tre dele; 
- Undersøgelse af bio-kinetikken af 131Cs, der var den Auger-emitter, som blev brugt i studiet  
- Beregning af SC-værdierne  
- Måling af RBE for intracellulære 131Cs henfald, med to anerkendte metoder: ƴH2AX og 
clonogenic cell survival.  
Metode: Der er udført undersøgelser over optagelsen, frigivelseshastigheden og akkumuleringen af 
131Cs in HeLa og V79 celler. Den intracellulære 131Cs aktivitet blev målt via væskescintillation. 
Geometrien, der blev brugt til beregning af de cellulære SC-værdier, var et konfluent cellulært 
enkeltlag, hvori cellekernerne var placeret. Højden af dette cellelag (for både HeLa og V79 
cellekulturer) samt cellekernernes størrelse og form, blev målt ved hjælp af konfokal mikroskopi. 131Cs  
var homogent fordelt i hele dette cellelag og de cellulære SC-værdier blev beregnet for ”hele cellen til 
kernen”.  Dose-kernel for monoenergetiske elektroner fra en punktkilde, blev beregnet ved brug af 
samme metode, som anvendes af MIRD ved beregning af cellulære S-værdier, og ved brug af Cole’s 
”pseudo stopping power” for elektroner i vand. Energien af K- og L- elektronerne og deres intensitet 
(24,6 keV (9,3 %) og 3,43 keV (79,7 %) blev intensitets-normaliseret med en faktor 1.17, og herefter 
brugt som input til beregning af SC-værdierne. For at finde RBEen blev HeLa og V79 cellekulturer 
inkuberet med vækstmedium tilsat 131Cs. Baseret på den opnåede viden om 131Cs´ biokinetik og de 
beregnede Sc-værdier, kunne dosis-hastighedes-profilerne og den absorberede dosis beregnes. Disse 
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dosishastighedsprofiler blev brugt til at planlægge ekstern bestråling af celler med 137Cs ƴ-stråling, 
således at cellerne blev udsat for den samme dosishastighedsprofil. Den biologiske effekt af den 
interne og den eksterne bestråling blev målt med ƴH2AX og clonogenic cell survival assay.  
Resultater: Begge cellelinjer var i stand til at optage, akkumulere og derefter frigive 131Cs.  Optaget og 
frigivelsen kunne beskrives ved brug af simple eksponentielle udtryk (A =  A0 ∗ (1 − e
−t∗kc) 
og A = A0 ∗ e
−t∗kout) hvor kc og kout var henholdsvis 1/283 min
-1 (HeLa), 1/204 min-1 (V79) og 1/339 
min-1 (HeLa) , 1/256 min-1 (V79). 131Cs blev taget op af cellerne via Na+/K+-ATPasen, hvilket 
understøtter hypotesen om den homogene intracellulære fordeling af 131Cs.  SC-værdierne for 29 HeLa 
og 50 V79 cellekerner af varierende volumen, blev beregnet til 7,78*10-4 -7,83*10-4 Gy/(Bq*Sec)/pL 
(HeLa) og 7,45*10-4 - 7.63 *10-4 Gy/(Bq*Sec)/pL (V79).  SC-værdierne viste sig at være meget robuste 
som beregnings-værktøj, fordi de næsten er uafhængige af celle og cellekernes størrelse.  
En RBE-værdi på 1 blev fundet for HeLa celler ved brug af ƴH2AX metoden.  
RBE-værdier på 4,5 ± 0,5 og 3,8 ± 0,8 blev fundet for HeLa henholdsvis V79 ved at undersøge 
overlevelsesraten med clonogenic cell survival. 
RBE-værdierne fundet i dette studie er højere end, hvad der normalt forventes for Auger-emitterer 
der er lokaliseret intracellulært, men ikke er bundet mellem DNA-strengene.   
Konklusion: Betydningen af dette studie todelt. De fundne RBE-værdier giver håb for udviklingen af 
fremtidig Auger-terapi, da Auger-emitteren muligvis ikke behøver at være bundet til DNAet for at 
opnå en høj radiotoksicitet. På samme tid burde disse RBE-værdier også give grund til bekymring over 
den nuværende undervurdering af Auger-elektroner i dosimetrien for isotoper anvendt i diagnostisk 
nuklearmedicin. Der er et klart behov for videre undersøgelse af RBEen af Auger-emitter henfald. Min 
nye eksperimentelle metode, med dens robuste beregning af absorberede dosis, de nye Sc værdier, 
anvendeligheden på de fleste celletyper og på alle Auger-emittere med en homogen intracellulær 
fordeling, vil være et brugbart redskab for sådanne undersøgelser.  
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List of Abbreviations and Acronyms 
 
AAPM   American Association of Physicist in Medicine¨ 
ATP   Adenosine triphosphate 
BER   Base excision repair (pathway) 
CK   Coster-Kronig 
CPS   Count per second 
CSDA    Continues slowing down approximation   
D37   Dose at 37 % survival 
DDR   DNA damage response  
DMEM   Dulbeccos’s modified eagle medium 
DMSO   Dimethylsulfoxid  
DNA   Deoxyribonucleic acid 
DPS    Disintegration per second 
DSBs   Double strand breaks  
EC   Electron capture 
ECACC   The European Collection of Cell Cultures  
EDTA   Ethylenediaminetetraacetic acid 
FBS    Fetal bovine serum 
FISH   Fluorescence in situ hybridization 
GRF   Geometric reduction factor 
HBSS   Hank´s balanced salt solution  
HHR   Homologues recombination repair  
HPV   Human papilloma virus 
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IC    Internal conversion 
IC50   Half maximal inhibitory concentration 
ICRP   International Commission of Radiation Protection 
IUdR   Idoxuridine 
LET   Linear energy transfer 
LMDS   Locally multiple damage sites  
LSC   Liquid scintillation counting  
LSM   Laser scanning microscope 
MEM   Minimum essential medium eagle 
MIRD    Medical Internal Radiation Dose (committee)  
NHEJ   Non-homologues end joining  
OER   Oxygen enhancement ratio  
PBS   Phosphate buffered saline 
pRb   Retinoblastoma protein  
RBE   Relative biological effectiveness 
SCK   Super Coster-Kronig 
s.d.   Standard deviation 
SPECT   Single photon emission computed tomography 
SSBs   Single strand breaks  
SSBR   Single strand break repair  
wR   Radiation weighting factor 
wT   Tissue weighting factor 
wx   Fluorescent yield 
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1. Introduction 
 
Ionising radiation was discovered in 1895 by the German physicist Wilhelm Conrad Röntgen and 
named X-rays, and were shortly thereafter, used for medical diagnostic purposes (radiology).  
Similarly, the discovery of radioactivity by Henri Becquerel and of radium by Marie and Pierre Curie 
quickly led to the treatment of cancer by radium preparations and ionizing radiation. However, in 
addition to the benefits gained in cancer treatment, these new types of radiation also possessed 
detrimental properties. In 1928 “The International X-ray and Radium Protection Commission” (later 
known as “International Commission of Radiation Protection”, ICRP) was established [1]. 
Today ionizing radiation is widely used for both diagnostic and therapeutic purposes. Over 40 million 
nuclear medicine procedures are performed each year spread over more than 10.000 hospitals. Many 
of these procedures are part of the diagnosis and treatment of cancer and nuclear medicine has been 
a major contributor to the increased survival rate of cancer patients [2][3]. However one of the 
current challenges in today’s radiotherapy is to limit the collateral damage to the healthy tissue near 
the irradiated tumor(s). It is the hope that the use of Auger emitters in targeted cancer therapy can 
overcome this problem. As an Auger emitter decays, several low energy electrons are released. These 
electrons have a range of only nanometers to micrometers and are therefore able to hit only the 
targeted cells, while sparing nearby healthy tissue [4][5]. In addition, the simultaneous release of 
multiple low energy electrons and their contorted path can cause clustered and complex DNA 
damage, resulting in a significantly increased radiotoxicity compared to photons at similar absorbed 
doses and a consequently very high relative biological effectiveness (RBE). It is these characteristics of 
the Auger cascade that are thought to be of advantage in a cancer treatment [6]. Still, for Auger 
therapy to ever become a reality, more experimental data on their increased radiotoxicity and their 
RBE have to be provided.   
90 % of the nuclear medicine procedures performed today, is part of diagnostic examinations, and 
here radioisotopes that also emit Auger electrons are already in use. These radioisotopes include 
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111In, 123I, 67Ga and 99mTc which photons emissions (not their Auger electrons) are utilized in diagnostic 
gamma-camera and single photon emission computer tomography (SPECT) imaging [2]. Despite the 
fact, that the simultaneous release of Auger electrons from these radioisotopes, are known to cause 
DNA damage disproportional to their energy deposition (absorbed dose), risk estimations for these 
diagnostic procedures still treats Auger electrons as “normal” electrons, and their contribution to the 
dose calculation is therefore minimal even though their biological effect could be significant[7][8][9]. 
It could be argued that the dose received by a patient during a diagnostic procedure is low (µSv – 
mSv). However, considering the number of patients undergoing a diagnostic procedure each year, an 
underestimation of the risk associated with these could affect a substantial amount of people [10].  
The interest in and the need to know more about the cellular effects and RBE of Auger emitters are 
therefore not only related to a potential future cancer treatment, but also to nuclear medicine 
procedures extensively used each day.    
Even though the increased RBE of Auger emitters has been studied and acknowledge since the late 
1960s [11][12], it is only recently that the official organizations involved in risk assessments of low 
doses of ionizing radiation, has begun to practically acknowledge this. In Publication 92 published in 
2003 by the International Commission of Radiation Protection (ICRP) it is stated that a radiation 
weighting factor (wR) of 20 or more is appropriate for Auger emitter bound to the DNA and that a 
radiation weighting factor for Auger emitters not bound to the DNA should also be considered [13]. 
This change has been underway for a long time, as it was already proposed by Pomplun et al  in 1987 
to assign a quality factor of 20 for Auger emitters bound to the DNA and of 1 for emitters not bound 
to the DNA [14]. However later, values above much higher than 1 for Auger emitters incorporated 
into cells, but not the DNA, have been recommended for use in risk estimations for specific cases and 
for deterministic effect [15][9]. Even though the American Association of Physicists in Medicine 
(AAPM), have proposed an alternative method for estimating equivalent doses, the official 
recommendation for ICRP are still that microdosimetry should be used to assess the effect of Auger 
emitters. However, several “issues” related to microdosimetric calculations are present, and no 
recommendations have so far been given on how the microdosimetric assessment is to be performed 
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[13][15][16]. The delayed action, in assigning an official radiation weighting factor for Auger electrons, 
is probably more a consequence of existing challenges and unanswered questions than due to a lack 
of interest.  
These challenges especially relate to the absorbed dose calculations and to the experimental 
conditions applied when investigating the RBE.  The challenges related to the absorbed dose 
calculation can be divided into two groups, comprising the problems in the calculations of the cellular 
S-values (computational, correct stopping powers etc. not covered here) and the compliance between 
the assumption made in the cellular S-value and absorbed dose calculations and the experimental 
reality [17][18].   
The absorbed dose to cellular targets is formally calculated using the cellular S-values from the 
Medical Internal Radiation Dose Committee (MIRDs). Due to the complexity of these cellular S-values 
calculations, S-values for some commonly used radioisotopes have been published by MIRD, in the 
report on cellular S-values [17]. The cellular S-values are calculated for cells and nuclei of different 
dimensions. Due to the short range of the Auger electrons these cellular S-values are very dependent 
on the cellular and nuclear dimensions and therefore very sensitive to small changes in them. In 
addition, the cellular S-values are only calculated for spherical cells (except a few for low energy 
electrons), a geometry which is suitable for cells in suspension but not for adherent cells [17][18]. One 
of the crucial assumptions in the MIRD cellular S-value calculations is the homogenous distribution of 
the radioisotope in one or more of the defined source compartments; cell surface, cytoplasm and 
nucleus [17][18]. This requirement is not easily met as the Auger emitting radioisotopes often have 
non-trivial intracellular organometallic chemistry. 
It is well known that the dose rate is an important factor for the biological effect observed, especially 
for low linear energy transfer (LET) radiation which is often used as reference radiation [13][20]. If the 
dose rate of the reference and test radiation are significantly different and the cells type are sensitive 
to this effect the obtained RBE can change dramatically. In studies investigating the cellular effect of 
Auger emitters, the dose rate of the reference radiation is often in the order of Gy/min while the dose 
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rate of the reference radiations is in the order of Gy/h (due to the uptake kinetics) potentially 
underestimating their RBE [21].  
The dose rate of the test radiation can be influenced by several factors including the kinetics of the 
cellular uptake and intracellular distribution of the radiochemical, its possible release from the cell 
and its subcellular distribution over time. These factors should therefore be elucidated for correct 
dose and dose rate calculation. In addition, depending on the bio-kinetics of the radioisotope and the 
biological endpoint used, the cell might be exposed to significant doses after the radiochemical is 
removed from the culture medium. Care should especially be given to this when clonogenic cell 
survival is used as an endpoint after exposure from a radioisotope with a relatively long half-life.  
All these dynamics will influence the dose, the dose rate and in the end the biological effect observed. 
When investigating the RBE, it is therefore of high importance that the experimental conditions for 
the cells exposed to the reference or test radiations are similar. At the moment, these components 
are only minor addressed and sometimes completely ignored, in studies investigating the radiotoxicity 
and RBE of Auger emitters [22][23][24]. However if reliable and consisting RBE values for Auger 
emitters can ever be obtained these vital parameters in the experimental setup will have to be 
consistently addressed.   
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1.1 Aim of the work 
The main aim of this study is to investigate the radiotoxicity and relative biological effectiveness of 
the Auger emitter 131Cs, based on an understanding of the in the introduction mentioned challenges.  
To accomplish this I will establish an experimental setup and develop new cellular S-values, named SC-
values which are much less sensitive to small changes in cellular and nuclear volumes. By using these 
robust SC-values I can obtained reliable absorbed dose calculations, and significantly decrease the 
(often high) uncertainty associated with these calculations using the MIRD cellular S-values.    
As my aim is to investigate Auger emitter decays and not a specific medical radioisotope, I have 
chosen the pure Auger emitter 131Cs, which decays by 100% electron capture (EC), for the work. It has 
no γ-ray emission (but of course some X-ray emission) and a relatively high abundance of Auger 
events [25]. In addition 131Cs, being an alkali metal, has some bio-chemical properties which are 
crucial for the developed SC-values.   
In order to properly calculate absorbed doses and dose rates for the 131Cs exposed cells, it is crucial to 
know the bio-kinetics of 131Cs. Thus, I will investigate the uptake and release of 131Cs in order to know 
the activity concentration in the cells over time. Also the cellular location of 131Cs (intracellular or 
bound to the cell surface) is examined, as this is also crucial parameter for the SC-value calculations, 
due to the short range of Auger electrons.  
In the end, to obtain RBE values for 131Cs decays, I will compare the observed biological effect of 131Cs 
exposed cells, to that of cells exposed to a reference radiation (γ-rays). RBE values for two different 
biological assays (γH2AX and clonogenic cell survival) along with two different cell lines (HeLa and V79 
cells) will be obtained. In addition, as several parameters are known to influence the biological 
response, applying a similar experimental setup for the two different exposures (test and reference 
radiation) will be highly prioritized. This will include using similar cell densities and absorbed doses, 
with a special focus on using similar dose rate profiles for the two exposures, in order to correct for 
any dose rate effects.  
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1.2 Outline of the work 
To provide a better overview of the main work, a flow chart showing the different experimental steps 
is presented in Figure 1.1 
1: Using the natural uptake of 131Cs in cells, the radiotoxicity and RBE for intracellular Auger decays in 
two cell lines (HeLa and V79 cells) will be studied.   
2:  Production and chemical separation of 131Cs to get a 131CsCl solution used in the study.  
3: Cells were incubated with 131Cs (produced in step 2) in order to investigate its bio-kinetics including 
uptake, release and cellular localization. For the RBE experiments cells were incubated with 131Cs 
and the cellular activity concentration measured at the end of incubation  
Step 4 and 5 were performed in parallel, with the other steps.  
4: Cells were grown to a confluent monolayer and the cell membrane and the nucleus were stained 
with fluorescent dyes. Images were taken (by confocal microscopy) of the stained cells, and these 
pictures were used to estimate the height of the cellular monolayer and the size of the nuclei. 
5: Using the results of the cell layer and nuclei geometry (obtained in step 4), SC-values were 
calculated for both cell lines. 
6. Using the measured cellular 131Cs concentration obtained in step 3 and the SC-values obtained in 
step 5, the absorbed dose and dose rate profiles were calculated.  
7. Knowing the absorbed dose and dose rate profile for the 131Cs exposed cells, the dose rate profile  
for the external ƴ-ray exposed (reference radiation) cells were matched, in order to avoid a dose 
rate effect. 
8. ƴH2AX assay and clonogenic cell survival were used to measure the RBE.  
-These steps were performed independently for the two cells lines.   
Outline of the work 
 22 
Flow chart 
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2. Background 
2.1 Auger emitters 
 Auger cascade 2.1.1
The Auger effect was discovered in 1923 by Lise Meitner and later in 1925 by the French physicist 
Pierre Victor Auger, whom it was also named after[26][27]. Pierre Victor Auger was investigating 
electron tracks produced in a cloud chamber by low energy photons, when he noticed that several of 
the electron tracks emanated from the same spot. He concluded that these electrons were the result 
of inner shell transition, in which the excess energy was transferred to orbital electrons instead of 
being released as photons. This process of release of multiple orbital electrons arising from inner shell 
transition is called the Auger effect, Auger process or the Auger cascade [27][15]. 
 
The Auger cascade begins with the creation of a vacancy in one of the inner shells.  To relax the atom, 
an electron from a higher energy orbital will fill the vacancy. In that process, the energy resulting from 
the energy difference between the two orbitals, will either be emitted as a characteristic X-ray or be 
transferred to another orbital electron which is ejected from the atom, creating another vacancy 
(Figure 2.1) This result in a cascade of electrons, being emitted from the atom and ends with the 
highly ionized atom absorbing electrons from the nearby environment in a process called charge 
neutralization [28][29]. 
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Figure 2.1 Relaxation of an atom with a vacancy in the K-shell 
Relaxation of a vacancy in the K-shell can result in two scenarios. Either an electron from a higher shell, here the L-shell 
transits to the K-shell and the energy difference between the two shell is emitted as an X-ray (KL X-ray) or the energy is 
transferred to another orbital electron, which gets ejected (KLL Auger electron) (courtesy by B. Q. Lee [30]).   
 
Depending on the orbitals involved in the transitions, the emitted electrons are called Auger-, Coster-
Kronig (CK) - or Super Coster-Kronig (SCK) electrons, but are often all referred to as Auger electrons 
(Figure 2.2). Their energy range from just below the K-shell binding energy (of the isotope) down to a 
few eV. [29][8]. 
 
 
Figure 2.2 Production of Auger-, Coster-Kronig- and Super Coster-Kronig electrons 
The ejected electron is called an Auger electron when the electron transition occurs between shells. Coster-Kronig and 
Super Coster-Kronig electrons are produced when the transition occurs between sub shells and the energy is transferred to 
an electron in the same shell (Super Coster-Kronig) or to an electron in a higher shell (Coster-Kronig). Figure is taken from 
[31]. 
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The emitted X-ray(s) has an energy corresponding to the difference in electrons binding energies in 
the two orbitals involved;   
E(X−ray) =  E(BE,x) –  E(BE,y)                              (Eq. 1) 
While the ejected electron(s) has energy corresponding to the differences in electron binding energies 
in the three orbitals involved; 
E(z,Auger electron) = E(BE,x) − E(BE,y) − E(BE,z)                          (Eq. 2) 
E(X−ray) and E(z,Auger electron) being the energy of the emitted X-ray and Auger electron respectively, 
E(BE,x) and  E(BE,y) the electron binding energies in the two orbitals (x, y) involved in the transition 
and E(BE,z) being the electron binding energy for the ejected Auger electron in orbital z [29]. 
 
The emission of X-rays and Auger electrons (including Coster-Kronig & Super Coster-Kronig) after the 
creation of a vacancy are competing processes. The probability that an X-ray will be emitted (radiative 
transitions) after filling of the vacancy is called the fluorescence yield (𝜔), while the probability that 
an Auger electron will be emitted (non-radiative transitions) is called the Auger yield (a)[32] . It 
follows that; 
                            ω + a = 1                                   (Eq. 3) 
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Figure 2.3 Fluorescence yield for K- and L-shells  
The fluorescence yield equals the number of X-rays emitted per vacancy. The fluorescence yield increases with increasing 
atomic number and becomes the dominating process for K-shells in elements with an atomic number above ~30.  For L-
shells it becomes the dominating process in elements with an atomic number above ~90. Figure is taken from [33]. 
 
The fluorescence yield depends (among other factors) on the atomic number (Z) and the orbitals 
involved in the transition. It increases with increasing atomic number and the radiative transition 
becomes dominant for K shells in elements with Z > 30. For the L shell the radiative transition first 
becomes dominant in elements with atomic number around 90 (Figure 2.3)[32] [34]. 
 
The inner shell vacancy that starts the Auger cascade can be created by several mechanisms including 
coulomb interactions between an energetic charged particle and an orbital electron, photon 
interactions (photoelectric effect, Compton effect, triplet production), electron capture and internal 
conversion. Electron capture and internal conversion, being the only two processes that involve 
nuclear transitions are described below [35]. 
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 Electron Capture 2.1.1.1
Radioactive isotopes that decay by electron capture are often proton-rich and lie to the left of the 
stability line. These isotopes can stabilize by converting a proton into a neutron, thereby increasing 
their proton/neutron ratio. In essence, a proton in the nucleus captures one of the inner shell 
electrons and transforms into a neutron and a neutrino. A vacancy is thereby created, which can lead 
to an Auger cascade;  
                                                               XZ
A + e− → YZ−1
A + ve                                (Eq. 4)  
For electron capture to occur the decay energy should be greater than the binding energy of the 
captured electron. The decay energy (much of which is carried away by the neutrino) is equivalent to 
the difference in the mass between the mother and daughter isotopes. As the daughter isotope is 
relatively heavy, the recoil energy is very small [35].  
 
 Internal conversion 2.1.1.2
After beta decay the nucleus can be left in an excited state. To relax, the nucleus can emit a photon 
(γ-decay) or it can interact with an orbital electron, “transferring” enough energy to it, to eject it from 
the atom. Thereby a hole in the shell is created, which can lead to an Auger cascade; 
                                                                 X∗Z
A → XZ
A +  eK
−                            (Eq. 5) 
The energy of the ejected electron is almost equal to the excitation energy minus the binding energy 
of the electron;  
                                                Ee ≈ E
∗ − EB                   (Eq. 6) 
𝐸𝑒 being the energy of the ejected electron, 𝐸
∗ he excitation energy and 𝐸𝐵 the binding energy of the 
ejected electron. The process competes with gamma emission but dominates in heavy nuclei at low 
excitation energies [35]. 
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2.2 Radiobiological effects of Auger emitters 
 Radiotoxicity and Relative biological effectiveness of      2.2.1
Auger emitters 
The radiotoxicity of Auger emitters has been investigated since the late 1960s where the first cell 
studies incorporating 125I into DNA were performed. These studies reported an increase in 
radiotoxicity around 4-5 fold and even up to 20 fold when compared to 3H and sparked the idea of 
using Auger emitters in cancer therapy [12][28][36].  Carlson & White published a paper in 1963 
showing a high degree of fragmentation (99%) after the decay of 125I incorporated into CH3I and C2H5I 
molecules [37]. These data were at that time used to explain the underlying mechanism of the 
increased biological effect that was experimentally observed. Since then, several experiments 
investigating the radiotoxicity of Auger emitters have been performed and the understanding of its 
effect has increased [28].   
A way of reporting radiotoxicity for different types of radiation is the “relative biological 
effectiveness” (RBE). The RBE was defined by The National Bureau of Standards in 1954 as; “The RBE 
of some test radiation (r) compared with X-rays is defined by the ratio D250/Dr, where D250 and Dr 
are, respectively, the absorbed doses of 250 kV X-rays and the test radiation required for the equal 
biological effects” [38][39]. 
RBE =  
abosrbed dose of 250 kV X−ray
absorbed dose of test radiaiton 
   , required to produce equal biological effect             (Eq. 7) 
 
The RBE is an empirical value. The RBE-value obtained by an experiment is linked to that specific 
experiment and the conditions used. It is therefore not only dependent on the radiation quality, but 
also on experimental variables such as cell type, dose, dose rate, oxygenation status, and the 
biological endpoint used. Differences in the experimental setup between studies investigating the 
radiotoxicity of Auger emitters can therefore (at least partly) explain the variations in the RBE-values 
obtained [13]. 
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However, it is agreed that the radiotoxicity of Auger emitters is highly dependent on the location of 
the decay in respect to DNA. When the Auger emitter is incorporated into the DNA, such as when 
using 125IUdR, the RBE-value is considered to be around 7. However, values between 2 and 20 have 
also been reported. In contrast, when the Auger emitter is not incorporated into the DNA, but still in 
close proximity to it (e.g. intercalated), the RBE-value is considered to be around 4. Auger emitters 
located in the cytoplasm or outside the cells, is thought the be much less radiotoxic with RBE-values 
around 1 [21][40].  
The high radiotoxicity of Auger emitters (located close to the DNA) is thought to be caused by the 
simultaneous release of several low energy electrons. In the case where the Auger emitter is 
incorporated into the DNA, charge neutralisation is also thought to significantly contribute to the high 
RBE. Low energy electrons travel in contorted paths and deliver a considerable amount of energy in a 
very small volume. These low energy electrons only travel nanometres to micrometres, and can 
consequently deposits their energy close together. Monte-Carlo simulations have shown, that the 
energy deposited within 2 nm from a 125I decay site, and the free radicals species concentration 
around the decay, can exceed that of a 5 MeV alpha particle track passing the DNA. However the 
energy deposition density sharply decreases with distance from the decay site. This is thought to be 
the underlying reason for the dependency of RBE-values on the cellular location of the Auger 
emitter[15][21][41][42]. 
Beside the release of several electrons, the short range of these makes it possible to damage/kill only 
the targeted cells while sparing the neighbouring cells. The K-Auger electrons have a range in the 
micrometre order, while the electrons with the lowest energies, the Super Coster-Kronig have a range 
of only a few nanometres. This ability to only hit targeted cells is in sharp contrast to the 
radioisotopes currently used in the clinic where the collateral damage to the healthy tissue is of great 
concern, as it can limit the activity used and hence the dose to the tumour cells [15]. 
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 Linear Energy Transfer (LET) and RBE 2.2.2
Ionising radiation is often divided into high LET (e.g. heavy charge particles, alpha) and low LET (e.g. γ-
rays, X-rays) radiation also denoted densely- and sparsely ionising radiation respectively. LET stands 
for linear energy transfer and describes the average energy locally deposited to the medium per unit 
length of track. In other words it relates to the ionisation density of the track [38][43]. The unit used is 
keV/µm 
                                                                                LET =
dE
dl
                                                                          (Eq. 8) 
High LET radiation shows an increased biological effect compared to low LET radiation at similar 
absorbed doses. This increase in the biological response is due to the differences in the spatial pattern 
of ionisations and excitations event and ultimately in the pattern of DNA damage. Several DNA lesions 
close to each other can results in clustered and complex DNA damage, which is much more harmful to 
a cell than the same amount of DNA lesion well separated [6][44]. 
As the LET increases, the energy deposition per unit length of track and ionisations density increases, 
which result in an increased RBE. The RBE increases slowly with increasing LET up to a LET value of 10 
keV/µm. From here the increase in RBE with LET occurs more rapidly until it reaches a maximum at a 
LET of 100 keV/µm. Above this value the RBE decreases with increasing LET (Figure 2.4) [39]. 
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Figure 2.4 Relative biological effectiveness in relation to LET 
The relationship between RBE and LET, and the average distance between events by radiation with different LET values are 
shown. As illustrated in the figure a particle with a LET of 100 keV/µm will have two events separated by a distance 20 Å 
(which corresponding to the distance between the two DNA strands) and therefore have a high probability of producing a 
DNA DSB. In contrast, a particle with a LET of 200 keV/µm will (on average) have three events separated by the 20 Å. The 
particle with a LET of 200 keV/µm will deposits more energy, but will not cause a proportional higher biological response.  
As absorbed dose is incorporated in the RBE, the RBE of the particle with a LET 200 keV/µm will be lower than the RBE of a 
particle with a LET of 100 keV/µm. Figure is taken from [39]. 
 
The LET value of 100 keV/µm corresponds to two ionisation events separated on average by a 
distance of 20 Å -the diameter of the DNA helix. It is thought that radiation with this LET is most 
efficient in producing DNA double strand breaks (DSBs). Radiation with LET values above 100 KeV/µm 
will also produce DNA DSBs. However as the absorbed dose is incorporated into the RBE-value, energy 
will be “wasted” in additional ionisations that do not cause a proportional increase in biological effect 
[39].   
  
Background 
 32 
 Mechanisms of DNA damage 2.2.3
Ionising radiation mainly causes DNA damage by two mechanisms; direct action and indirect action. 
For photons it is of course the secondary electrons that are involved in the interactions. In direct 
action the ionising radiation interacts directly with the target (DNA). In indirect action the ionising 
radiation interacts with a molecule other than the DNA. As cells consist mainly of water the radiation 
will very often produce free radicals in the process of water radiolysis. These free radicals then 
interact with the DNA causing DNA damage. The primary free radicals are eaq, OH
. and H. 
[43][6](Figure 2.5). 
 
Figure 2.5 Representation of the direct and indirect action of DNA damage by ionising radiation 
Ionising radiation can produce DNA damage by different mechanisms. An ejected electron can either ionise the DNA 
directly (direct action), or it can produce free radicals by radiolysis, which then interact with the DNA, resulting in DNA 
damage (indirect action). Figure is taken from [39] 
 
Which of these two processes (direct and indirect) that dominates, depends on the LET of the 
radiation. For high LET radiation the direct action dominates, while for low LET radiation the indirect 
action is dominant. Auger emitters can also produce DNA damage by a third mechanism called charge 
neutralization [43]. During the Auger cascade several electrons are released, leaving the atom highly 
charged. If the Auger emitter is incorporated into the DNA (as when using covalently labelled DNA 
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bases with 125I) electrons from surrounding molecules (the DNA) will be transferred to the Auger 
emitter, leaving the donor molecules ionised. In addition DNA damage can be caused by the recoil 
energy and chemical transmutations [45]. However these last two processes are not thought to be 
contributing significantly to the radiotoxicity of ionising radiation. The dominant mechanism behind 
DNA damage by Auger decays depends on the location of the decays in relation to the DNA. If the 
Auger emitter is incorporated into the DNA, charge neutralisation and direct action have been found 
to be the dominating actions. In contrast, if the Auger emitter is located just a few Angstroms to few 
nanometres away, most of the DNA damage is produced by indirect actions [28][46][47]. 
 
 Clustered and complex DNA damage and repair 2.2.4
DNA damage caused by ionising radiation can be divided into base damage, single strand breaks 
(SSBs) and double strand breaks (DSBs). Because of the relatively simple nature and effective repair of 
base damage and single strand breaks, these are thought not to be particularly harmful to the cell. In 
contrast double strand breaks are thought to be the main contributor to cytotoxicity and the amount 
of DSBs are sometimes used to predict the biological response and the severity of a treatment [48]. 
However, this view is too simplistic. Several DNA lesions occurring close to each other produce 
clustered and/or complex DNA damage. These types of DNA damage have been shown to be highly 
detrimental to a cell (Figure 2.6).  The term clustered DNA damage or locally multiple damage sites 
(LMDS) was introduced by Ward in 1981. The term sought to explain an underlying reason for a 
disproportionally high biological response in comparison to the amount of DSBs observed [49][50]. 
Clustered DNA damage is defined as two or more lesion within one or two helical turns, made by a 
single track. The complexity of the damage depends on the number of lesion within the cluster. These 
lesions can be of different nature (e.g. DSB, SSB, base damage, cross linking). Clustered DNA damage 
can be divided into DSB-clustered DNA damage and non-DSB-clustered DNA damage [51] [52].   
 
Background 
 34 
 
Figure 2.6 Clustered and complex DNA damage  
The spatial distribution of DNA damage is important for the biological response. In the figure, both pieces of DNA have 2 
DNA lesions created by 8 events (ionisation or excitation). However the DNA lesions produced by the high LET are in close 
proximity to each other, resulting in clustered DNA damage, while the 2 lesions created by the low LET radiation are well 
separated. The DNA lesions produced by the high LET radiation will be more difficult to repair, and consequently more 
detrimental to the cell. Figure is taken from [53] 
 
The increased biological effect of clustered DNA damage is thought to be a result of poor or error-
prone repair [50]. DSB are repaired through one of the two main repair pathways; Homologues 
recombination repair (HRR) and non-homologues end joining (NHEJ). HRR can only take place during 
the late S-phase and in G2-phase where a full replicate of the chromatid is present. HHR uses this 
sister chromatid as a template and is therefore relatively error-free but slow. In contrast, NHEJ repair 
process can be utilized in all the cell cycle phases. As no template is needed (for NHEJ), the repair 
process is fast but error-prone [48]. Base damage is repaired by the base excision repair (BER) 
pathway, where either a single nucleotide is removed (short patch BER) or several nucleotides are 
removed (long-patch BER). DNA SSBs are repaired through a fast single strand break repair (SSBR) 
process, which involves the last steps of the BER. The repair of these types of DNA damages can use 
the opposing strand as a template and the DNA lesions are therefore effectively repaired [54][55]. 
When base damage and SSBs are located within a cluster (of DNA lesions), the repair of these DNA 
damages is less efficient.  When multiple types of DNA lesions are located in a cluster, the DNA 
damaging repair mechanisms used for each lesion must interplay, which might affect the repair 
efficiency.  The severity of this reduction in repair efficiency is dependent on the complexity of the 
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cluster; number of lesions, inter-lesion separation and the types of lesions present [44]. A hierarchy 
between the DNA lesions exist, and so the DSBs and SSBs within a cluster will be repaired before base 
damages. In addition, the first base lesion encountered in a cluster will be repaired before the next 
occurring base damage. The reduced repair efficiency can result in an increase in the life-time of the 
clustered lesion (up to 8 hours compared to single lesion) and increase the risk of error-prone repair. 
Moreover, during the repair of base lesions and SSBs present in a cluster, de novo DSBs can be 
generated. It has been estimated that 10 % of non-DSB clustered lesions is converted into DSB 
clustered lesions during repair processing [44][56][57].    
The amount of clustered DNA lesions and the complexity of these lesions increase with the LET of the 
radiation. 30-40 % of DSBs induced by low LET radiation are found to be complex while for high LET 
radiation the fraction has been found to be up to 90 % [51] [58]. This increase with LET is quite 
intuitive as a higher ionisation density will have a higher probability of creating multiple DNA lesions 
in close proximity to each other. Moreover, the repair of DNA damage induced by high LET and high 
LET –like radiation shows a considerably decrease in repair efficiency compared to DNA damage 
produced by low LET radiation [59] [60] [61].  
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Figure 2.7 Relationship between cell survival and LET 
Typical survival curves for cells exposed to radiation with increasing LET is showed. The survival curve for X-ray exposed 
cells shows a typical shoulder, representing repair of sub-lethal DNA damage. As the LET increases, the size of the shoulder 
decreases and for cells exposed to alpha radiation (high LET), no shoulder is evident. Figure is taken from [39] 
 
The high induction of clustered DNA damage with the subsequently reduced repair is also evident in 
survival curves. The typical shoulder seen in cell survival curves when cells are exposed to low LET 
radiation represents repair of sublethal DNA damage. This shoulder is getting smaller as the LET of the 
radiation increases (Figure 2.7). For Auger emitters the shape of the survival curve is not yet fully 
determined and reported survival curves reflect both high LET- and low LET like behaviour 
[62][63][22]. However, the current view  is that Auger emitters covalently bound to DNA produce 
survival curves with no shoulder, while Auger emitters, that are not covalently bound to the DNA can 
exhibit survival curves with and without shoulders [28]. 
 
 Cell cycle arrest and sensitivity 2.2.5
The cell cycle consists of four phases; G1-phase, S-phase, G2-phase and M-phase. Between the 
different cell cycle phases are checkpoints. These checkpoints are controlled by cyclin and cyclin-
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dependent kinases and control, that (DNA) damaged cells do not progress through the cell cycle. The 
check points between the G1/S -phase and the G2/M –phase completely arrest the cells, while the 
intra S-phase the check point just slows down the progression through the phase so the cell gets time 
to repair their DNA damage [64].  
In response to DNA damage, a mechanism called DNA Damage Response (DDR) is activated. This 
consists of a complex signalling network, which activates several pathways involved in DNA repair, 
transcription, cell cycle checkpoints, and apoptosis. Several of the main proteins in this network are 
not confined to a single pathway, but can be involved in several of them (BRACA1, 53BP1, etc.). Two 
main players in the DDR are ATM and ATR. These are involved in the G1/S, intra S-phase check point 
and the G2/M check point, and through several mediators (53BP1, BRACA1), transducers (Chk1/2) and 
effectors (p53), they try to retain the cell in cell cycle arrest. The proteins p53 and BRACA1 are 
especially important in the DDR response and cells lacking a functional copy of one of them often 
transform into cancerous cells [48][65].  
The sensitivity of a cell for radiation varies between cell cycle phases. The cell is most sensitive in the 
mitotic phase and most resistant in the last part of the S phase. The G2 phase often shows a high 
sensitivity too, while the G1 phase shows intermediate sensitivity. If the G1 phase is long, as for HeLa 
cells, the G1 can be divided into a resistant period in the beginning and a more sensitive period in the 
end [66] (Figure 2.8). 
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Figure 2.8 Representation of radiation sensitivity of cells in the different cell cycle phases 
The sensitivity to ionising radiations varies between cells cycles phases. The G2-phase and the M-phase is thought to be the 
most radiation sensitive, while the late S-phase is the most radiation resistant. This difference is thought to be related to 
the DNA damaging repair pathways available and the chromatin structure in the different phases. Figure is modified from 
[67] 
 
The difference in sensitivity between the cell cycle phases is not well understood, but several factors 
are known to play a role. The S-phase is the most radiation resistant. Indeed, if DNA replication has 
taken place, DNA damage can be repaired through homologue recombination, which is less prone to 
errors (than non-homologue end joining).  However, this does not explain why the G2 phase is 
radiosensitive. Another parameter that could play a role in the sensitivity to radiation of the different 
cell cycle phases, is the topology of the chromatin structure. The DNA in the G1 phase has a very open 
chromatin structure, which gives relatively easy access for the repair proteins to the DNA lesion. In 
contrast, the chromatin structure in G2/M is compact, which could result in less efficient repair and 
consequently a higher sensitivity. Although the underlying mechanisms for the differences in radiation 
sensitivity between the different cell cycle phases are not fully understood, this feature is still one of 
the basic ideas underlying fractionation in the clinic [66][68].  
The G1/S checkpoint is a sensitive but slow process. Cells have been observed to enter the S-phase 
even after high doses of radiation. Cells irradiated in the G1-phase might enter the S-phase even with 
a high amount of DNA damage. However, if the G1/S check point is fully activated it is very sensitive. 
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This could be an explanation for the division of G1-phase into a radiation resistant and a more 
radiation sensitive period [64].    
The G2/M checkpoint is passed relatively fast, and has a low sensitivity to DNA damage. Only at high 
absorbed doses does the check point succeed in arresting all the damaged cells. Still, the check point 
does not managed to arrest the cells until all the DNA damage has been repaired, but releases them 
when a small amout of DNA damage are still present. Cells can therefore enter the mitotic phase with 
unrepaired DNA damage [64].    
If the DNA damage is too severe to be properly repaired, the cell can go into senescence, where it 
loses its ability to divide but maintain its normal functions, or it can go into apoptosis. Proteins 
involved in senescence are generally also part of the DNA damage response and cell cycle check 
points. These include p53 and the retinoblastomas protein (pRb)[69][70]. 
 
 Dose rate effects & inverse dose rate effects 2.2.6
The rate at which the radiation is deposited is called the dose rate and has the unit Gy/Sec or more 
practically for internal radiation Gy/h. Especially for low LET radiation, the dose rate is an important 
factor for the biological response . In general the lower the dose rate, the lower the biological effect. 
When cells are exposed to low dose rates, they will have time and capacity to repair the sublethal 
DNA damage and thereby avoid acummulations of DNA lesions [20]. 
However a phenomenon called the inverse dose rate effect has been observed. Here lowering the  
dose rate will decrease cell survival, and can be just as effective as an acute exposure [71][20]. If the 
dose rate is low the cell will not be arrested in the G1-phase, but can continue into the G2-phase 
where it will be arrested. At a continuous low dose rate,  a normal asynchronous cell population can 
thereby become a synchronous cell population, all arrested in the radiation sensitive G2-phase. Due 
the increased radiation sensitivity of cells in this phase, the exposure will results in a higher cell killing 
compared to an asynchrome cell populations [20]. The inverse dose rate effect seems to be more 
pronounced when cells are exposed to high LET radiation. The mechanims for this inverse dose rate 
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effect is not fully understood, but thought to be a results of a complex interaction of dose, dose rate 
and radiation quality and might be related to exposure of cells in the different cell cycle phases 
[72][73]. 
 
 The oxygen effect 2.2.7
The indirect action of DNA damage is mediated by free radicals. These free radicals can interact with 
the DNA and turn it into a DNA radical. If the area is hypoxic (reducing) the DNA can be restored by 
reduction by a sulfhydryl (SH) group. However, if oxygen (O2) is present the DNA radical will interact 
with the oxygen and become oxidized (DNA-O2). This DNA derivate cannot be chemically restored and 
are therefore said to be “fixed”. These “fixed” DNA lesions are very difficult to repair. This is the 
underlying mechanism of the oxygen effect, and the increased resistant to radiation observed in 
hypoxic tumours (Figure 2.9) [74]. 
 
 
Figure 2.9 Mechaisnm of the oxygen effect. 
 
In the presence of O2 DNA radicals created by free radiacals can become oxidized to produced DNA-O2. This type of DNA 
damage cannot be chemically repair and are therefore referred to as “fixed”.      
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The ratio between the absorbed doses needed to achieve the same biological effect under hypoxic 
and aerated conditions is called the oxygen enhancement ratio (OER)  
 
 OER =  
absorbed dose under hypoxic condition
absorbed dose under aerated  conditions
   , required to produce equal biological effect            (Eq. 9) 
 
For high abosrbed doses of low LET radiation, the OER are typically around 2.5 to 3, while for high LET 
radiation (alpha) it is close to 1. In contrast to low LET radiaiton, of which most DNA lesions are 
produced by free radicals (indirect action), the dominant mechaims for high LET radiation is direct 
action [39]. 
Not many experiments have investigated the oxygen effect for Auger emitter decays. However an 
OER around 1 have been found for 125I incorporated into DNA [75][76]. The oxygen fixation hypothesis 
is dependent on the indirect action. With this low OER for Auger emitters, it could be thought that 
Auger emitters mainly produce DNA damage by direct action or charge neutralisation.  However the 
OER of Auger decays could, like the RBE, be dependent on the distance between the decay site and 
the DNA. 
 
2.3 Dosimetry 
The term dosimetry used in the field of health and medical physics, is the calculation or measurement 
of absorbed dose in the human body or other biological entity. The absorbed dose is an essential 
component in the prediction of the effect of a radiation treatment, the risk assessment associated 
with a diagnostic procedure (in nuclear medicine) or after exposure to ionising radiation in 
circumstances relevant for radiation protection.  
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 Internal Radiation Dosimetry 2.3.1
In 1965 the MIRD (Medical Internal Radiation Dose) Committee was established in order to develop a 
unified approach to calculate absorbed doses to organs from internal distributed radionuclides during 
diagnostic procedures. This resulted in the publication of MIRD Pamphlet No. 1 which was published 
in 1968. It was later revised (1976) and re-published in 1988 and 1991.  In 2009 the MIRD Pamphlet 
No. 21 was publish with the aim of standardizing the nomenclature within nuclear medicine and 
radiation protection and adopting the dosimetric quantities;  “equivalent dose” and “effective dose” 
formulated by the International Commission of Radiological Protection (ICRP) [77].  
The medical internal radiation dose (MIRD) committee has developed a general formalism for 
calculating the mean absorbed dose (D̅k) to the target (𝑟𝑘) from the source (rh): 
 
?̅?(𝑟𝑘 ← 𝑟ℎ) = ?̃?ℎ𝑆(𝑟𝑘 ← 𝑟ℎ)                 (Eq. 10) 
           
Ãh being the cumulated activity (total number of decays) in the source region (rh) and S the absorbed 
dose to the target region per unit cumulated activity in the source region [78]. 
S is defined as  
                                                          𝑆(𝑟𝑘 ← 𝑟ℎ) = ∑
∆𝑖∅𝑖(𝑟𝑘←𝑟ℎ)
𝑚𝑘
𝑖                                      (Eq. 11) 
 
∆i being the mean energy emitted per nuclear transition, øi the fraction of energy emitted by the 
source region that is absorbed in the target region for the ith radiation component, and mkthe mass of 
the target region. Ø depends on the quality and energy of the radiation plus the volume and 
composition of the target and its distance to the source [78]. This formalism was developed by MIRD 
to calculate absorbed doses to organs during diagnostic procedures and Ø for several organ pairs 
(source & target) has therefore been calculated and tabulated using a standard human model [77] 
[79] (Figure 2.10).  It is only recently that MIRD has moved from a very “schematic” standard human 
model composed of boxes, spheres and cones into the present “anatomical” model. The MIRD cellular 
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model described below can still be seen as a very primitive “non biological” model, far from real 
biological variation.  
  
 
Figure 2.10 Representation of the standard human model 
Figure taken from [80] 
 
In parallel the ICRP established guidelines regarding risk estimation for stochastic effects (cancer and 
hereditary effects). These guidelines also involved calculations of the absorbed dose using similar 
principles as MIRD and differs more in nomenclature than in substance. The ICRP established the 
concepts equivalent dose and effective dose (later adopted by MIRD) relating the radiation quality 
and tissue “sensitivity” respectively to the absorbed dose and to the risk of stochastic effects.  To get 
the equivalent dose, the absorbed dose is multiplied by the radiation weighting factor (wR) [77].  
 
Equivalent dose = Absorbed dose ∗  𝑤R                            (Eq. 12) 
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The radiation weighting factor is based on relevant RBE-values for stochastic effects and is 
conservatively set by the ICRP. The wR can therefore NOT be used to estimate deterministic effect as 
it might (in such case) result in an overestimation of occurrence and severity.  The wR is set to 1 for 
electrons and (hence) photons, 20 for α-particles and is energy dependent for neutrons. The current 
recommendation regarding radiation weighting factors for Auger emitters is that a wR of 20 or more is 
appropriate if the Auger emitter is incorporated into the DNA and that a wR for Auger emitters more 
uniformly distributed should be addressed in the future. The ICRP states that the effect of Auger 
electrons should be assessed by microdosimetry, even though several “issues” related to 
microdosimetric calculations exist, and no recommendation for how this assessment should be 
performed has been given [13][77]. However the American Association of Physicists in Medicine has 
proposed an alternative approach for estimating equivalent doses for Auger emitters. As the decay 
scheme for different Auger emitters are so diverse, a wR should ideally be ascribed to each 
individually Auger emitter [15][16]. Using the equation below (eq.13) the equivalent dose to an organ 
(𝐻𝑇.𝑅𝐴𝑢𝑔𝑒𝑟) from Auger emitters taken into account its subcellular distribution.   
 
HT.RAuger  = [1 + f0(WRAuger − 1)] ∑ DT.RAuger
RAuger
            (Eq. 13) 
 
𝑤𝑅 being the radiation weighing factor (for stochastics effect) for Auger electrons only, 𝑓0 the fraction 
of organ activity that is bound to the DNA and 𝐷𝑇.𝑅 the mean absorbed dose from radiation 𝑅𝐴𝑢𝑔𝑒𝑟 
[15][16]. 
 
The effective dose incorporates the sensitivity of a given organ or tissue to radiation. To get the 
effective dose, the equivalent dose is multiplied by the tissue weighting factor (wT).  
 
                                                  Effective dose = Equivalent dose ∗  𝑤T                   (Eq. 14) 
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The tissue weighting factor states the relative risk of stochastic effects in the giving organ or tissue 
compared to the whole body. The sum of all the tissue weighting factors is therefore 1. The effective 
dose for the organs/tissue irradiated, can be summed to give the effective dose for the whole body 
[77]. 
 
 Cellular dosimetry 2.3.2
During the 1970’es the special problem of the Auger-cascade in dosimetry and in estimations of the 
biological effects became clear to many medical physicists. While diagnostic nuclear medicine at that 
time focused on the nuclear emissions of gamma rays for imaging, it now became clear that many 
diagnostically important isotopes (99mTc, 123I and 111In) had strong Auger emissions. Also, as targeted 
radionuclide therapy developed through better bio-vectors and better understanding of the targeting 
problem in vivo, more precise dosimetry at the cellular level was needed for better prediction of 
biological effect and risk assessment. This was especially relevant for “radiation” with ranges on the 
cellular scale. Obviously, for some radiation types and energies (e.g. Auger electrons) the range are so 
short that dosimetry on a cellular level is needed. For that reason the MIRD S-value formalism was 
extended to treat the cellular dosimetry [17]. 
 
 Cellular S-values 2.3.2.1
The principal behind the MIRD absorbed dose calculations on the organ and cellular level are the 
same [78]. The cellular S-value is still defined by;  
𝑆(𝑟𝑘 ← 𝑟ℎ) = ∑
∆𝑖∅𝑖(𝑟𝑘←𝑟ℎ)
𝑚𝑘
𝑖                      (Eq. 15) 
However the absorbed fraction (∅(𝑟𝑘 ← 𝑟ℎ)) has now incorporated a geometrical reduction factor 
(GRF) and electron stopping powers; 
  
∅(rk ← rh) = ∫ Ψrk←rh
∞
0
(x)
1
Ei
dE
dX
|X(Ei)-X  dX                    (Eq. 16) 
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𝐸𝑖 being the initial energy of the 𝑖
th particle, 𝛹𝑟𝑘←𝑟ℎ(𝑋) the geometrical reduction factor and 
 
1
𝐸𝑖
𝑑𝐸
𝑑𝑋
|X(Ei)-X 𝑑𝑋 is the stopping power evaluated at  X(Ei). The geometrical reduction factor is the mean 
probability that a randomly directed vector of length (𝑋) from a random point in the source region 
will end within the target region. The value of the geometrical reduction factor depends on the length 
X, the geometrical shape of the source and target regions and their dimensions [77][78]. 
 
As the calculation of GRF is complex, only cellular S-values for simple geometrical shapes (spheres and 
ellipsoids) have been calculated by MIRD. The geometrical shape of the cell is customary assumed to 
be two concentric spheres. The radionuclide is assumed to be evenly distributed within one of the 
source compartments: whole cell (C), cell surface (CS) cytoplasm (Cy) or nucleus (N). Cellular S-values 
for monoenergetic electrons (1 keV to 1 MeV), for alpha particles and for the continuous electron 
spectrum emitted from certain radionuclides have been calculated using either the nucleus or the 
whole cell as target region. The calculation has been done for various combinations of cell sizes (Rc 3-
10 µm) and nucleus sizes (RN 1-9 µm). Surprisingly, cellular S-values for the combination of whole cell 
as source and nucleus as target (S(N←C)) is missing [17][18]. The MIRD publication states that when 
the source compartment constitutes more than one of the above mentioned compartments, the S-
values can be found by multiplying the cellular S-values (that in combination gives the source and 
target combinations, you seek) with the fraction of the total radioactivity present in their source 
compartment. [17] 
 
    D̅N =  ÃC [fN S(N ← N) +  fCy S(N ← Cy)]               (Eq. 17) 
 
The “missing” cellular S-values for 131Cs with the combination of whole cell as source and nucleus as 
target (S(N←C)), have been calculated and is shown in appendix 8.2.1 p. 196. 
  
While the geometrical reduction factors (GRF) are just a computational problem (the GRFs have only 
been tabulated for a very limited set of cellular sizes and geometries), the need for a correct electron 
stopping power is a true physics problem. The electrons do not move in straight paths, and especially 
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low energy (few keVs) electrons will have a very twisted and bent track. Standard Continuously 
Slowing Down Approximations (CSDA) for the electron stopping cannot be used to calculate the 
absorbed dose distribution around a hypothetical point source of monoenergetic electrons in the low 
range [81]. The MIRD cellular S-values authors turned to an experimental solution. They based their 
“electron stopping powers” recommendation on an extended experimental set of measurements 
published by Author Cole  [18][82]. Cole actually measured the penetration depth of monoenergetic 
electrons in plastic (placeholder for water or tissue), and gave polynomial approximations to the 
measured range versus energy.  This range versus energy polynomial can be inverted to formally give 
energy versus penetration depth expression, that has the dimension of stopping power and look like a 
stopping power [82]. It is this expression of “electron stopping power” that the MIRD cellular S-value 
publication endorses for cellular dosimetry [18]. 
 
The tabulated MIRD cellular S-value states the mean absorbed dose to the target (cell or nucleus). 
This means that in a given cell population, some of the cells will have been exposed to a higher 
absorbed dose, while other will have been exposed to a lower absorbed dose. This variation in 
absorbed dose is caused by heterogeneity in the cell population, in cellular and nuclear sizes and 
shapes and in differences in their uptake of the radioisotope as well as stochastic effects related to 
energy deposition. This is important to keep in mind especially if the uptake of the radioisotope varies 
a lot between the cells. This variation is an additional complication in the dosimetry and should ideally 
be taken into account as well as the true microdosimetric variation (see section 2.3.3 p. 49).  
 
The tabulated cellular S-values are, as said, calculated for cells with the geometry of two concentric 
spheres. However this geometry is not always a suitable representation of a cell. Cellular S-values for 
cells with the geometry of two concentric ellipsoids have therefore also been calculated for a limited 
set of electron energies and compared to the cellular S-values with the standard geometry (spherical) 
(Figure 2.11 & Figure 2.12). The comparisons were done for monoenergetic electrons with four 
different energies and for two ellipsoids geometries [17]. 
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Figure 2.11 Geometries of the two ellipsoids used for the MIRD Cellular S-values, for non-spherical cells  
For ellipsoids 1, the semi-axes of the whole cell in the x,y and z direction are 12.5 µm, 5 µm and 2 µm respectively, while the 
semi-axes (x, y, z) of the nucleus are 8 µm, 4 µm and 2 µm. For ellipsoid 2, the semi- axes of the whole cell are 10 µm, 5 µm 
and 2.5 µm, while the semi-axes for the nucleus are 8 µm, 4 µm and 2 µm. The total volume of these two ellipsoids 
geometry equals that of a sphere with a cell diameter of 10 µm and a nuclear diameter of 8 µm [17].  
 
 
 
Figure 2.12 Comparison of MIRD Cellular S-values for two different geometries (spherical & ellipsoid) 
Table taken from [17] 
 
When the “electrons” were “located” on the cells surface the cellular S-values were higher for the 
cells with the ellipsoid geometry, while the cellular S-values were higher for the cells with the 
spherical geometry when the “electrons” were “located” inside the cell. When the ”electrons” were 
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“located” in the nucleus the change in geometry did not change the cellular S-values considerably. 
The difference in the cellular S-values was especially high when the energy of the electrons was low, 
the they were “located” on the cells surface and the ellipsoid was very elongated [17]. The stated 
variability between the cellular S-values demonstrates how important it is to take the actual realistic 
cellular and nuclear geometries into account if precise absorbed doses are to be calculated. 
 
 Microdosimetry 2.3.3
The need for microdosimetry relates to the stochastic nature of energy deposition by ionising 
radiation. As ionising radiation traverse matter, it interacts and deposits energy in a discontinuous 
way. In contrast to the conventional dosimetry where these fluctuations in energy deposition can be 
ignored (due to the high number of events) they cannot be neglected in microdosimetry. Therefore 
microdosimetry must utilize the probability distribution of energy deposition, instead of the average 
energy deposition used in conventional dosimetry [83]. This raises the need for some new quantities 
substituting the macrodosimetric quantities “absorbed dose” and “LET” with their stochastic 
equivalents; the specific dose (𝑧) and lineal energy (𝑦) [84].  The specific dose is defined as the energy 
imparted (𝜀) by one or more events in a volume of mass (m) and has the unit Gy; 
𝒛 =
𝜺
𝒎
                  (Eq. 18) 
The lineal energy (𝑦) is defined as the energy imparted in a given volume by a single energy 
deposition event (𝜀𝑠), divided by the mean chord length (𝑙)̅ of that volume and has the unit keV/µm; 
𝐲 =  
𝛆𝐬
𝐥̅
                (Eq. 19) 
During the Auger cascade, several low energy electrons (Auger, CK and SCK), with very different 
energies are released. In contrast to cellular dosimetry, where the K-and L-Auger electrons (being the 
most energetic) are the ones that almost exclusively contribute to the calculated absorbed dose, it is 
the very low energy electrons (higher shell Auger electrons, CK and SCK) that are of most interest in 
microdosimetry [85].Due to the very short range (in the order of nm) of these very low energy 
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electrons, their contorted paths and especially their multiplicity, the energy deposition density near 
the decay site of an Auger emitter can be very high and equivalent to that of an alpha particle [42]. 
Microdosimetry of Auger emitters deals with these very low energy electrons and their “track 
structures”, in order to predict/estimate and understand the biological effect of Auger emitter decays 
[85].  
The official recommendation from ICRP in assessing the effect of Auger electrons is explicitly to use 
microdosimetry. However, no official recommendation on how this assessment should be performed 
has been given [13]. This is a problem as there are several parameters needed for the microdosimetric 
calculations for these special Auger emitters, for which the details are not know. As an Auger emitter 
decays, several low energy electrons are released. As these electrons and their tracks are correlated 
in time and space they constitute a single event. However the number of electrons and their 
respective energies released per single decay, has not been mapped. Several energy spectrums for 
different Auger emitters have been calculated, but these are all obtained as averages from several 
thousands of decays and do not contain information of the distribution of the actual number of 
electrons and their energies in the individual decay. Equally important is the lack of knowledge on the 
possible angular correlations between the emitted electrons ([85] [86]and personal communication 
with prof. Mikael Jensen). Another issue relates to the size of the target. In cellular dosimetry the cell 
nucleus in often considered to be the target (as it contains the DNA) and its mass therefore used for 
the absorbed dose calculations. However, as is evident by the RBE >1 for high LET radiation, the “real” 
target must be smaller than the nucleus [87].  For microdosimetry, a more accurate representation of 
the target (the DNA) must therefore be used. This is however not easy, as the DNA is highly organized 
in a complex chromatin structure. The DNA double helix has a diameter of about 2 nm, but is wrapped 
around histones (with a diameter of 11 nm), which in turn makes up a nucleosome cluster (with a 
diameter of 30 nm), that again is packed in 300 nm sized sections. The size of the “real” target that 
should be used in the microdosimetric calculations is therefore not obvious [87][88]. Unfortunately, 
these unresolved questions hinder “true” microdosimetric calculations of the precise energy 
deposition density and hence microscopic dose calculation for Auger decays.  
Background 
 51 
 
 
Figure 2.13 Monte Carlo simulations of the position of reactive species produced by Auger emitter decays 
The initial positions of reactive chemical species in relation to the DNA double helix, produced by the decay (of a 
representative cascade) of different Auger emitters and by a passing (perpendicular) 5.3 MeV alpha particle. Figure taken 
from [42] 
 
Nevertheless, by using Monte Carlo codes, the localized energy deposition following the decay of an 
Auger emitter has been simulated. Figure 2.13 from [42] shows the localized energy deposition 
(illustrated by the position of the reactive chemical species) following the decay of the three Auger 
emitters (55Fe, 111In and 125I) and the passage of a 3.5 MeV alpha particle.  As can be seen, the energy 
deposition density after a 125I or 111In decay is comparable to that produced by the passing 3.5 MeV 
alpha particle, while the energy deposition density following a 55Fe decay much is smaller [42]. 
However, the decay of 55Fe only emits 5.1 Auger electrons (on average) per decay, while 125I and 111In 
on average emit 24.9 and 14.7 electrons per decay respectively [86] and so a much higher energy 
deposition density for 125I and 111In would also be expected. The figure clearly illustrates the potential 
of an Auger emitter (positioned very close to the DNA) to produced DNA damage comparable to that 
of an alpha particle. 
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Figure 2.14  Monte Carlo simulation of localized energy deposition 
Figure shows the localized energy deposition around the decay site of the Auger emitter 
125
I. The top curve shows the 
energy absorbed by 1 nm thick concentric spherical shells of unit density. The lower curve shows the average absorbed 
energy density with distance for the decays site. Note that an energy density of 10 eV/µm
3
 corresponds to a locally 
absorbed dose of 1.6 MGy. Figure & text taken from [63] & [89] 
 
Another calculation, now of the energy deposition density for 125I with increasing distance to the 
decay site has been given by Kassis and Sastry et al [63] and is pictured in Figure 2.14. As can be seen 
the energy density decreases rapidly with increasing distance to the decays site (in nm), illustrating 
the very short range of the lowest energy electrons (released from the 125I decay). This rapidly 
decrease in energy density can explain the difference in biological effect between Auger emitters 
incorporated into and intercalated with the DNA. It is noteworthy that the energy density, within the 
first few nanometres (~ 0-3 nm) from the decay site corresponds to an incredible high absorbed dose 
in the order of MGy [63].  
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2.4 Physical and biochemical characteristics of Caesium and 
131Cs 
 Physical characteristics 2.4.1
The alkali metal caesium has many radioactive isotopes, with a range of half-lives and emissions [25]. 
The highly published and rightfully feared radiotoxic fission product 137Cs with a 30 year half-life, is a 
good example of the combined effect of decay characteristics, chemical availability and biological 
uptake. It is well know that nuclear accidents (and bombs) have spread large activities of 137Cs into the 
biosphere, leading to continental scale food chain contamination and measurable human uptake. 
Because of the very large populations exposed, this more or less homogeneous internal radiation 
from 137Cs has been a major radiological concern after the major accidents at Chernobyl and 
Fukushima [90][91][92]. 
However, 137Cs like most of the other radioactive caesium isotopes, decay by particular beta emission 
and very often companied by strong gamma branches. This makes the 137Cs dosimetry simpler, and 
much less localised, and the intracellular distribution becomes unimportant because the ranges of all 
radiations are long compared to cell sizes. It is only the organ distribution that has been studied for 
such fission product [92].  
As we are interested in studying the isolated effect of the Auger cascade, the “standard” long half-life 
caesium isotopes 137Cs and 134Cs are not useful. They both have weak Auger branches, but the 
overwhelming part of the local and distant absorbed dose from these isotopes comes from radiation 
that is not localised at the cellular scale. 
131Cs is a rather unique isotope which turns out to suit our purpose well. It has a decent half-life 
(9.689 +/- 0.016 days [25]) making it easy to work with in the laboratory, easy to use for exposure, 
and making activity measurements possible at a not too stressing timetable. 
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131Cs decays by pure and absolutely gamma-silent electron capture directly to the ground state of 
131Xe. The only ionising radiation comes from the Auger cascade following the K-shell capture 
(dominating) and the competing X-ray emission [25]. 
The Auger yields and energy is tabulated in the NuDat 2.7 database [25]: 
Auger L  3.43 keV 79.7 % 
Auger K      24.6 keV   9.3 % 
Of course there are more Auger cascade electrons than these, but of much lower energy. There are 
strong branches of Coster-Kronig and Super Coster-Kronig electrons.The total electron emission 
multiplicity is unkown, but now estimated to be 10.1, with an average energy of 613 eV (personal 
communication with Quan Lee Boon, based on Monte Carlo calculations as described in his paper 
[93]) 
 
  
     
  
 
 
 
 
 
 
Figure 2.15 
131
Cs decay scheme.  
Data from NuDat 2.7 [25] 
 
The finer details and the lower energy branches of the 131Cs cascade are not at all important for our 
SC-value calculations (section 2.5 p. 57), where the above two branches (from NuDat 2.7) are more 
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than enough. However the knowledge that there are many more low energy electrons in the cascade 
is important, if there is more damage observed than the pure “absorbed dose” can account for. 
 
 Biochemical characteristics 2.4.2
As said, the release of 134Cs and 137Cs under nuclear accidents (and by nuclear bombs) lead to major 
radiological concerns including food chain contaminations. Due to the importance of microorganism 
in the biogeochemical cycle and primary production, forming the basis of all food chains, the cellular 
kinetics and biochemistry of caesium in microorganism, became of importance to human health and 
were therefore investigated.  Although microorganism (bacteria, algae and fungi) are very different 
from mammalian cells, the knowledge about the bio-kinetics of caesium in these organisms, has given 
some clues to the bio- kinetics of caesium in mammalian cells [91] [92]. Caesium is taken up and 
accumulated through similar routes as potassium in cyanobacteria [90], bacteria [94] algea [95]and 
fungi [91] and has also been shown to compete with potassium uptake in cells from higher organisms 
[96][97]. In human erythrocytes caesium has been found (in 1964) to be transported by an active 
pump, that also transported potassium and sodium [98]. This description of the pump sounds very 
familiar to the pump that today is called the Na+/K+-ATPase. 
 
 Homogenous distribution of caesium 2.4.2.1
As stated, caesium mimics potassium in biological settings and since they are both group 1 elements, 
the intracellular chemistry of caesium, might be similar to that of potassium.  They both have low first 
ionizations energies and therefore give off their valence electrons very easily. They also have a low 
tendency to form complexes with other ions, consequently making them highly soluble in water 
[91][99][100]. The difference between the extracellular and intracellular potassium concentration and 
its transport across the plasma membrane, form the basis for the electrochemical potential across the 
cell membrane [88]. In contrast to other metals involved in the biochemistry of cells, such as Zn2+ 
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(that form tightly bound complexes), potassium ions only form weak bindings to other biomolecules 
and exert its biological function primary as a charge carrier. As it is known that potassium  is an ion 
that is highly mobile in the cell, mainly unbound and exist in its ionic state and it is justified to assume 
that caesium, will also be freely moveable, unbound and inside the cell,  if it gets taken up as an ion. 
[91][99][100].   
To summarise, 131Cs is a pure Auger emitter which decays by electron capture (100%). It has a half-life 
of 9. 689 days, which is highly suitable for biological experiments.  It has been shown to mimic 
potassium in biological settings, and might be taken up by the cells through the Na+/K+-ATPase. Its 
alkali chemistry makes it unlikely to get incorporated into biological molecules and a homogenous 
distribution inside the cells can be assumed, if it gets taken up as an ion. 
All these characteristics make 131Cs an ideal radioisotope for investigating the radiotoxicity of 
intracellular Auger decays.  
131Cs is not commercially available and is seldom used as an open radioactive source. The production 
of pure 131Cs with high molar activity is difficult and the availability therefore limited. 
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2.5 Introduction to SC-values 
In this work I would like to introduce a new type of S-values, which I have chosen to name SC-values. 
In the results and discussion sections, I will talk more about these SC-values, which we have 
“developed” and used for this work. I will show results and discussed the difference between these 
SC-values and the MIRD cellular S-values (see section 2.3.2.1 p. 45) and the implications of using these 
SC-values. I will also show results, to back the statements I will make below. However, I would like 
already now to give a short description to these SC-values and their qualities.   
 
The SC-values have the unit Gy/(Bq*Sec)/pL. The SC-values are denoted with a subscript C, as they 
relate the activity concentration of the radioisotope to the absorbed dose. This is in contrast to the 
MIRD cellular S-values that use the total activity in a given cellular compartment to calculate the 
absorbed dose.  
The computation of SC-values uses the same “input” (“stopping power” ect.) as the MIRD cellular S-
values, but differs from them in two important ways; the assumed geometry and the unit. 
 
In order to be able to use these SC-values, the geometry has to be a relatively big cell layer (big, when 
compared to the range of the Auger electrons). In addition the radioisotope has to be homogeneously 
distributed throughout this cellular layer, both in the cytoplasm and the nuclei. However, if these 
requirements are met, there are benefits of using these SC-values instead of the MIRD cellular S-
values. 
  
First of all, our SC-values are almost independent of the cellular and cell nuclear sizes. This is a very big 
difference from the MIRD cellular S-values that are very sensitive to small changes in these. A change 
in the size of the nucleus of only 1 µm changed the tabulated cellular S-values on average by a factor 
2. Dependent on the precise geometry, this change varied from a factor 1.3 to 6.3 (for 131Cs S(N←C)) 
(for these cellular S-values see appendix  8.2.1 p. 196). Such a difference will accordingly, change the 
absorbed dose by the same factor. In sharp contrast, our SC-values only change with a few percent 
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over this range of nuclear sizes. In addition the shape of the cell and the nucleus is not important 
either. The concentric spheres model most often used by MIRD, does not fit the geometry of 
adherent cells. The ellipsoid geometry used in a few MIRD cellular S-value calculations comes 
somewhat closer to reality. However, every biologist having looked into a microscope knows that the 
shape of attached cells and the nuclei are diverse and very difficult (if not impossible) to model. Our 
SC-values do not depend on the shape and size of the nucleus and the individual cells, but only on the 
height of the cell layer. The only thing that these SC-values are dependent on is therefore the height of 
the cellular monolayer and the position of the nucleus in respect to the monolayer top and bottom.        
All this makes the SC-values robust to use and significantly decreases the uncertainty in absorbed dose 
calculations. This in turn, will considerably reduce the uncertainty in the RBE-values obtained for 
Auger emitter decays.   
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3. Materials & Methods 
3.1 Biological assays 
 The γH2AX assay 3.1.1
The γH2AX assay is widely used within the ionizing radiation field as a marker for DNA double strand 
break.  The DNA DSB is in contrast to other DNA lesion (base damage, single strand break) considered 
to be highly detrimental to the cell. This is due to the high risk of destabilization of the chromatin 
structure, sequence loss and incorrect repair. The amount of DNA DBS is therefore thought to be a 
good indicator for the severity of cellular damage and the radiotoxicity of an irradiation [48].    
As the name of the assay indicates the method involves the specific phosphorylation (γ) of the histone 
H2AX on the serine 139th residue. H2AX belong to the H2A histones that are one of the five histone 
families (H1/H5, H2A, H2B, H3 & H4) that together make up the nucleosome, the core unit, which the 
DNA double helix is wrapped around (Figure 3.1). The H2AX differs from the rest of the H2A histones, 
as it is the only one that is phosphorylated after DNA DSB formation. This is due to a highly conserved 
sequence of a serine 139th and a glutamine 140th, known as the SQ motif. The phosphorylated version 
of 139th serine on the H2AX (histone) is called γH2AX [101]. The amount of H2A histones, which are of 
the variant H2AX, varies between cell lines, constituting between 2-20 % of the total H2A histones. 
Dependent on the cell line and their fraction of H2AX histones the response observed after an 
irradiation can be more or less pronounced [102].  
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Figure 3.1 Representation of the nucleosome 
The DNA double helix (blue) is wrapped around the nucleosome. Each nucleosome consists of 8 histones (purple spheres), 
belonging to 5 different families. After the formation of a DNA DSB, the H2AX histone (belonging to the H2A family) gets 
phosphorylated and plays a crucial part in the DNA damage repair process. Figure taken from [103]     
 
Upon the formation of a DNA DSB, the serine 139th on the (nearby) H2AX is phosphorylated. This 
phosphorylation is carried out by the ATM/ATR and MRN complex, which have recognized the DNA 
DSB. The phosphorylation of the serine 139th is one of the first steps in the DNA damage repair 
process and serves to recruit mediators and repair proteins to the damaged site. To amplify the 
“signal”, the phosphorylation of H2AX then propagates to neighboring H2AX histones, and spread 
along the DNA resulting in several hundreds to thousands H2AX histones getting phosphorylated per 
DNA DSB. The phosphorylation of H2AX does not occur immediately after irradiation. Rather, the 
amount of detected γH2AX foci increases over the first 30-60 min until it peaks. Thereafter, as the 
DNA DSBs gets repaired, the γH2AX (foci) become dephosphorylated and the amount of γH2AX foci 
decreases [102] [104]. 
In the γH2AX assay, it is the cluster (foci) of phosphorylated Serine 139th that is detected using the 
immune-fluorescence technique. The γH2AX method does therefore not detect the DNA DSB directly 
but rather detects the initiation of the DNA DSB repair process (Figure 3.2).  
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Figure 3.2 Representation of the γH2AXimmunofluorescence technique 
The DNA represented by black lines is wrapped around the histones represented by grey cylinders. In step 1 a DNA DSB is 
produced by ionizing radiation. The ATM DNA-PK and MRN complex recognizes the DSB and phosphorylates the serine 
139
th
 on H2AX (step 2). In step 3, the phosphorylation (of H2AX) is propagated along the DNA, in order to amplify the 
signal. In step 4, the γH2AX focus is detected by fluorescent antibodies binding specific to the phosphorylated serine 139
th
. 
The γH2AX foci, can then be detected, counted and the fluorescence intensities measured. Figure modified from [105] 
 
 
The γH2AX assay used in this work was developed by Merck Millipore. The assay is provided as a kit 
produced to run on the “MUSE”, a small tabletop “flow cytometer” (Figure 3.3).  
1. 
2. 
3. 
4. 
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Figure 3.3 A picture of the “muse”, a small table top flowcytometer that was used to obtain the data in the γH2AX assay  
Figure taken from [106] 
 
Besides permeabilization- fixation and washing -buffers, the kit contains two fluorescent antibodies; 
anti-phospho-Histone H2A.X (Ser139)-Alexa Fluor®555 and an anti-Histone H2A.XPECy5 conjugated 
antibody. The former specifically recognizes the phosphorylated serine 139th on histone 2AX (γH2AX) 
and the latter recognizes the unphosphorylated H2AX.  
 
This assay measures the intensity of the two antibodies, representing the amount of phosphorylated 
and non-phosphorylated histone 2AX in each cell. It does not, as other γH2AX assays, count the 
number of γH2AX foci. 
The data is presented in a on a plot with arbitrary scales, representing the intensities of 
phosphorylated H2AX (γH2AX) (x-axis) and the non-phosphorylated H2AX (y-axis) (Figure 3.4. A, C). A 
“red dot” represents a cell. The threshold (represented as red lines) for cells to be included in the 
categories non-expressing, inactivated and activated can be set and modified manually after all test 
samples and control samples have been analyses. The results are also presented in a bar plot (Figure 
3.4. B, D) and in an excel table, stating the total cell number in each category. Before the analysis is 
run, a minimum cell size is chosen, and so, most cellular debris should have been excluded from the 
test.   
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Figure 3.4 Representation of the data analysis in the γH2AX assay used in this work 
The data is presented in a Cartesian coordinate system with arbitrary scales representing intensities of phosphorylated 
H2AX (γH2AX) (x-axis) and the non-phosphorylated H2AX (y-axis). Each red dot represents a cell. The cells are group into 
three categorized (inactivated, activated and non-expressing) based on their fluorescent intensities. The amount of cells in 
each group (in percentage) is given in a bar plot (B,D). The data presented in A & B shows the distribution of HeLa cells in a 
sample not exposed to any ionizing radiation. The data in C & D shows the distribution of cells in a sample, ~30 min after 
receiving 5Gy (γ-rays) from a Co
60
source, using a dose rate of 1.5 Gy/min. As can be seen the cells have moved to the right 
(along the x-axis) and a higher percentage of the cells now lie in the green area representing activated cells. 
A B 
C D 
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As the cell are exposed to higher doses of radiation, the cell population move to the right along the x-
axis indicating a higher amount of γH2AX-specific antibody binding and consequently more DNA DSBs. 
Sometimes the cell population is also observed to move up and down along the y-axis. 
   
In this assay the number γH2AX foci in each cell are not directly counted. Instead the fluorescent 
intensities of the two antibodies in each cell are measured, indicating the level/amount of DNA DSBs 
present. A threshold for the intensities of the antibodies are manually decided, and groups the cells 
into three categories; non-expressing, inactivated and activated cells.  
It is important to note, that the cells categorized as inactivated, will most likely still have DNA DSBs 
and γH2AX foci, however they will not have as many (or as big) as the cells categorized as activated 
cells. The cells categorized as non-expressing, are cells which did not bind “enough” of the two 
antibodies, representing a lack of Histone 2AX. This group should contain almost no cells.  
For more information see http://www.merckmillipore.com/DK/en/product/Muse-H2A.X-Activation-Dual-Detection-
Kit,MM_NF-MCH200101 
 
In the thesis, the results are presented as ƴH2AX response “fold over control level”, (as a function of 
absorbed dose) representing the percentage of cells categorized as activated in the test sample over 
the percentage of cells categorized as activated in the control sample;  
 
 
ƴH2AX response, fold over control level =  
% cells catagogrized as activated in test sample
% cells catagogrized as activated in control sample
           (Eq. 20) 
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 Clonogenic cell survival assay 3.1.2
The clonogenic cell survival assay was developed by Puck and Marcus in the 1950s to study the effect 
of ionizing radiation on cells and is still considered by many the golden standard [107]. The clonogenic 
cell survival assay is used to study the effect of a treatment or an insult on the reproductive capability 
of cells. The assay is simple and does not required special equipment, but still gives the most 
important information when investigating potential cancer therapies; whether a cell will be able to 
continuously proliferate or not. A cell that has lost its ability to continuously proliferate is said to have 
lost its reproductive integrity or to be reproductively dead [39].  
 
The mechanisms behind this loss of reproductive integrity are many incl. apoptosis, mitotic 
catastrophe and senescence.  A cell that is reproductively dead is therefore not necessarily dead. It 
can still have maintained its ability to synthesize proteins, and fulfill its normal function. It can even be 
able to divide a couple of times before this capability cease [39] [108]. In the clonogenic cell survival 
assay, a cell that is able to form a colony of at least 50 cells is considered to be clonogenic, and is 
thought to have maintained its ability to divide and proliferate.  
 
The clonogenic cell survival assay can be performed with both cells that grow attached or in 
suspension. The cells can be seeded either after or before the treatment. In the latter case, it is 
important to begin the treatment shortly after seeding (or after the cells have attached, if the cells 
grow adherent), so the cells will as little time as possible to divide. However in the case where the 
radioisotope is internalised or in other ways bound to the cells, the cells will also be exposed during 
the attachment phase, which might have an influence on the observed effect. 
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Figure 3.5 Representation of the clonogenic cell survival assay  
In step 1 the cells are exposed to different absorbed doses of ionizing radiation. Thereafter (step 2) an appropriate number 
of cells are seeded. Sometimes, however, the cells are seeded before they are exposed. In this work, the cells were exposed 
both before and after seeding, due to the intracellular location of the radioisotope. The appropriate amount of cells seeded 
is different for the different absorbed doses. The appropriate number is estimated based on the expected survival fraction. 
After the cells are seeded and exposed they are incubated for several days in order to form colonies (step 3).  The 
incubation time depends on the cell cycle time of the cell lines used. A group of cells (all originating from one cell) is defined 
as a colony if it consists of 50 cells or more. At the end of the incubation time, the number of colonies formed is counted 
(step 4) and the plating efficiency and survival fraction are calculated. Figure taken from [108]    
 
A schematic representation of the different steps in the assay can be seen in (Figure 3.5). Either 
before or after the exposure, an appropriate number of cells are seeded. The appropriate number of 
cells differs within the experiments, and is estimated based on the expected survival fraction (SF). 
Preferably ~100 colonies should be present in each sample. A control sample, where the cells have 
not been exposed to the treatment, but otherwise handled in the same way, is always prepared 
together with the test samples. The control is used to determine the plating efficiency. The plating 
efficiency (PE) can vary between experiments, and is used to correct for factors other than the 
radiation, that could have an influence on the clonogenic cell survival [109].  
 
 
 
1. 
2. 
3. 
4. 
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The plating efficiency (PE) is defined for the control sample as; 
 
PE =  
colonies counted 
number of cells plated 
              (Eq. 21) 
 
The survival fraction (SF) is defined as; 
SF =  
colonies counted 
number of cells plated x PE
              (Eq. 22) 
 
A survival curve represents the relationship between the survival fraction and the absorbed dose and 
is usually plotted on a semi-logarithmic plot. Dependent on the shape of the survival curve, the curve 
is fitted to the linear model ( 𝑦 = 𝑒−𝛼𝑥) or the linear quadratic model(𝑦 = 𝑒−(𝛼𝑥+𝛽𝑥
2)), where 𝑦 is 
the survival fraction and 𝑥 the absorbed dose [39].  
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3.2 Materials 
 Chemicals & Solutions 3.2.1
Accutase, StemPro, (cat#  A11105), (Gibco by Life Technologies, Brand owned and represented by 
Thermo-Fischer, NY, USA) (“ready to use solution”) 
AG 1x8 ion exchange material 200-400 mesh, Dowex© , supplied by Sigma Aldrich, St. Louis, MO, USA 
Americium-241 source, ISOTRAK calibration source, traceable to Deutsches kalibrerungs Dienst.  
Ammonium carbonate, p.a., ACS reagent, (Sigma Aldrich, St. Louis, MO, USA) 
Antibiotic Antimycotic Solution, (cat# A5955) (Sigma Aldrich, St. Louis, MO, USA) 
Barium-130, 49 % enriched,  as nitrate ( Supplied by ILL, Grenoble, France)  
Barium carbonate 99.999% pure on trace metal basis, (Sigma Aldrich, St. Louis, MO, USA) 
Bovine Albumin Fraction V Solution (BSA, 7.5% ) (cat# 15260-037) (Gibco by Life Technologies, Brand 
owned and represented by Thermo-Fischer, NY, USA) 
Crystal violet (Sigma-Aldrich, St. Louis, MO, USA) 
Dimethyl sulfoxide, anhydrous 99.9% (DMSO) (Cat # 27.685(Sigma-Aldrich, St. Louis, MO, USA) 
Dulbecco´s Modified Eagle´s Medium (DMEM) (cat# D6546), (Sigma Aldrich, St. Louis, MO, USA) 
EDTA (0.5 M), ultra-pure (Cat# 15575-038) (Invitrogen by Life Technologies, Grand Island, NY, USA) 
Fetal Bovine Serum (FBS) (Cat# F22442) (Sigma-Aldrich, St. Louis, MO, USA) 
Giemsa Stain, Modified Solution (cat# 48900) (Fluka Analytical by Sigma-Aldrich, St. Louis, MO, USA) 
Hank’s balanced salt solution (HBSS) (Cat# 14025-0.50)(Thermo Fisher Scientific, Waltham, MA, USA) 
Hoechst 33342 (Sigma-Aldrich, St. Louis, MO, USA) 
L-Glutamine (200 mM) (cat# G7513) (Sigma Aldrich, St. Louis, MO, USA) 
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Minimum Essential Medium Eagle (MEM), (cat# M2279), (Sigma Aldrich, St. Louis, MO, USA) 
MUSE kit:  H2A.X Activation Dual Detection Kit (Cat # MCH200101) (Merck Millipore, Billerica, MA, 
USA) 
Count & Viability Kit (Cat# MCH600103) (Merck Millipore, Billerica, MA, USA) 
Ouabain Octahydrate (Cat # 03125) (Sigma Aldrich, St. Louis, MO, USA) 
Phosphate buffered saline (PBS) 10x (Cat # P5493)(Sigma-Aldrich, St. Louis, MO, USA) 
Scintillation fluid Ultima Gold (cCat # 6013329) (Perkin Elmer, Waltham, MA, USA) 
Trypsin, 2.5% (cat# 15090-046) (Gibco by Thermo Fisher Scientific, Waltham, MA, USA) 
Ultra pure water. FLUKA Trace Select Ultra Pure Water (via Sigma-Aldrich, St. Louis, MO, USA) 
Wheat Germ Agglutinin Sampler kit, Oregon Green® 488, Alexa Fluor® 488 conjugate (cat # W7024) 
(Thermo Fisher scientific , Waltham, MA, USA)  
  
 Cell culture medium  3.2.2
Freeze medium (HeLa): MEM medium, 14 % FBS, 7,8% DMSO   
Freeze medium (V79): 40% normal growth medium (DMEM), 50% FBS, 10% DMSO 
Growth medium (HeLa): DMEM medium supplemented with 10% FBS, 4 mM L-glutamine and 1% 
antibiotic antimycotic 
Growth medium (HeLa): MEM medium supplemented with 10% FBS, 4 mM L-glutamine and 1% 
antibiotic antimycotic  
Growth medium (V79): DMEM medium supplemented with 10% FBS, 4 mM L-glutamine and 1% 
antibiotic antimycotic 
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 Equipment & instruments 3.2.3
Centrifuge: Micro CL 17 (Thermo Fisher Scientific, Waltham, MA, USA) 
Cell culture microscope: Olympus CKX41 (Olympus, Tokyo, Japan) 
Confocal Laser Scanning Microscope LSM780 (Zeiss, Oberkochen, Germany) 
HP-GE X-ray spectroscope/detector (Canberra, now Mirion, Uppsala, Sweden) 
Incubator (calibration facility): Cell culture CO2 incubator Compact Midi 40 (VWR, Søborg, Denmark) 
Incubator (cell lab): Cell culture CO2 Incubator, model CCL-170B-8 (ESCO, Singapore) 
MUSE analyser (Merck Millipore Corporation, Billerica, MA, USA) 
Passive cooler with isopropanol (Nalgene by Thermo Fisher Scientific, Waltham, MA, USA) 
Sceptor 2.0 (Merck Millipore, Billerica, MA, USA) 
Scintillation Counter Hidex 300SL (Hidex, Turku, Finnland) 
 
 Software 3.2.4
GraphPad  Prism 7 (GraphPad Software, Inc. La Jolla, CA, USA) 
Matlab R2014b (Mathworks, Natick, MA, USA)  
Microsoft Excel 2010, with Data Analysis Tool Package. 
MUSE 1.4 cell analysis 
NuDat 2.7 database at Brookhaven National Laboratory (www.nndc.bnl.gov/nudat2/) 
Zeiss ZEN-light version 2.3 (Carl Zeiss, Microscopy GmbH, Jena, Germany) 
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 External radiation sources 3.2.5
Caesium-137:  
CANBERRA NUCOMAT UNIVERSAL CALIBRATOR SYSTEM, Nutech Building 201, room K17. 
Nominal source strength: 137Cs 200 Ci 8 TBq, Dose rate at 100 cm distance: 664 ± 8.4 mGy / h 
with reference date 25 October 2001. Calibration traceable to SIS, Herlev, Denmark 
Cobalt-60: 
Terabalt T100 Dosimetric Irradiator, UJP, Praha, Czec Republic with a GK60T03 60Co source. 
Nominal activity 455 TBq in 2012, 1 Gy/min at 100 cm distance April 2017.   
 
 Cell lines 3.2.6
Two cell lines were chosen for the experiments. These were HeLa cells and V79 cells. Both cells lines 
are easy to grow in the laboratory and are often used in biological research.  
 HeLa cells 3.2.6.1
HeLa cells are famous for being the first human cell line to be continuously grown in the laboratory. 
Despite nearly a decade of experience and success in establishing continuously rodent cell lines, 
nobody had succeeded in keeping human cells growing in culture for more than a few weeks. In 1951 
an especially aggressive cervical cancer (adenocarcinoma) was isolated from the 30-year old black 
woman Henrietta Lacks (Figure 3.6) and given to George Gey at The John Hopkins Hospital in 
Maryland, who managed to culture these cells continuously. Despite the tragic passing of Henrietta 
Lacks only a few months later, and the heavy debated ethical circumstances in obtaining the cells, the 
HeLa cells have undoubtedly contributed to the understanding and treatment of various human 
conditions including cancer [110].  
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Figure 3.6 A picture of Henrietta Lack, the women from 
whom the HeLa cell line was isolated from   
Picture taken from [111] 
 
HeLa cells are a cervical cancer cell line. Even 
though they are epithelial cell they are 
fibroblast like and grow adherent as a 
monolayer. HeLa cells have a cell cycle time of 
~24 hours which is divided between the four 
cell cycle phases; G1-phase (11 hours), S-phase 
(8 hours), G2-phase (4 hours) and M-phase (1 
hours)[39]. HeLa cells express a low level of 
p53. This might be due to the presence of 
Human Papilloma virus type 18, (HPV18) and 
the expression and production of HPV E6 onco-
protein which destabilizes p53 [112]. The HeLa 
cells are positive for the retinoblastoma 
protein (pRb) a tumour suppressor protein 
dysfunctional in many cancer [113]
 
 V79 cells 3.2.6.2
V79 cells are a lung fibroblast cell line. It was isolated after a spontaneous transformation from a 
young male Chinese hamster and was developed by Ford and Yerganian in 1958. The cell line was 
originally designated Strain V, but got renamed by Elkind to V79. V79 cells were originally grown as an 
adherent monolayer but can also be grown in suspension in the right medium. The cell cycle of V79 
has a cell cycle time of ~12 hours divide into G1-phase (1 hours), S-phase (6 hours), G2-phase (3 
hours) and M-phase(1 hours). The V79 cells used here were p53 negative and pRb positive [39][114].  
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3.3 Methods 
 Production of 131Cs 3.3.1
131Ba (11.5 d half-life) was produced by high flux neutron irradiation at the ILL reactor (Institut Laue-
Langevin, Grenoble, France) with 6 to 10 days irradiations at a flux of (1.1-1.3) * 1015 n cm-2 Sec-1 of 
either natural Ba (17-25 mg as carbonate) or 49 % enriched 130Ba (0.15 mg as nitrate, supplied by ILL). 
Upon reception at Hevesy Laboratory (1-2 weeks after end of irradiation), the outside of the quartz 
ampules were washed in 2 M HCl and ultra-pure water (to remove significant amounts of 65Zn, 60Co 
etc, but also to remove possible external contamination with salts). After breaking the ampules open, 
the target materials were dissolved in 2 M ultrapure hydrochloric acid. The clear solution was 
immediately re-precipitated by addition of a saturated solution of ammonium carbonate. This forces 
barium carbonate (with > 95% of the barium activity) to settle within a few minutes as heavy, well 
defined precipitate while initially produced caesium activity was discarded with the supernatant. This 
caesium fraction was found to be radionuclidic impure due to 1-2 % 132Cs made by either (n,p) or 
second order capture during the irradiation. Discarding the first caesium fraction proved important 
for a reliable and high cellular uptake in the following incubation experiments. The precipitate was 
washed with 2-3 ml of ultra-pure water, the water decanted and discarded after spinning at 3000 
rpm, after which the precipitate was left to stand for 2-7 days for build of new caesium activity.  
Shortly before time of use, the barium carbonate precipitate was dissolved in the smallest possible 
amount of 2 M hydrochloric acid, and then precipitated with saturated ammonium carbonate. The 
supernatant at this stage contains only 131Cs, with barium effectively removed by the total absence of 
any 131Ba or 133Ba activity in the final 131Cs. The decontamination factor from barium in one 
precipitation was found to be bigger than 30.000 – in accordance with the low solubility of barium 
carbonate at room temperature and neutral pH.  
The supernatant was dried out at 85°C under nitrogen flow, leaving all the caesium activity and a 
slight white skirt of ammonium chloride in the upper, coldest part of the drying vessel.  Drying and 
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firing at higher temperatures than 85 °C led to significant loss of caesium activity to the gas and was 
subsequently avoided.  
The dry caesium fraction was dissolved in 2-4 ml ultrapure water and then passed over a small ion 
exchange column AG 1x8 to remove remaining ammonium ion. The column eluate was evaporated in 
a clean, carefully weighed 10 ml glass vial, and then dried at 80 °C to absolute dryness. At this stage, 
visual inspection of the vial showed no residuals whatsoever, and the mass balance invariable showed 
a total mass less than 0.2 mg at this stage. (This corresponds to less than 1 µmol of ammonium 
chloride).  
The activity was recovered from the vial by the ready dissolution in 100-200 µl PBS. Activity 
concentration and radionuclidic purity was established by HP-GE X-ray spectroscopy of a 1 µl sample. 
The re-precipitated targets were stored for 1-2 weeks for build-up of 131Cs, and then the process could 
be repeated. We have milked up to 4 batches of useful 131Cs activity from a single activated barium 
batch from ILL. The harvested, 131Cs in PBS was added the HeLa and V79 cells in normal growth 
medium. 
Using natural barium as target and 10 days for transport/decay before first 131Cs extraction, 80 MBq 
131Cs could be obtained. With an enriched 130Ba target, more than 500 MBq were obtained from first 
extraction. The 131Cs harvesting has been repeated up to 4 times on each neutron activated sample. 
No difference was seen in the purity or the cellular uptake profile whether the 131Cs came from 
enriched or natural barium targets. In principle, the specific activity should be equally high in both 
methods and should approach carrier free conditions. 
 
 Liquid Scintillation Counting (LSC) of 131Cs  3.3.2
131Cs activity was counted using Liquid scintillation counting. The machine used for counting was a 
Hidex 300SL (Hidex, Turku, Finland). The 131Cs sample to be counted was added to 10 ml scintillation 
fluid, in oximate glass vial. For counting a maximum of 1ml sample solution was added each vials. 
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Before counting, the LSC vials were shaken thoroughly to ensure a proper mixing of the sample and 
scintillation fluid. The counting was done using channel 218-480 (covering the K-Auger branch and 
possible K- X-ray interactions in the scintillation cocktail) The spectrometer was operated in the triple-
double coincidence mode to minimise background and lower any quenching effects.  A blank was 
always counted with the samples to measure the background.  
 
 Standard curve 3.3.3
A standard curve was made in order to calculate the real 131Cs activity in a sample based on counts 
per second (CPS). A standard sample of 131Cs was first measured on the germanium X-ray detector 
that was efficiency calibrated against a standard 241Am source to know the real activity in the sample. 
A linear extrapolation between the 26.3 keV and the 59.5 keV X-ray emitted by 241Am was used to 
“calibrate” against the two 29.5 keV and 29.8 keV X-rays emitted by 131Cs  
A small amount (49.3 mg) of the 131Cs standard sample was mixed with 197.6 mg of ultra-pure water. 
From this, a dilution series was made by mixing 200 µl of the previous 131Cs sample with 200 µl of 
ultra-pure water. In this way every new sample had an activity around half of the previous. For each 
sample both the amount of 131Cs containing solution and the amount of ultra-pure water added were 
measured using a scale. The mass was converted to volume assuming a density of 1 mg/µl. 15 
samples were made ranging in activity from 1 CPS to 4000 CPS. 100 µl of each 400 µl sample was 
transferred to LCS vials containing 10 ml scintillation fluid. The samples were counted for either 20 
min or untill 10.000 counts were registered. The measured CPS was corrected for background and 
decay during the measurement protocol.  
To find the dead time of the LSC, the 15 samples were allowed to decay for 24 days (~2.5 half-life) and 
were thereafter counted using the same settings. Based on the CPS of the two countings, the dead 
time of the LSC was found using solver in Excel. Samples which activity was so low, that the 
background had a significant influence, were not used in the fitting.  
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To convert CPS to disintegration per second (DPS or formally Bq) the counting efficiency was found. 
The CPS from the first counting of the samples was first corrected for the dead time. Then the Bq in 
each sample were calculated using the known activity in the 131Cs standard sample and the known 
amounts of 131Cs containing solution and water added to each sample. The count efficiency was then 
calculated by dividing CPS with Bq and finding the average, excluding outline samples that had a too 
high or too low activity.             
 
 Cell cultures and storage 3.3.4
 HeLa cells 3.3.4.1
HeLa cells were obtained from The European Collection of Cell Cultures (ECACC) (93021013), as 
passage (P5). They were grown in MEM or DMEM medium supplemented with 10 % FBS, 4 mM L-
glutamine and 1 % antibiotic antimycotic. They were cultured in a humidified atmosphere containing 
5 % CO2 at 37°C. The HeLa cells were passaged 1-2 times a week when reaching 80-90 % confluency or 
when needed for experiments. For passage the cells were washed with PBS and either accutase 
(“ready to use solution”) or 0.1 % trypsin containing 0.5 mM EDTA in PBS was used to detach the cells. 
If accutase was used the cells were centrifuged at 200 G for 5 min and the supernatant was removed 
before resuspension of the cells in growth medium. Otherwise cells were trypsinizated for 5 min at 5 
% CO2, 37 °C. The trypsinization was stopped by addition of growth medium to the cells. 
For long time storage, HeLa cells were grown in T25 flask to 90 % confluency. The old medium was 
discarded and the cells were washed with PBS. To release the cells from the culture flask surface, they 
were incubated with 5 ml accutase for 5 min. Thereafter the cells were centrifuged at 200 G for 5 min 
and the supernatant was removed. The cells were re-suspended in ~1.5 ml HeLa freeze medium 
consisting of MEM medium, FBS (14 %) and DMSO (7.8 %)  and transferred to cryo-tubes (~2x106 
cells/ml). The cells were pre-cooled at -80 °C in a passive cooler over night before long-time storage in 
liquid nitrogen (-196 °C). 
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 V79 cells 3.3.4.2
The V79 cells were a generous gift from Dr. Priscilla K. Cooper (Lawrence Berkeley National 
Laboratory, USA). They were grown in DMEM medium supplemented with 10 % FBS, 4 mM L-
glutamine and 1 % antibiotic antimycotic. They were cultured in a humidified atmosphere containing 
5 % CO2 at 37 °C. The V79 cells were passaged 1-2 times a week when reaching 80-90 % confluency or 
when needed for experiments. For passage the cells were washed with PBS before being trypsinized 
for 5 min at 5 % CO2, 37°C, using 0.1 % trypsin/EDTA (0.5 mM) in PBS. Trypsinization was stopped by 
addition of growth medium to the cells. 
For long time storage the V79 cells were kept in a liquid nitrogen tank. The old medium was discarded 
and the cells were washed with PBS. To release the cells from the culture flask surface the cells were 
trypsinated using 0.1 % trypsin/EDTA (0.5 mM) in PBS. Freeze medium consisting of 40 % normal 
growth medium (DMEM medium supplemented with 10 % FBS, 4 mM L-glutamine and 1 % antibiotic 
antimycotic), 50 % FBS and 10 % DMSO were added to the cells. 1 ml cell suspension was transferred 
to cryo-tubes (max. 4*106 cells/ml). The cells were either pre-cooled at -80 °C in a passive cooler over 
night or cooled at dry ice with isopropanol (-77 °C) for 3-4 hours, before being transferred to liquid 
nitrogen (-196 °C)  for long time storage.  
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131Cs bio-kinetics 3.3.5
 Experimental setup 3.3.5.1
All experiments were carried out using 48-well plates.  48-well plates were chosen in order to use the 
smallest amount of medium and thereby as little 131Cs as possible (as 131Cs was not easily available), 
while still having enough cells for the experiments. As both the HeLa and V79 cells grow attached, 
each sample (e.g. time point) in each experiment was obtained using separate wells (Figure 3.7). 
 
Figure 3.7 Experimental setup for HeLa and V79 cells incubated with 
131
Cs in 48-well plates  
A volume of 200 µl 
131
Cs containing medium was added each well. As the cells grow attached each sample (e.g. time 
points) in an experiment was obtained from different wells (e.g. well nr. 1 being time point x, while well nr. 2 would be time 
point y). Cross dose from neighbouring wells (e.g. from well nr. 2 to well nr. 3) was ignored. 
 
In this geometry of closely spaced wells, a cross-dose effect from one well to the next should in 
principle be considered. However, cross dose resulting from the Auger electrons can immediately be 
dismissed because the electron ranges are smaller than the thickness of the plastic walls. The X-ray 
cross-dose can be disregarded for the same reasons that cell-to-cell and medium to cell X-ray dose 
could be neglected. Due to the geometry of the wells (cylinders) with shallow layers of (radioactive) 
cells, there is only a very small solid angle for interaction of one cell layer with the X-rays from the 
other wells.  
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 Uptake of 131Cs in HeLa and V79 cells 3.3.5.2
HeLa and V79 cells were seeded in 48-well plates and incubated overnight at 37 °C, 5 % CO2. 
131Cs in 
the form of CsCl (dissolved in saline or PBS) was mixed with growth medium to get an activity 
concentration of ~25 kBq/ml. The cells were washed with PBS before 200 µl 131Cs containing growth 
medium was added. The cells were incubated for up to 12 hours (24 hours in one experiment) at 37 
°C, 5 % CO2. As the cells were grown attached, 
131Cs uptake for each time point was obtained using 
separate wells. After incubation the 131Cs containing medium was removed and the cells were washed 
with PBS before trypsinization (0.1 % trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37 °C, 5 % CO2). 
The cells were thereafter re-suspended in growth medium. To determine the 131Cs uptake in the cells, 
a part of the cell suspension was transferred to LSC vials for counting.  The LSC counting was 
performed as described in section 3.3.2 p. 74. The number of cells in each sample and the sizes of the 
cells were measured using the Sceptor 2.0 from Millipore. In each experiment a control for the 
washing efficiency was made by adding and immediately afterwards removing the 131Cs containing 
medium from the control cells. The 131Cs activity measured in this control was subtracted from the 
other samples. The cellular activity of 131Cs (the intracellular 131Cs activity concentration, Bq/pL cell) 
for all time points (in each experiment) was calculated by dividing the total 131Cs activity (obtained by 
LSC counting) by the total cellular volume (number of cells * average cell volume, measured by the 
Sceptor 2.0).  
    Cellular 131Cs actvity concentration at time (t) =  
total 131Cs activity in the cells  at time (t)
total cellular volume at time (t)
           (Eq. 23) 
 
To calculate the accumulation of 131Cs in the cells compared to the medium, this cellular activity 
concentration was dividing by the activity concentration in the medium. The cellular 131Cs activity 
concentration at each time point (for each experiment) was normalized to the cellular 131Cs activity 
concentration at time (T) 380 min (HeLa cells) or 480 min (V79 cells) to get the relative 131Cs activity 
concentration. 
Relative 131Cs actvity concentration at time (t) =  
cellular 131Cs activity concentration at time (t)
cellular 131Cs activity concentration at time (T)
    (Eq. 24) 
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T, being time point 380 min for HeLa cells, and 480 min for V79 cells. These two time points were 
chosen in order to include as many “uptake experiments” as possible in the fitting analysis, but did 
not otherwise affect the exponential constant (kc).  
The data from all the experiments was fitted together as a single fit to the below exponential 
equation (Eq. 25) using the curve fitting toolbox in Matlab and kc determined.  
A = A0 ∗ (1 − e
−t∗kc)              (Eq. 25) 
A, being the relative activity concentration in cells at time t, A0 the relative activity concentration in 
cells at equilibrium and kc the exponential constant.  
 
 Release of 131Cs from HeLa and V79 cells 3.3.5.3
HeLa and V79 cells in 48-well plates were incubated with 131Cs containing growth medium (~20 
kBq/ml) over night (13-16 hours) at 37°C, 5 % CO2, in order for them accumulate a suitable amount of 
131Cs. The cells were thereafter washed and fresh growth medium (not containing any 131Cs) was 
added. The cells incubated (at 37°C, 5% CO2) for different time periods (0-10 hours) before being 
trypsinized (0.1 % trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37 °C, 5 % CO2). The 
131Cs activity in 
the cell sample was measured by LSC (see section 3.3.2 p. 74). The cell number and size was 
measured using the Sceptor2.0 from Millipore. The cellular 131Cs activity concentration in the cells at 
the different time points was calculated as above (Eq. 23) and normalized to the 131Cs activity 
concentration in the cells at time point zero.   
The data were fitted to an exponentially decreasing function using both solver in Excel and Matlab 
and the rate constant kout was found for both HeLa and V79 cells. 
A = A0 ∗ e
−t∗kout                   (Eq. 26) 
A, being the activity concentration in the cells at time (t),  A0,the activity concentration in the cells at 
time 0, and kout being the rate constant. The results from three independent experiments were fitted 
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independently in Excel using solver and the least square method.  The results were also fitted as a 
single fit in Matlab (using the fitting toolbox) to obtain confidence intervals. The two different fitting 
methods used had a small influence of the obtained kout for HeLa cells, but had no effect on kout for 
V79 cells. For reasons of the chronological progression of the experimental work, the kout value for 
HeLa cells obtained by Excel solver was used in later calculations. 
 
 Inhibition of 131Cs uptake by Ouabain 3.3.5.4
HeLa and V79 cells were seeded in 48-well plates and incubated overnight. The cells were washed in 
PBS and incubated for 5.5 & 6.5 hours in growth medium containing  ~20 kBq/ml 131Cs and different 
ouabain concentrations ((HeLa: 10 nM, 50 nM, 0.1 µM, 0.5 µM, 1 µM, 5 µM),(V79: 10 µM, 50 µM, 0.1 
mM, 0.5 mM, 1 mM).  After incubation the cells were washed with PBS and trypsinized (0.1 % 
trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37 °C, 5 % CO2). The cellular 
131Cs activity in each sample 
were measured by LSC (see section 3.3.2 p. 74) and cell number and their sizes were measured with 
the Scepter 2.0 from millipore. The cellular 131Cs activity concentration was calculated (using Eq. 23) 
and normalised to a control sample in which only 131Cs but no ouabain had been added. The data was 
fitted to a sigmoid curve using the least square fit methods in GraphPad prism 7.03  
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 SC-values 3.3.6
 Cell layer height and nuclei volumes 3.3.6.1
The height of the cellular monolayer and the nuclear sizes of the HeLa and V79 cells were determined 
by confocal microscopy. The microscope used was a Laser Scanning Microscope (LSM 780) from Zeiss 
provided by and operated by the Core Facility for Integrated Microscopy (CFIM), at the University of 
Copenhagen.  The cells were seeded on high precision cover glasses with a thickness of 0.17 ± 0.01 
mm and grown to full confluency overnight at 5% CO2, 37°C. The living cells were stained with Wheat 
Germ Agglutinin (WGA) Oregon Green® 488 and Hoechst 33342. WGA Oregon Green® 488 is a green 
fluorescent dye, which selectively binds to N-acetylglucosamine and N-acetylneuraminic acid 
residues, and can thereby be used to stain the plasmamembrane. Hoechst 33342 is a blue fluorescent 
dye that binds to the minor groove of the DNA and can be used to stain the nucleus. Both fluorescent 
dyes can be used to stain living cells. The staining were performed using a WGA concentration of 5 
µg/mL, diluted in growth medium and a Hoechst 33342 concentration of 20 µg/ml diluted in growth 
medium. Cells were stained for 10-20 min at 5% CO2, 37°C. After the staining the cells were washed 
with Hank´s balanced salt solution (HBSS) before being view in the microscope (alive) still submerge in 
HBSS. A 10x objective was used. 71 pictures with a spacing of 0.37 µm, covering an axial length of 
26.08 µm were taken of the HeLa cell culture. 59 pictures with a spacing of 0.3, covering an axial 
length of 21.6 µm were taken of the V79 cells. The height of the cell layer and the nucleus sizes were 
afterwards determined using the Zeiss ZEN-light software package operating directly on these image 
stacks (Z-stack) obtained by CFIM. Due to limitations in the confocal microscopy technique, the 
precise location (within 1-2 µm) of the top and bottom of the cellular monolayer and thereby its 
height were difficult to estimate. However, by scrolling through the Z-stack (image stacks), a sudden 
drop in the green fluorescent intensity were observed. This drop in fluorescent intensity appeared 
near what seemed to be the top and bottom of the cellular monolayer (displayed by the picture bars 
showing an axial cross section of the cell layer) and coincided with the appearance of plasma 
membrane “overlying” the nuclei and so these locations were chosen as the top and bottom of 
cellular monolayer, and its height found as the distance between these two position given by the 
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inbuilt scale in the Zen software. To determine the volume of a nucleus, the image in the Z-stack in 
which the nucleus appeared largest was first found. Its two different axes in the x-y plane were then 
measured using the tools in the Zen software. The length of the third axis (in the z-direction) was 
measured by finding the first and last image in the Z-stack in which the nucleus was present and 
taking the distance between them again using the tools in the Zen software.  The shape of the nucleus 
was assumed to be an ellipsoid and using the standard formula for volume for such geometry 
(V =
4
3
πabc), in which a, b & c are the semi-axes, the nucleus volume was calculated. This was done 
for all nuclei that were completely contained inside the confocal images, in order to obtain the 
nuclear volumes and their distribution. Although this axis measurement is not necessarily completely 
geometrical correct (the horizontal imaging planes are not necessarily aligned with the ellipsoid axes), 
it is a fair approximation given the otherwise big biological variations in shape. 
 
 Calculation of the 131Cs SC-values, SC(N←CM). 3.3.6.2
The geometry used was a confluent cellular monolayer with a height of 10 µM (HeLa) or 8 µM (V79). 
This geometry is not treated by MIRD Cell.  The cell nuclei were approximated by ellipsoids with 3 
axes. The axis lengths as measured above were used to calculate the volume of each nucleus, but also 
to make a scoring volume in Matlab, inside which the deposited energy was sampled. The energy 
deposited in each volume element of the cell monolayer is given by the 3 dimensional convolution of 
the 131Cs dose kernel with a simple rectangular slab representation of the uniform activity 
concentration in cell monolayer. The average of the Sc-values found (from each cell line) from the 
individually measured and modelled nuclei, also corresponded to the Sc-value for the average nucleus 
size (for each cell line) and so this (these) value(s) was used in the dose calculations.  
The 131Cs was assumed to be equally distributed throughout the entire cellular monolayer, including 
the cytoplasm and the nucleus. The K- and L-Auger electron energies and intensities (24.6 keV (9.3 %) 
and 3.43 keV (79.7 %) respectively) provided by the NuDat 2.7 database [25] were used in the 
calculations. Monoenergetic electron emission  dose kernels (as 3-dimensional matrices centred on 
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the point of emission)  for a point source were calculated using the same method applied by MIRD for 
cellular S-values, using Cole´s inverted formula for energy versus range as a stopping power [17][82].  
To do this for a given single electron energy E, the maximum penetration depth (Cole’s “range” is 
found from the numerical expression in [17][82] for E as function of range R: 
E = 5.9 ∗ (R + 0.0007)0.565 + 0.00413 ∗ R1.33 − 0.367            (Eq. 27) 
Where 𝐸 is given in keV and rang e in µm. Cole states the expression to be valid in the range from 20 
eV to 20 MeV.   
This expression does not lend itself easily to inversion by analytical methods, but ranges at given 
energies can be found by successive approximations. In practice, however, for 131Cs with maximum 
electron energy below 40 keV, a good third degree polynomial approximation was found to be: 
R =  −0.0001353 ∗ E3 + 0.0214 ∗ E2 + 0.07272 ∗ E            (Eq. 28) 
Having found the maximum range of each electron branch (𝑅𝑚), the Cole “stopping power” equation 
dE
dx
= 3.333 ∗ (R + 0.007)−0.435 + 0.0055 ∗ R0.33             (Eq. 29) 
is used to find the energy loss per radial distance length from the point source. 
Again, this formula has 𝑬 in keV and 𝑅 in µm. Cole and ”MIRD Cellular S values” uses this expression 
over the range from 20 eV to 20 MeV. 
 
The expression for the dose at a given distance Rx < Rm from the point source is now 
D(Rx) =
dE
dx
 |  R=Rm−Rx
Volume of sperical shell between Rx and Rx+dx
             (Eq. 30) 
This expression is the radial dose kernel. It is used to fill a three cubical Matlab matrix 𝐃 centered 
around the emission point with doses according to the above formula and its distance from the center 
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of the matrix. The matrix has voxel sizes dx3, with dx = 0.2 µm. The “Cole” range of K electrons from 
131 Cs is 12.7 µm or 64 voxels, while L electrons have substantially shorter range. 
The matrix elements inside this”dose matrix” 𝐃 have dose values when closer than Rm to the matrix 
center, and zero otherwise. A consistency check is always made that the total energy contained in the 
dose matrix is equal to the electron energy emitted.  
 
For each Auger electron branch, the monoenergetic dose matrix 𝐃 is thus calculated, then weighted 
by the emission probability for that branch, and finally all individual dose matrixes summed over 
branches to the composite dose matrix 𝐃𝐓 for the decay.  This matrix is calculated with the energies 
and emission rates given in NuDat 2.7 and accordingly only contain a K-Auger and L-Auger branch.  
The more modern calculations by Boon [93]  give energies and intensities for many more Auger 
branches. The total Auger electron energy released per decay as calculated by Boon is a factor of 
about 1.2 higher than the total of the K and L branches in NuDat 2.7.  Of course the total energy in the 
EC decay is known, but the distribution between X-ray and Auger emissions is not necessarily known. 
As explained in appendix 8.3.2 p. 204 I do not want to underestimate the absorbed dose (to the 
nuclei), as this will lead to apparently higher RBE values. Based on the available knowledge of the 
Auger branching ratios we (I and supervisor Mikael Jensen) have decided to use a scaling factor of 
1.17 to the dose matrix 𝐃𝐓, hereby slightly changing the magnitude of the matrix elements, but not 
the shape and extension of the dose kernel.  
The final size of the 𝐃𝐓 matrix was 131x131x 131 elements corresponding to 13x13x13 µm3. 
 
The homogeneous activity concentration in the confluent cellular monolayer is represented by 
another three dimensional matrix 𝐀. It is a large rectangular slab matrix, with x and y dimensions 
much larger than the size of the 𝐃𝐓 but with z ( height dimension) equal to the cell layer height. 
 Inside this matrix, a uniform activity concentration of 1 Bq/pL is represented by the value                   
1/ voxelvolume, where voxelvolume is the number of µm3 per pL. 
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Now the dose distribution 𝐃𝐂𝐞𝐥𝐥𝐚𝐲𝐞𝐫 inside the cell layer can be found be the three dimensional 
convolution in Matlab:  
𝐃𝐂𝐞𝐥𝐥𝐚𝐲𝐞𝐫 = 𝐃𝐓  𝐀               (Eq. 31) 
In this geometry, the absorbed dose only depends on the depth position in the cell layer (z-direction) 
and not the horizontal position (x-y direction), because the horizontal extension of the layer is very 
large compared to the electron ranges.  Any absorbed dose to a nucleus volume inside this monolayer 
could be calculated by collecting dose from all the matrix elements within a given mathematically 
defined nucleus shape (spherical or ellipsoid) (Figure 3.8). The absorbed dose to nucleus was scored1 
for each nucleus measured (29 HeLa and 50 V79). 
Results were expressed as SC-values (monolayer to nucleus) with the units Gy/ (Bq*Sec)/pL or Gy Bq
-1 
Sec-1 pL. The direct X-ray contribution to the cell nuclei from the 131Cs inside the monolayer could 
safely be ignored because the cell layer thickness is very small compared with the mean free path of 
the relevant X-ray photons (29-34 keV) in water (0.01 mm versus 25 mm). Likewise, the X-ray 
absorbed dose contribution (and the dose contribution from the Auger electrons incl. SCK and CK) 
from the 131Cs in the medium could be ignored.   
 
Figure 3.8  Representation of the geometrical model of the cellular monolayer used to calculate the SC-value, 
SC(N←CM), and the dose kernels 
Because of the evenly distributed 
131
Cs in cytoplasm and nucleus and the confluency of the cells, the cell culture can be 
thought of as a “sea” of cytoplasm in which the cell nucleus is floating. The dose kernels (blue lines) for direction x and y 
are constant through most of the cell layer, and only change close to the edge. The dose kernel for the z direction depends 
on the height of the cell layer and is the only one that is important for the calculation of the composite dose kernel. 
                                                     
1
 Actual calculations in Matlab done by supervisor Mikael Jensen.  
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 Absorbed dose and dose rate calculations 3.3.7
To calculate the absorbed dose and dose rate profiles, the intracellular 131Cs activity concentration (at 
at least one time point), the exponential/rate constants (kc & kout) and the SC-value had to be known. 
The constants (kc & kout) have been found by the uptake and release experiments described above. If 
the 131Cs activity concentration at more than one time point was known, activity concentration used 
for further calculations were first found by fitting the known values to the equation                              
A = A0 ∗ (1 − e
−t∗kc) applying the least square method using solver in Excel. 
 
 Dose rate profile 3.3.7.1
The dose rate to any time point (x) can be found by multiplying the 131Cs activity concentration at 
time (x) with the Sc-value; 
Dose rate (x) = 131Cs activity concentration at time (x) ∗ SCvalue         (Eq. 32) 
 
Using the “natural” unit of Bq/pL for the activity concentration this equation gives us dose rate as 
Gy/s.  For ease the dose rates using approximations of 10 min time intervals were used in the 
subsequent dose rate profiling.  
Extrapolating activity concentration measured at one time point to other time points is done by using 
equation 47 ( section 8.3.1. p. 201) 
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 Total absorbed dose and integration period for the total 3.3.7.2
absorbed dose. 
To calculate the absorbed dose relevant for the the ƴH2AX  experiments, integration of activity and 
dose rate should be stopped at the time when the cells are removed from the medium.  
For the clonogenic survival experiments, exposure actually continues after removal of activity from 
the medium, and a cummulative activity and dose should in principle be extended to infinity. In 
section 4.3.1 it is argued that the integration is stopped at t=1440 minutes, without significant error. 
A more elaborate example is given in section 4.3 p. 122. 
 
 Radiotoxicity and RBE of intracellular 131Cs exposure 3.3.8
 Radiotoxicity of intracellular and extracellular 131Cs exposure  3.3.8.1
HeLa cells (~55. 000) were seeded in 48-well plates and incubated overnight at 37°C, 5% CO2. The cells 
were washed in growth medium before 200 µl 131Cs containing medium (9.5 MBq/ml -15 MBq/ml) 
with or without 8.45 µM ouabain was added. A control sample for the effect of ouabain (cells 
incubated with ouabain, but with no 131Cs) was also made. The cells incubated at 37°C, 5% CO2 for 
different periods of time (0 – 8 h). Thereafter the cells were washed with PBS before being trypsinized 
(0.1% trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37°C, 5% CO2). The trypsinization was stopped 
using growth medium. The number of cells and their sizes were measured by the Scepter 2.0 from 
Millipore and the 131Cs activity in the cells was measured by LSC (see section 3.3.2 p. 74). The 131Cs 
activity concentration was calculated (Eq 23). Around 100.000 cells were used to measured DNA 
double strand breaks by γH2AX assay on the Muse cell analyser (see section 3.3.8.3 p. 90) Three 
independent experiments were performed.    
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 RBE of Intracellular 131Cs exposure (γH2AX) 3.3.8.2
3.3.8.2.1 Intracellular 131Cs exposure. 
The cells exposed to intracellular 131Cs (without ouabain) in the experiment investigating the effect of 
intracellular versus  extracellular 131Cs decays (section 3.3.8.1 p. 88) are the same cells used in this 
experiment investigating the RBE of intracellular 131Cs exposure. The methods applied are therefore 
exactly the same. 
HeLa cells (~55. 000) were seeded in 48-well plates and incubated overnight at 37°C, 5% CO2. The cells 
were washed in growth medium before 200 µl 131Cs containing medium (9.5 MBq/ml -15 MBq/ml). 
The cells incubated at 37°C, 5% CO2 for different periods of time (0 – 8 h). Thereafter the cells were 
washed with PBS before being trypsinized (0.1% trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37°C, 
5% CO2). The trypsinization was stopped using growth medium. The number of cells and their sizes 
were measured by the Scepter 2.0 from Millipore and the 131Cs activity in the cells was measured by 
LSC (see section 3.3.2 p. 74). The 131Cs activity concentration was calculated (Eq. 23). Around 100.000 
cells were used to measured DNA double strand breaks by γH2AX assay on the Muse cell analyser. 
The absorbed dose and dose rate profiles were calculated based on the obtained  exponential 
constant (kc) for 
131Cs uptake. Three independent experiments were performed. 
 
3.3.8.2.2 External ƴ-ray exposure (reference radiation),  
HeLa cells (~55.000) were seeded in 48-well plates and incubated overnight at 37°C, 5% CO2 The cells 
had reach nearly 100 % confluency at that point (90-100% of the surface of the well was covered with 
cells). The cells were washed in growth medium and 200 µl growth medium was added the cells. The 
cells were placed in an incubator in our calibration facility and were thereby exposed at 37°C, 5% CO2. 
The cells were exposed to γ-rays from 137Cs at increasing dose rates according to the corresponding 
dose rate profile (from the 131Cs experiments) by moving the incubator closer to the source. After 120 
min, 250 min 370 min and 490 min the samples were removed from the incubator. The cells were 
washed in PBS and trypsinized(0.1% trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37°C, 5% CO2). The 
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trypsinization was stopped using growth medium and the cell numbers and cell sizes were counted by 
the Scepter 2.0 from Millipore. Around 100.000 cells were used to measured DNA double strand 
breaks by γH2AX on the MUSE cell analyser. Three independent experiments were performed.  
 
 yH2AX assay 3.3.8.3
The H2A.X Activation Dual Detection Kit from Millipore was used to analyse DNA double strand break 
in HeLa cells following exposure to either 131Cs or external γ-rays. The cells were treated according to 
the protocol provided by the manufacture with minor modifications. 
The protocol was divided into two parts.  The first part was performed immediately after the end of 
exposure and included fixation of the cells. The second part included permeabilisation, staining and 
analysis of the cells and was performed later (1-3 days). This was done in order to stain and analyse all 
samples in a giving experimental series together. Between the 1st and 2nd part the samples were 
stored at 4°C 
1st  part 
Approximately 100.000 cells were transferred to Eppendorf tubes. The cells were spun down at 300 G 
for 5 min and the supernatant discarded. The pellet was re-suspended in 100 µl assay buffer and 
centrifuged again at 300 G for 5 min. The supernatant was discarded and the pellet was re-suspended 
in a mixture of 100 µl assay buffer and 100 µl fixation buffer. The cells were fixed for 5 min on ice, 
before the cells were spun down and the fixation solution was removed. The cells were re-suspended 
in 200 µl assay buffer and stored at 4°C 
2nd part 
The cells were centrifuged at 300 G for 5 min and the supernatant was removed. The cells was re-
suspended in 200 µl ice cold permeabilisation buffer and incubated on ice for 5 min. The cells were 
spun down again and re-suspended in 90 µl assay buffer. 50 µl of equal parts of the two antibodies 
directed against non-phosphorylated histone H2AX (anti-Histone H2A.X-PECy5 conjugated antibody) 
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and the phosphorylated serine-139 H2AX (anti-phospho-Histone H2A.X (Ser139)-Alexa Fluor®555) 
were added and the cells incubated 30 min at RT in the dark. A negative control with only the anti-
Histone H2A.X-PECy5 conjugated antibody added was also prepared. After incubation 100 µl assay 
buffer was added to the cells whereafter they were spun down and the supernatant was removed. 
The cells were washed one more time with 200 µl assay buffer. The cells were re-suspended in a 
suitable volume (100-200µl) assay buffer and analysed on the Muse cell analyser from Millipore. For 
elaboration of this particular assay see section 3.1.1 p. 59.   
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 RBE of intracellular 131Cs exposure (clonogenic cell 3.3.9
survival) 
 Intracellular 131Cs exposure 3.3.9.1
HeLa and V79 cells (approximately 85.000 and 100.000 cells respectively) were seeded in 48 well 
plates and incubated overnight. At that point, the cell cultures had reached nearly 100% confluency 
and 90-100% well bottom was covered by cells. The cells were washed with PBS before ~15 MBq/ml 
(HeLa) or ~7.5 MBq/ml (V79) of sterile 131Cs containing growth medium was added. The cells were 
incubated at 37°C, 5% CO2 for either 420 min or 480 min. After incubation the cells were washed with 
PBS, trypsinized (0.1% trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37°C, 5% CO2) and re-suspended 
in growth medium.  A control for the washing efficiency was made by adding and immediately 
afterwards removing the 131Cs containing medium. The 131Cs activity measured in this control was 
subtracted from the other samples. The 131Cs uptake was measured by LSC and cell number and sizes 
were measured by the Scepter 2.0 from Millipore. The cells were also counted and the viability 
measured using the Muse Count & Viability Kit and the Muse cell analyser from Millipore. The cell 
counts obtained by this Count & Viability Kit were used to seed the right amount of cells for the 
clonogenic cell survival assay. 50 µl of the cell suspension were added 450 µl of the count & viability 
reagent and incubated for 5 min at RT in the dark before it was analysed on the MUSE giving the cell 
concentration and the proportion of live and dead cells. Cells were seeded in T25 flask and incubated 
at 37°C, 5% CO2 for 7 days (V79) or 14 days (HeLa). The HeLa cells were seeded in triplicates using 200 
or 300 cells for control samples and 10.000 or 20.000 cells for the 131Cs exposed samples. The V79 
cells were also seeded in triplicated using 200 for control samples and 500 or 1000 for the 137Cs 
exposed samples.  After incubation the cells were stained with Crystal violet (0.5 %) in methanol for 
30 min – 1 h and thereafter washed in normal tap water. Three independent experiments were 
performed. A colony was defined as a group of minimum 50 cells, all originating from a single seeded 
cell.  Due to the high number of HeLa cells seeded, the colonies were counted under a light 
microscope using a 5X objective. The colonies in the control samples, as well as the colonies in the 
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V79 samples were however counted by eye.  The absorbed dose and dose rate profiles were 
calculated based on the obtained “rate” constants (kc & kout) for 
131Cs uptake and release obtained 
from the experiments investigating the 131Cs bio-kinetics. (For a more throughout description of these 
calculations, see section 4.3 p. 122). The survival fraction was obtained as explained in section 3.1.2 p. 
65. The survival curve was fitted to the linear model (𝑦 = 𝑒−𝑎𝑥), using the curve fitting tool in Matlab.  
 
 Protracted external ƴ-ray exposure (reference radiation) 3.3.9.2
HeLa and V79 cells (approximately 85.000 and 100.000 cells respectively) were seeded in 48 well 
plates and incubated overnight so the cells would be close to 100% confluent the next day. The cells 
were washed with PBS and 200 µl medium containing the same proportion of PBS as the 
corresponding 131Cs experiment was added the cells. The cells were placed in an incubator in our 
calibration facility and were thereby exposed at 37°C, 5% CO2. The cells were exposed to γ-rays from 
137Cs at increasing dose rates according to the corresponding dose rate profile (matched to the dose 
rate experience by the 131Cs incubated cells) by moving the incubator closer to or further away from 
the source. After 420 min and 480 min the samples were removed from the incubator.  The cells were 
washed in PBS and trypsinized(0.1% trypsin/EDTA (0.5 mM) in PBS for 3-5 min, at 37°C, 5% CO2). The 
number of cells and their sizes were counted by the Scepter 2.0 from Millipore. In addition the 
number of cells and the viability was measured using the Muse Count & Viability Kit and (as explained 
above). These cell counts were used to seed an appropriate number of cells (for clonogenic cell 
survival). The cells seeded in T25 flask were placed back into the incubator in the calibration facility 
for further exposure (This break in exposure was around 30-45 min long). The HeLa cells were seeded 
in triplicates using 300 cells for control samples and 2000, 5000 or 10.000 cells for the exposed 
samples. The V79 cells were also seeded in triplicates using 100 cells for control samples and 300 or 
400 cells for the exposed samples. The cells were exposed to γ-rays at decreasing dose rates for 
another 15-16 hours.  
After end of exposure the cells were incubated at 37°C, 5% CO2 (with no exposure) for a total of 8-9 
days (V79) or 14 days (HeLa) to form colonies. The colonies were stained with Crystal violet (0,5%) in 
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methanol  for 30 min – 1 hour and thereafter washed in normal tap water. A colony was defined as a 
group of minimum 50 cells, all originating from a single seeded cell. The V79 colonies were easily 
scored by eye. Due to the high number of Hela cells seeded, the colonies were counted using a light 
microscope and a 5X-objective.  The T25 flask were (if needed) divided into two equally big and 
geometrically similar parts. Only colonies in one of the two parts were counted and multiply by 2 to 
get the total number of colonies. Three independent experiments were performed. The survival 
fraction (as calculated by Eq. 22 p. 657) Page, was plotted against the absorbed dose and the data 
were fitted to the linear model (𝑦 = 𝑒−𝑎𝑥) using the curve fitting tool in Matlab. 
 
 Acute external ƴ-ray exposure 3.3.9.3
HeLa and V79 cells were sparsely seeded in T-25 flask and incubated at 37°C, 5% CO2. The cells were 
exposed at room temperature in T25 flask to y-rays from a 60Co source with a dose rate of 1.5 Gy/min, 
1 m from the source. 5 mm of plastic was used as build-up. The cells were exposed to doses between 
0-10 Gy. After exposure a suitable amount of cells were seeded in T-25 flask containing a total of 6 ml 
growth medium. The HeLa cells were seeded in triplicates using 150 cells for control samples, 200 
cells  (0.5Gy), 300 cells (0.75, 1 & 2 Gy), 500 cells (3 & 4 Gy), 1000 cells (5 Gy), 2000 cells (8 Gy) and 
5000 cells (10 Gy). The V79 cells were also seeded in triplicated using 100 cells for the control 
samples, 100 cells (0.5 Gy), 200 cells (0.75, 1 & 2 Gy), 300 or 500 cells (3 Gy), 300 or 500 cells (4 Gy), 
500 or 1000 cells (5 Gy) 2000 cells (8 Gy) and 2000 or 5000 cells (10 Gy). The cells incubated at 37°C, 
5% CO2 for 7 days (V79) or 12 days (HeLa) without any medium change.  The cells were stained with 
Crystal violet (0,5%) in methanol  for 20 min – 1 hour and thereafter washed in normal tap water. A 
colony was defined as a group of minimum 50 cells, all originating from a single seeded cell and were 
easily scored by eye. Three independent experiments were performed. The survival fraction was 
obtained as explained in section 3.1.2 p. 65. The obtained survival curve was fitted to the linear 
quadratic model (𝑦 = 𝑒−𝑎𝑥+𝑏𝑥
2
), using the curve fitting tool in Matlab.  
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4. Results 
Recapitulation: The aim of this study is to investigate the RBE of the Auger emitter 131Cs. The RBE is 
obtained by comparing dose-effect curves for the test and reference radiation. Obviously as the 
absorbed dose constitute one of the two key parameters (absorbed dose & biological effect) in 
obtaining the RBE it is vital that this quantity is correctly calculated. In order to calculate the absorbed 
dose of internal Auger emitters, the SC-value (introduced in section 2.5 p. 57) and the bio-kinetics of 
the Auger emitter used needs to be known.  Results have been found for the subcellular distribution, 
the uptake kinetics, cellular accumulation and release kinetics of 131Cs. With this in hand HeLa and V79 
cells were exposed to intracellular 131Cs decays and absorbed dose and dose rates calculated. Cells 
were also exposed to external ƴ-rays (reference radiation) at similar absorbed doses and dose rates. 
The biological effect of the exposures was examined using the ƴH2AX assay and clonogenic cell 
survival.  In the end RBE values of intracellular 131Cs decays were obtained.  
 
4.1 131Cs bio-kinetics 
In order to be able to calculate reliable absorbed doses and dose rates, it is important to have 
knowledge about the 131Cs bio-kinetics. The uptake and release of 131Cs over time were therefore 
investigated. Because of the short range of Auger electrons it is essential for the calculation of the SC-
values to know if the 131Cs is located intracellularly or extracellularly (perhaps bound to the cell 
surface) and therefore this was also examined. In addition, the cellular accumulation of 131Cs 
compared to the medium is also important for the SC-value calculations. The intracellular activity 
concentration (Bq/pL) of 131Cs over time is used in the absorbed dose calculations and is therefore 
also studied. Since all these processes can differ between different cells line, they were all 
investigated for both the HeLa and V79 cells used in this work.       
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 Uptake of 131Cs in HeLa and V79 cells 4.1.1
To investigate 131Cs uptake by HeLa and V79 cells, the cells were incubated with 131Cs, in the form of 
(non-carrier added) CsCl, which was added to the medium (in activity concentrations of ~25 kBq/mL) 
for various time periods. The activity concentration of 131Cs in the cells (Bq/pL cell), at various time 
points, were measured (by LSC) and the data from 8 (HeLa) or 7 (V79) independent experiments were 
used to find and fit the “uptake curves”.  
As can be seen on Figure 4.1 131Cs is taken up by both the HeLa and V79 cells. The activity 
concentration in the cells increases over time until it reaches equilibrium after ~800 min for HeLa cells 
and ~600 min for V79 cells. The data were first normalised to an internal time point (380 min for HeLa 
cells, and 480 min for V79 cells) and thereafter fitted (in Matlab) to the exponential function; 
A =  A0 ∗ (1 − e
−t∗kc)              (Eq. 33) 
A, being the relative (due to the normalisation) activity concentration in the cells at time (t). A0, the 
activity concentration in cells at equilibrium and kc, the exponential constant. The exponential 
constant (kc) for HeLa and V79 cells were determined to be 1/283 min
-1 and 1/204 min-1 respectively. 
(For confidence intervals see 4.1.5 p. 103).  Figure 4.1 shows the increase in the relative intracellular 
activity concentration of 131Cs over time. The exponential constant kc is not to be confused with the 
classical influx rate constant. 
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A 
 
B 
Figure 4.1 Uptake of 
131
Cs in HeLa and V79 cells over time 
The cellular activity concentration (relative to A380, or A480 respectively) of 
131
Cs in HeLa cells (A) and V79 cells (B) over time 
is shown. The cellular activity concentration in the cells increases over time until it reaches equilibrium after ~800 min for 
HeLa cells and ~600 min for V79 cells.  The data were fitted to the exponential equation (𝐴 = 𝐴0 ∗ (1 − 𝑒
−𝑡∗𝑘𝑐). The circles 
represent the obtained data points for HeLa (blue) and V79 (purple), and the lines represent the fitted functions. The 
exponential constants (kc) were found to be 1/283 min
-1
 for HeLa cells and 1/204 min
-1
 for V79 cells. Note that the 
exponential constant kc is not the classical influx rate constant.  
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 Accumulation of 131Cs in HeLa and V79 cells 4.1.2
To quantify the accumulation of 131Cs in the cells (compared to the medium) over time, the activity 
concentrations in the cells were measured at different time points. This was done by measuring the 
activity of 131Cs in the cells along with the cell number and their sizes in 9 independent experiments 
(the data from 8 (HeLa) or 7 (V79) of these were also used to establish the 131Cs uptake shown in 
Figure 4.1). The cellular accumulation factor of 131Cs over time was found by dividing the activity 
concentration in the cells by the activity concentration in the medium (Figure 4.2).  
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B 
Figure 4.2 Cellular accumulation of 
131
Cs in HeLa and V79 cells    
Cellular accumulation of 
131
Cs in HeLa cells (A) and V79 cells (B) over incubation time is shown.  
The activity concentration of 
131
Cs in the cells were measured at different time points and compared to the activity 
concentration in the medium to find the accumulation factor. An accumulation factor of ~30 was reach after 800 min in 
Hela cells (A), while an accumulation factor of ~70 was reach after 600 min in V79 cells (B). The data is presented as 
average ± s.d. of a least 3 independent experiments. The data points (circles) without any visible error bars are result of 
one or two observations and a standard deviation could therefore not be calculated.      
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In HeLa cells, the accumulation factor increases over time until it reaches a plateau around a factor 30 
after 800 min. In V79 cells, the accumulations factor also increases over time and reaches an 
accumulation factor around 70 after 600 min. However the clear plateau seen in the HeLa cells is not 
that evident in V79 cells and the variation between the samples is also higher. This could be an effect 
of a possible difference in the chemical purity of the 131CsCl solutions used in the experiments.  
 
 
 Release of 131Cs from HeLa and V79 cells 4.1.3
To determine the rate of 131Cs release from the cells, HeLa and V79 cells were first allowed to 
accumulate 131Cs.  Thereafter, the 131Cs containing medium was removed and the cells were 
incubated in fresh medium. The amount of 131Cs remaining in the cells was measured at various time 
points and normalized to the sample, that was taken just after medium change (time point zero) and 
therefore had the highest 131Cs activity concentration. 
The activity concentration of intracellular 131Cs decreased exponential over time, confirming the 
release of 131Cs from the HeLa and V79 cells (Figure 4.3).  The data were fitted to the exponential 
decreasing function; 
A = A0 ∗ e
−t∗kout              (Eq. 34) 
The data were first fitted in independently in Excel using solver and the least square method using 
solver later fitted as a single fit in Matlab (using the fitting toolbox) to obtain confidence intervals. The 
two different fitting methods used had an influence of the obtained kout for HeLa cells, but had no 
effect on kout for V79 cells. The rate constants (kout) for the 
131Cs release were found to be 1/339 min-1 
(using solver in Excel) and 1/337 min-1 (using Matlab) for HeLa cells and 1/256 min-1  (using Matlab) 
for V79 cells. (For confidence intervals see section 4.1.5 p. 103)  
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A 
 
B 
Figure 4.3 Release of 
131
Cs from HeLa and V79 cells 
The release of 
131
Cs from HeLa cells (A) and V79 cells (B)  over time is presented as percent 
131
Cs left in the cells compared 
to the cellular activity when the 
131
Cs containing medium was removed. 
 131
Cs is released from the cells, following an 
exponential decreasing course. The data are fitted to an exponential decreasing fuction  (𝐴 = 𝐴0 ∗ 𝑒
−𝑡∗𝑘𝑜𝑢𝑡)). The fits are 
represented by the blue (HeLa) and purple (V79) lines. The rate constant (kout) was 1/339 min
-1
 for HeLa cells and 1/256 
min
-1
 for V79 cells. The data is presented as average ± s.d of 3 independent experiments. The data points (circles) without 
any visible error bars only include one or two observations and a standard deviation can therefore not be calculated.        
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 Inhibition of 131Cs uptake by ouabain 4.1.4
To further study the uptake of 131Cs and confirm that the 131Cs was transported into the cells and not 
bound to the cell surface, it was examined if the uptake of 131Cs could be blocked. It has  previously 
been hypothesised/reported that caesium is transported into cells by the Na+/K+-ATPase [115]. To 
examine this hypothesis HeLa and V79 cells were incubated with 131Cs containing medium and  
ouabain, a known inhibitor of the Na+/K+-ATPase [116], was added at different concentrations.  
 
 
 
Figure 4.4 Inhibition of 
131
Cs uptake by ouabain 
The inhibition of 
131
Cs uptake by ouabain in HeLa cells (blue) and V79 cells (purple) is shown. IC50 and the maximum 
achievable inhibition were estimated to be 2.6*10
-8
M and ~11 % respectively for HeLa cells, and 2.77*10
-4
 M and ~7 % for 
V79 cells. The apparent rise in V79 uptake at low ouabain concentrations is most likely just experimental variation. The 
data were fitted to a sigmoid curve (R
2
 = 0.917 (HeLa), R
2
 = 0.8904 (V79). The fitted curves and the  average ± s.d. of 3 
independent experiments is presented. Error bars might be too small to be seen.  
 
As can be seen on Figure 4.4 ouabain was able to block the uptake of 131Cs in both HeLa (blue) and 
V79 (purple) cells. An ouabain concentration of 10-6 M was able to maximize the decrease in 131Cs 
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uptake in HeLa cells to ~12 %. However, an ouabain concentration of 10-5 M did not have any effect 
on the 131Cs uptake in V79 cells. At the highest ouabain concentration used (10-3 M) 131Cs uptake was 
decreased to ~28 % in V79 cells. However, it might have been possible to decrease the 131Cs uptake in 
V79 cell even further, by using a higher ouabain concentration. The concentration of ouabain needed 
to inhibit the uptake by 50 % (IC50) and the maximum achievable inhibition was estimated (using 
Prims GraphPad) to be 2.6*10-8 M and ~11% respectively for HeLa cells and 2.77*10-4 M and ~7 % for 
V79 cells. The results confirm that 131Cs stays in its ionic form in the growth medium and that at least 
88 % (HeLa) and 72 % (V79) of the 131Cs taken up by the cells is located inside the cells and not on the 
cell surface. As will be explained in the discussion section 5.1.1 p. 151, the fact that 131Cs is 
transported into the cells, while it is in its ionic form, makes it very likely that it will be homogenously 
distributed in the whole cell (cytoplasm and nucleus).    
 
 Summary & uncertainty 4.1.5
The homogenous distribution of 131Cs is very important for the SC-value calculations, and likewise is 
the accumulation of 131Cs in the cells.  Both cell lines were found to accumulate 131Cs, reaching an 
accumulation factor of ~30 (HeLa) and ~70 (V79). However, the precise value of the accumulation 
factor is not of importance, as it is only used to see if the dose contribution from the medium can be 
ignored. By inhibiting the uptake of 131Cs by Ouabain, it was found that 88% (±1, n=6) (HeLa) and 72% 
(± 3, n=3) (V79) of the 131Cs was located inside the cells. This strongly indicates that 131Cs stays in its 
ionic form in the medium, is transported into the cells by the  Na+/K+-ATPase and is homogenously 
distributed throughout the cell. Whether or not 131Cs was also transported into the cell by another 
mechanism was not examined (Figure 4.5). 
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Figure 4.5 Mechanisms of Caesium uptake and release 
Caesium is transported into the cells through the Na
+
/K
+
-ATPase, which also transports potassium into the cells in exchange 
for sodium. Other channels might also be involved in caesium uptake, but this was not further investigated. Caesium was 
also found to be released from the cells, whether this export was mediated by a channel or happened by diffusion through 
the bilipid-layer of the plasma membrane was not investigate. (My own figure)    
 
The uptake and release bio-kinetics of 131Cs is important for the absorbed dose and dose rate 
calculations.  131Cs was found to be taken up by both HeLa and V79 cells. The uptake and release were 
fitted to the exponential equations (A = A0 ∗ (1 − e
−t∗kc) and  (A = A0 ∗ e
−t∗kout ) in Matlab and kc 
and kout for HeLa and V79 cells were found to be; 
HeLa. 
kc:  1/283 min
-1 (with 95% conf. limits 1/251 min-1 to 1/325 min-1,R2 = 0.922)  
kout:  1/337 min
-1 (with 95% conf. limits 1/304 min-1 to 1/381 min-1, R2 = 0.958) 
1/339 min-1 (using solver in Excel) 
V79.  
kc:  1/204 min
-1 (with 95% conf. limits 1/154 min-1 to 1/303 min-1, R2 = 0.841)  
kout:  1/256 min
-1 (with 95% conf. limits 1/237 min-1 to 1/280 min-1, R2 = 0.9768)  
The confidence limits are not symmetric as the fitted functions are not linear. 
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The release data were first fitted in Excel using solver, and later in Matlab to obtain confidence 
intervals. The two different fitting methods used had a small influence on the obtained kout for HeLa 
cells, but had no effect on kout for V79 cells. The small difference in the fits of HeLa kout is insignificant 
for the further use in the calculation of cumulative activity. For reasons of the chronological 
progression of the experimental work, the value of kout =1/339 min
-1 for HeLa was used in the further 
calculations. 
The absolute value of the intracellular 131Cs activity concentration was in each of the internal dose 
delivery experiments measured by taking a sample of cells at the end of the uptake period. From this 
sample the cellular activity concentration was obtained. The kinetic constants only served to expand 
this measured instantaneous activity concentration into the cumulative activity concentration.  
The uncertainty in the absorbed dose and dose rate calculations from the uptake and release results 
was accordingly estimated to be small. A further elaboration on this argument and the entire 
uncertainty budget for absorbed doses and survival fractions is given in appendix 8.3 p. 198. 
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4.2 SC-values 
To calculate the absorbed dose, the cellular activity concentration of the Auger emitter and the SC-
value has to be known. In the above section, the bio-kinetics of 131Cs was elucidated including the 
subcellular distribution and cellular accumulation of 131Cs, which are important parameters for the SC-
values calculations. In addition to these parameters, the SC-value is also dependent on the geometry 
model used and on the cell monolayer height.  
In this work I have used a modified version of the MIRD cellular S-values, which I have chosen to 
denote SC-value. The SC-value was introduced earlier in section 2.5 p. 57. In this section I will 
elaborate on the implications of using this SC-value and show results supporting the statements I gave 
in the earlier introduction.     
 SC-values for 
131Cs, SC(N←CM) for HeLa and V79 cells 4.2.1
The geometry used in the SC-value calculations was a 100 % confluent cellular monolayer, in which the 
ellipsoid nuclei were positioned. The height of the cellular monolayer was 10 µm and 8 µm for the 
HeLa and V79 cells respectively. The source compartment was taken as the whole cell or rather the 
whole cellular monolayer and the nucleus was considered the target compartment. The SC-values 
have the unit Gy/(Bq*Sec)/pL (or more formal Gy * Bq-1 * Sec-1 * pL). A graphical representation of the 
geometry can be seen in Figure 4.6. 
 
 
Figure 4.6 Graphical representation of the geometry used for the SC-value calculations (not to scale) 
The pink “disc” represents the 100 % confluent cellular monolayer. The blue ellipsoids dispersed within it represent the 
nuclei.  The height of the cellular monolayer was 10 µm for HeLa cells and 8 µm for V79 cells.  
X 
y Z 
Results 
 107 
The important parameters for the SC-value calculations using this geometry turns out to be:  
o The confluency of the cells 
o The height of the cellular monolayer 
o The size (volume), shape and orientation of the nucleus (to a lesser degree). 
The average height of the cellular monolayer was found by confocal microscopy as explained in 
material and methods (section 3.3.6.1 p. 82). The confocal microscopy also gave us measurements of 
the nucleus sizes, although this is of minor importance in our model as will be show later in section 
4.2.1.5 p.117.  
 
 Cell layer height, confluency (denseness) and nuclei volumes 4.2.1.1
The average height of the cellular monolayer and the volumes of the nuclei were measured using the 
images obtained by confocal microscopy of living cells. The cells were grown to the same level of 
confluency as cells used in the experiments in order to take into account any change in cell layer 
height due to confluency level. Figure 4.7 A (HeLa) and Figure 4.8 A (V79) show a cross section (x-y 
plane) through the cellular monolayers. The nuclei are red (were originally stained blue, but the 
colour were afterwards digitally changed to red), while the plasma membranes are green. As can be 
seen, the entire image plane (horizontal or x-y plane) is covered by cells lying so close together that 
their plasma membranes are touching each other, leaving no space in between. This denseness is 
central for the geometry assumed in the SC-value calculations and its verification is important for 
correct absorbed dose calculations.  The average heights of the cellular monolayers were estimated 
using the stack of image planes covering the z direction (Z stack images). Figure 4.7 B (HeLa) and 
Figure 4.8 B (V79) show the estimated top of the cellular monolayer (seen from above) of HeLa and 
V79 cultures respectively. The “picture bars” (z axis), display the (vertical) cross sections in the y-z 
plane (through the red line) and the x-z plane (through the green line). The blue lines indicate the 
estimated position of the “top” of the cellular monolayer. This estimation was based on the 
observation of a sudden drop in the fluorescent intensity (in the x-y plane) at this location along, with 
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the presence of plasma membrane “on top” of the nuclei (see arrows Figure 4.7 B and Figure 4.8 B) 
and the information giving in the picture bars. Due to limitations in the confocal microscopy 
technique, the nuclei can still be seen “through” the plasma membrane. The position of the “bottom” 
of the cell culture was also estimated based on the observation of a sudden drop in the fluorescent 
intensity (pictures not shown).  
The average heights of the cellular monolayers were estimated to be 10 µm for the HeLa cells and 8 
µm (round off from 7.5 shown) for the V79 cells. 
      
 
A       B 
Figure 4.7 Confocal microcopy pictures (~600X magnificantion) of HeLa cells 
Picture A shows a cross section (x-y plane) in the middle of the cellular monolayer. Picture B shows the estimated “top” of 
the cellular monolayer in the x-y plane. The red and green lines indicate the position of the cross section in the z plane 
visible in the “picture bars” (x-z plane (red) and y-z plane (green)).The blues lines in the “picture bars” indicate the top of 
the cellular monolayer and were used for estimating the average monolayer height, which was estimated to be 10µm. The 
blue arrows show the presence of plasma membrane (green spots) “on top” of the nuclei (red). The shown hardcopy 
version are only for illustration, the “real” images as handled and displayed in the Zeiss ZEN software package are more 
rich in contrast and details. All geometrical measurements were taken directly in ZEN as described in methods (section 
3.3.6.1 p. 82). Cells were stained with WGA Oregon green 488 (5 µg/ml) (plamsammembrane) and Hoechst (20 
µg/ml)(nuclei, the colour digitally changed from blue to red) for 10-20 min at 5 % CO2, 37°C. Pictures were required by 
confocal laser scanning microscope (LSM 780) from Zeiss, using a 10x objective.   
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A       B 
Figure 4.8 Confocal microcopy pictures (~600X magnificantion) of V79 cells. 
Picture A shows a cross section (x-y plane) in the middle of the cellular monolayer. Picture B shows the estimated “top” of 
the cellular monolayer in the x-y plane. The red and green lines indicate the position of the cross section in the z plane 
visible in the “picture bars” (x-z plane (red) and y-z plane (green)).The blues lines in the “picture bars” indicate the top of 
the cellular monolayer and were used for estimating the average monolayer height, which was estimated to be 8 µm 
(round off from 7.5 µm shown in the figure). The blue arrows show the presence of plasma membrane (green spots) “on 
top” of the nuclei (red). The shown hardcopy version of are only for illustration, the “real” images as handled and displayed 
in the Zeiss ZEN software package are more rich in contrast and details. All geometrical measurements were taken directly 
in ZEN as described in methods (section 3.3.6.1 p. 82.) Cells were stained with WGA Oregon green 488 (5 µg/ml) and 
Hoechst (20 µg/ml)(nuclei, the colour digitally changed from blue to red)for 10-20 min at 5 % CO2, 37°C. Pictures were 
required by confocal laser scanning microscope (LSM 780) from Zeiss, using a 10x objective. 
 
 
 
The volumes and shapes of the nuclei were also estimated using the images obtained by confocal 
microscopy. It was found that the nuclei in general displayed an ellipsoid geometry, rotated at 
different angles in respect to the x-y plane (Figure 4.9). This rotation had only a minor influence on 
the calculated SC-values. 
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Figure 4.9 Shape and orientation of the nuclei (not to scale) 
The figure shows a simpler representation of the geometry of the cellular monolayer shown in Figure 4.6. The box 
represents the cellular monolayer and the blue ellipsoids represent the nuclei. As shown the nuclei display an ellipsoid 
shape, and were rotated at different angles in respect to the x-y plane.   
 
To determine the volume of the different nuclei, the lengths of the two axes (of the ellipsoid in the x-y 
plane) were measured using the image (in the Z-stack) in which each nucleus appeared largest. The 
length of the third ellipsoid axis was measured using the Z stack images. This was done for all nuclei 
that were completely contained inside the confocal image. These axes parameters of 29 HeLa cell 
nuclei and 50 V79 cell nuclei were thus measured. Although this axis measurement is not necessarily 
completely geometrical correct (the horizontal imaging planes are not necessarily aligned with the 
ellipsoid axes), it is a fair approximation given the otherwise big biological variation in shape. Figure 
4.10 A  and Figure 4.11 A  show HeLa cell nuclei and V79 cell nuclei that were measured, while Figure 
4.10 B and  Figure 4.11 B show the distribution in volumes of the nuclei for HeLa and V79 cells 
respectively, as found by the standard formula for ellipsoid volume; 
V =
4
3
∗ πabc               (Eq. 35) 
a, b and c, being the length of the three semi-axis. The volume of the HeLa cell nuclei ranged from 
below 0.1 pL to above 1.1 pL with an average of 0.84 pL ± 0.295, while the V79 cell nuclei ranged from 
around 0.1 pL to above 1.0 pL with an average of 0.53 pL ± 0.243.  
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A                                                                                                              B 
Figure 4.10 Distribution of HeLa cell nuclei volume 
The volumes of entirely visible nuclei were measured using the confocal microscopy images. The 29 numbered nuclei that 
were measured are displayed in (A), while (B) shows the distribution of the nuclei volumes. The nuclei volumes displayed a 
normal distribution and ranged from below 0.1pL to above 1.1pL, with an average volume of 
0.84 pL ± 0.295.(Microscopy and staining details as in Figure 4.7. 
 
 
                             A                                                                                                               B 
Figure 4.11  Distribution of V79 cell nuclei volume 
The volumes of entirely visible nuclei were measured using the confocal microscopy images. The 50 numbered nuclei that 
were measured are displayed in (A), while (B) shows the distribution of the nuclei volumes. The nuclei volumes displayed a 
normal distribution and ranged from around 0.1 pL to above 1.0 pL, with an average volume of  
0.53 pL ± 0.243. (Microscopy and staining details as in Figure 4.8) 
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 Calculation of the 131Cs SC-values. 4.2.1.2
-(SC(N←CM)) for HeLa and V79 cells in confluent, cellular monolayers 
SC-values for intracellular 
131Cs decays with whole cellular monolayer as source compartment and the 
nucleus as target compartment were calculated. The K- and L-Auger electron energies and intensities 
(24.6 keV (9.3 %) and 3.43 keV (79.7 %) respectively) provided by the NuDat 2.7 database were used 
in the calculations [25].  The absorbed dose contributions from MXY and higher shell Auger, Coster-
Kronig and Super Coster-Kronig electrons were ignored and so was the X-ray contribution. 
Monoenergetic electron dose kernels for a point source were calculated for each of the two electrons 
branches, and then added, using the same method applied by MIRD for cellular S-values. In 
agreement with MIRD, the dose kernels were found using Cole´s inverted formula for energy versus 
range as a stopping power [18] [82]. As argued in appendix 8.3.2 p. 204, the total electron energy 
emitted per decay was normalized to a 17 % higher value than given by NuDat 2.7 numbers. This 
normalization can be seen as an increase in the intensities and not the energy of the individual 
braches, and is made to allow for the higher emission calculated by Boon Quan Lee ([93] and personal 
communication with B.Q. Lee).The 131Cs was assumed to be homogenous distributed in the source 
compartment. The geometry was a confluent cellular monolayer with a respective height of 10 µm 
(HeLa) and 8 µm (V79). The nucleus was an ellipsoid with a volume of 0.84 pL (HeLa) or 0.53 pL (V79), 
dispersed in the confluent cellular monolayer. The dose contribution from the 131Cs present in the 
medium was ignored. The SC-values were expressed as Gy/(Bq*Sec)/pL. 
 
 Axial dose distribution 4.2.1.3
Due to the geometry (100% confluent cellular monolayer) the dose distribution in the x and y 
direction is constant (except for small edge effects near the wall of the cell culture well). The dose 
rate in the middle of the cell layer approaches the homogeneous, infinite volume value of 9.4*10-4 
Gy/(Bq*Sec)/pL. The axial (z-direction) dose distribution is however not constant. Figure 4.12 shows 
the axial dose distributions for the HeLa and V79 cellular monolayers. As can be seen the dose 
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distribution remain nearly the same along most of the cell layer (depth) varying between 7.4 *10-4 to 
8.1 10-4 Gy/(Bq*Sec)/pL for HeLa cells and 7.2 *10-4 to 7.8 *10-4  Gy/(Bq*Sec)/pL for V79 cells. The 
dose only diminishes more drastically very close to (<1 µm) the bottom and top of the monolayer. The 
SC-value is the integral of the dose distribution of the volume of the nucleus, divided by the mass 
(volume, because the cellular density = 1 g/cm3) of the nucleus. As the axial dose distribution is not 
constant, changes in the nucleus volume and rotation, will results in variation of the SC-values for the 
different nuclei. These variations are however small, due to the relatively “flat” dose distribution in 
the axial direction.  
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B 
Figure 4.12 Axial dose distributions for HeLa and V79 cellular monolayers 
The axial dose distributions for HeLa (A) and V79 (B) cellular monolayer are shown. The “bottom” of the cellular 
monolayers is located at 0 µm, while the top of the cellular monolayers are located at 10 µm (HeLa) and 8 µm (V79). The 
dose distribution remains nearly the same along most of the cell layer (depth) and only changes more drastically very close 
to the bottom and top of the monolayer (<1 µm).    
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 Dose contribution from the medium.  4.2.1.4
In the calculation of the SC-values, the 
131Cs located in the medium was ignored. The cells (both HeLa 
& V79) were shown to accumulate 131Cs (see section 4.1.2 p. 98) and an accumulation factor of at 
least 30 (compared to the medium) was found. Due to this accumulation of 131Cs in the cells, it was 
hypothesized that the dose contribution from the medium (to the nuclei) was neglectable, and it was 
therefore ignored in the SC-value calculation. To confirm that this was indeed true, the axial (z 
direction) dose distributions, ignoring or including, the dose contribution from the medium were 
calculated for both HeLa and V79 cellular monolayers (Figure 4.13). A 131Cs accumulation factor of 30 
(as this was the smallest of the two accumulation factors found) was used in the calculations. Figure 
4.13 shows the axial dose distribution for HeLa and V79 monolayer respectively, either ignoring (blue 
curve (HeLa) or purple curve (V79)) or including (green curves) the dose contribution from the 
medium. As can be seen the two curves are almost identical, only differing slightly towards the top of 
the cellular monolayer. This confirms that the dose contribution from the medium could be ignored 
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Figure 4.13 Dose contribution from the medium 
The axial dose rate distribution for HeLa (A) and V79 (B) cellular monolayers either ignoring (blue or purple curve) or 
including (green curve) the dose contribution from the medium are shown. The “bottom” of the cellular monolayers are 
located at 0 µm, while the top of the cellular monolayers are located at 10 µm (HeLa) and 8 µm (V79). The two curves are 
almost identical and only differ slightly towards the top of the monolayer.   
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 The impact of nucleus size on the SC-value 4.2.1.5
It was hypothesized that due to the geometry used (100% confluent cellular monolayer) and the unit 
of the SC-value Gy/(Bq*Sec)/pL, the SC-values would be very robust and change very little with change 
in the size of the nucleus. To confirm this, SC-values for all (except the smallest,< 0.1 pL) the different 
nuclei volumes of HeLa (~0.2 pL to >1.1 pL) and V79 cells (~0.1 to >1.0 pL) found in section 4.2.1.1 (p. 
107) were calculated. The SC-values for all these 29 HeLa and 50 V79 nuclei and their distribution are 
shown in Figure 4.14 and Figure 4.15 respectively. As can be seen, the SC-values for the HeLa nuclei 
(with volumes of 0.238 pL to 1.55 pL) ranged from 7.78*10-4 to 7.83*10-4 Gy/(Bq*Sec)/pL. The SC-
values for the V79 nuclei (with volumes of 0.107 pL to 1.440 pL) ranged from 7.45*10-4 to 7.63*10-4 
Gy/(Bq*Sec)/pL. The SC-values changes with less than 1% for HeLa cells and less than 2.5% for V79 
cells even though the nucleus volume changes by a factor 10. This shows that the SC-values are very 
robust and confirms that they are almost independent of the nucleus volume.   
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Figure 4.14 SC-values and distribution for HeLa nuclei with different volumes 
 SC-values (A) and their distribution (B) for HeLa cell nuclei with volumes ranging from around 0.2 pL to above 1.0 pL, 
positioned in the cellular monolayer, were calculated. Each blue mark in graph (A) represents the SC-value for one of the 29 
HeLa nuclei. As can be seen the SC-values almost do not change over the big range of nuclei volumes. The SC-values change 
with less than 1% even though the nuclei volume changes by a factor of 10.    
    
 
Results 
 119 
 
A 
 
 
B 
Figure 4.15 SC-values and distribution for V79 nuclei with different volumes 
SC-values (A) and their distribution (B) for V79 cell nuclei with volumes ranging from around 0.1 pL to above 1.0 pL, 
positioned in the cellular monolayer, were calculated. Each blue mark in graph (A) represents the SC-value for one of the 50 
V79 nuclei. As can be seen the SC-values almost do not change over the big range of nuclei volumes. The SC-values changes 
with less than 2.5% even though the nuclei volume changes by a factor of 10.      
 
 
 
Results 
 120 
 SC-value for HeLa cells 4.2.1.6
The SC-values for HeLa cells were calculated to be between 7.78*10
-4 to 7.83*10-4 Gy/(Bq*Sec)/pL , 
depending on the size of the nucleus. The value of 7.80 *10-4 Gy/(Bq*Sec)/pL was used in dose 
calculations. The uncertainty of the SC-value was estimated to be 3 %, dominated by uncertainty in 
cellular monolayer height. The influence of the cell layer height on SC-values has been derived from 
convolutions of the dose kernel over cell layer heights of 8 µm and 10 µm and 12 µm (calculation not 
shown) (Figure 4.16). 
 
Figure 4.16 Model of the cell culture geometry for HeLa cell 
A cellular monolayer height of 10 µm was used in the SC-value calculations. 
 
 
 SC-value for V79 cells 4.2.1.7
The SC-values for V79 cells were calculated to be between 7.45*10
-4 to 7.63 *10-4 Gy/(Bq*Sec)/pL , 
depending on the size of the nucleus, for the geometry stated above. The value of 7.50*10-4  
Gy/(Bq*Sec)/pL was used in dose calculations. The uncertainty of the SC-values was estimated to be 7 
%, dominated by uncertainty in the cellular monolayer height. The influence of the cell layer height on 
the SC-values for V79 cells was based on the influence for SC-values for HeLa and the influence of the 
nuclear volume of the V79 cells. As the V79 cellular monolayer was thinner, the influence of height on 
the SC-values was thought to be bigger (Figure 4.17). 
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Figure 4.17 Model of the cell culture geometry for V79 cell. 
A cellular monolayer height of 8 µm was used in the SC-value calculations. 
 
The calculated SC-values (SC(N←CM)) for 
131Cs were found to be around 7.8*10-4Gy/(Bq*Sec)/pL for 
HeLa cells,  and 7,5*10-4 Gy/(Bq*Sec)/pL for V79 cells. These values are comfortingly close to the 
simple, first principle value of 9.41*10-4 Gy/(Bq*Sec)/pL (using our “normalised” emission rates) that 
is easily calculated for the absorbed dose anywhere inside an infinitely large homogenous water 
solution of 131Cs using the decays information for the Auger electrons provided by the NuDat 2.7 
database [25].  
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4.3 Absorbed dose calculations and dose rate profiling. 
To calculate the absorbed dose, the SC-values and the activity concentration of 
131Cs in the cells over 
time have to be known.  Note that since our SC-values are expressed as Gy/(Bq*Sec)/pL, it is the 
activity concentration of 131Cs in the cells that is multiplied with the SC-value, and not the activity 
(used in the MIRD cellular S-values).  
To calculate the absorbed dose and dose rates we need; 
- The SC-value, which was determined to be 7.8*10
-4 Gy/(Bq*Sec)/pL (HeLa) and 7.5*10-4 
Gy/(Bq*Sec)/pL (V79)        
 
- The uptake kinetics or rather the activity concentration of 131Cs in the cells over time. This 
“uptake” could be described by the exponential equation (A = A0 ∗ (1 − e
−t∗
1
283 min)) for HeLa 
cells and (A = A0 ∗ (1 − e
−t∗
1
204 min )) for V79 cells. A0 is the activity concentration at 
equilibrium. 
 
- The cellular activity concentration of 131Cs, at least at 1 time point. For experimental reasons 
this time point was when the cells were removed from the 131Cs containing medium. 
 
- The release kinetic could be described by the exponential equation (A = A0 ∗ e
−t∗
1
339 min) for 
HeLa cells and (A = A0 ∗ e
−t∗
1
256 min)) for V79 cells. Here A0 is the activity at the time when 
activity is removed from the medium. The time (t) is now the time that has passed since 
removal of activity. 
 
- The combined activity expression becomes (exemplified by HeLa cells): 
 
Aup = A480 ∗ (1 − e
−480 min
283 min  )
−1
∗ (1 − e
−t
283 min) for t ≤ 480 min 
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Aout = A480 ∗ e
−
t−480 min
239 min  for t > 480 min              (Eq. 36) 
The cumulative activity concentration (A∗) relevant to internal absorbed dose in a given experiment is 
now 
A∗ =  ∫ Aup
480
0
∗ dt +  ∫ Aout ∗ dt
1440
480
             (Eq. 37) 
The total internal absorbed dose to cell nuclei in such experiment is  
D = Sc(N ← C) ∗ A
∗                   (Eq. 38) 
An example of the absorbed dose and dose rate calculation for cell exposed to intracellular 131Cs and 
evaluated by γH2AX or clonogenic cell survival can be seen below (Figure 4.18). The example is based 
on the calculation of the absorbed dose and dose rates for HeLa cells, but they are essential the same 
for V79 cells (just using, the values obtained for V79 cells instead).  
 
The activity concentration of 131Cs in HeLa for this example was set to be 0.20 Bq/pL after 480 min of 
incubation. Using this value and the equation that described the activity concentration of 131Cs over 
time, the cellular activity concentration at every time point was calculated (Figure 4.18 A &C). By 
multiplying the cellular activity concentrating (at ever time point) with the SC-values, the dose rate (at 
every time point was obtained) (Figure 4.18 B & D). The absorbed dose over time was found by 
integration of the dose rate curve (Figure 4.18 B & D). At time point 480 min, the cells were removed 
from the 131Cs containing medium and either prepared and fixation for the γH2AX assay (blue arrow) 
or seeded for clonogenic cell survival (blue arrow). Cells prepared for the γH2AX were permeabilized 
and fixed shortly after they were removed from the 131Cs containing medium, and so intracellular 
131Cs decays after this point (480 min) were not considered in the absorbed dose calculations. In 
contrast, cells seeded for clonogenic cell survival, would still be exposed to intracellular 131Cs decays, 
as the 131Cs is slowly released from the cells. By using the equation describing the release kinetic and 
the activity concentrating at time point 480 min, the cellular activity concentration and so the dose 
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rates and absorbed dose for the cells from time point 480 min and onwards to 1440 min were 
calculated.  
 
A       B 
 
C       D 
Figure 4.18 Representation of change in cellular activity concentration (Bq/pL), absorbed dose and dose rate as a 
function of time for HeLa cells with an activity concentration of 0.2 Bq/pL at 480 min. 
The 
131
Cs activity concentration (blue curve) increases over time until the 
131
Cs is removed from the medium (blue arrow), 
whereafter it decreases exponentially. The dose rate (green curve) follows the same pattern. The absorbed dose (purple 
curve) increases over time but flattens out as the cellular activity concentration approaches zero. Note, that the absorbed 
dose after 24 hours is approximately 2 times higher than it is after 8 hours (the time where the 
131
Cs is removed from the 
culture medium). 
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After 24 h, the activity concentration of 131Cs in the cells has decrease to ~6 % (HeLa) and ~2 % (V79) 
of the maximum value, and the dose rate is only ~33 mGy/h (HeLa) or ~ 16 mGy/h (V79). After 24 
hours, HeLa and V79 cells would also have had time to pass through the cell cycle once or twice. 
Therefore it was decided, that it was reasonable to end activity integration, absorbed dose calculation 
and dose rate profiling after 24 hours after starting the experiment. 
As can be seen on Figure 4.18 the cellular 131Cs activity concentration increases till 480 min, where the 
131Cs is removed from the medium. Thereafter it decreases exponentially. The change in dose rate 
over time has a similar time course and is directly proportional to the change in cellular activity 
concentration. The absorbed dose continues to increase over time but flattens out as the cellular 
activity concentration approaches zero. It is worth noticing that the absorbed dose is around a factor 
2 higher at 24 h than at 8 h where the 131Cs was removed. 
This is how the absorbed doses and dose rate profiles for all the cells exposed to 131Cs were obtained. 
The dose rate profiles for each independent experiment were then mimicked by the external γ-rays 
exposures. This was done by moving the incubator with the cells (in steps) closer to (or farther away 
from) the γ-rays source. The dose rates used (at each step) for the individually experiments (γH2AX 
and clonogenic), are show in those sections (section 4.4.2.1.1 p. 132 and section 4.4.3.1 p. 136).  
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 Uncertainties  and errors 4.3.1
Two simplifications were made in the absorbed dose and dose rate calculations. First, the physical 
half-life of 131Cs was ignored. The cellular activity concentration measured (at time point 480 min) was 
used to give activity both before and after 480 min ,but as the half-life of 131Cs is 9.689 days, the error 
introduced is small (<1 %). 
Second, it was assumed that all the intracellular 131Cs activity had disappeared after 24 hours and so 
the cellular activity concentration curve was not integrated to infinity (and the absorbed dose stated 
equalled the absorbed dose at time point 24 h). Likewise, the external reference γ-ray exposures were 
ended after 24 h. This 24 h truncation causes an error less than 1 % in the total absorbed dose.  
Other uncertainties in the absorbed dose and dose rate calculations come from: 
-Uncertainty in the SC-value. The total uncertainty was estimated to be 3 % and 7 % for HeLa and V79 
cells respectively. The uncertainty was dominated by: 
o The height of the cellular monolayer  
o Uncertainties in the decay data used. The stated uncertainties on Auger branch 
intensities in NuDat 2.7 are very small (<0.5%) but the calculations by Boon Q. Lee [93] 
indicate substantially higher Auger yields. This is discussed in appendix 8.3.2 p. 204 and 
has led to a 17 % higher value for the total energy released. It lead to a systematic bias 
of all internal doses by 17%, but it is conservative as far as the RBE measurements is 
concerned, and at present it is not possible to make this more accurate.  The decay 
scheme uncertainty is not included in the internal absorbed dose uncertainty given 
below. 
-Uncertainty in the uptake and release bio-kinetics of 131Cs. This is described in appendix 8.3.1 p. 201.  
1 s.d. errors in kc and kout give an error of 1.5-3.3 % in the cumulative activity (A∗) for Hela cells. 
Corresponding numbers for V79 are 0.23 - 4.0 %. 
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The span in errors reflects differences in assumptions about the nature of uncertainties in kc and kout. 
If they are systematic, the may well be biased in the same direction. If the uncertainty is purely 
statistical it is only a low (but finite) chance that they are both wrong by more than 1 standard 
deviation in opposing directions. In the end, I conclude that the impact of the uncertainty of the 
caesium kinetics on the cumulative activity is less than 4 %. As I will show below, the uncertainty on 
the cell counting has a much large impact (in the order of 20 %). The kinetics uncertainty is hence 
forward ignored.    
- uncertainty in the measured cellular activity concentration. This was dominated by: 
o The estimated total cell volume. The cell concentration and the cell sizes were measured by 
the Sceptor (from Merck Millipore®). In addition cell concentrations (but not sizes) (from the 
same sample) were measured by the Muse (from Merck Millipore®). The Muse estimated on 
average the cell concentration to be 20 % higher than the Sceptor. However, as the Sceptor 
measured both cell number and their size (and this was the parameters needed), the results 
from the Sceptor were used. 
When combining these errors in quadrature it will by far be dominated by the cell counting 
uncertainty. The total uncertainty in the absorbed doses and dose rate calculations were therefore 
estimated to be 22 % for HeLa cells and 23 % for V79 cells 
For further elaboration on the calculation and estimations of the uncertainties, see appendix 8.3 p. 
198.  
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4.4 Radiotoxicity of 131Cs 
The SC-values and the bio-kinetics of 
131Cs in HeLa and V79 cells had now been elucidated and 
absorbed dose calculations and dose rate profiling was established. It was therefore time to advance 
to the examination of the radiotoxicity and RBE of the Auger emitter 131Cs. The radiotoxicity of 
intracellular and extracellular Auger decays was investigated using the γH2AX assay, whereas the RBE 
of 131Cs was studied using the γH2AX and the clonogenic cell survival assay. Due to a possible dose 
rate effect, it was highly prioritized to use similar dose rate profiles for both the 131Cs exposed and the 
γ-ray exposed (reference radiation) cells when measuring RBE values. (For further elaboration on the 
data presentation of this specific γH2AX assay and the clonogenic cell survival assay see section 3.1 p. 
59).  
 
 Radiotoxicity of intracellular and extracellular 131Cs 4.4.1
decays 
The dosimetry model used to calculate SC-values only considers the 
131Cs located inside the cells, and 
completely ignores the majority of 131Cs which is located in the medium outside the cells. This was 
done to simplify the model and was justified by the relatively small dose contribution from this source 
(see section 4.2.1.4 p. 115). Furthermore, it is agreed on that for an Auger decay to be (highly) 
radiotoxic it has to occur intracellular and preferable intranuclear. Auger emitters located 
extracellularly are believed to cause minimum DNA damage [28]. However to investigate this 
assumption, HeLa cells were incubated with the same activity concentration of 131Cs in the medium 
for the same amount of time, but in the absence or presence of 8.45 µM ouabain. Ouabain blocks 
131Cs uptake (see section 4.1.4 p. 102) and ouabain incubated cells were therefore exposed to much 
less intracellular 131Cs decays, but (almost) the same amount of extracellular 131Cs decays. 
Radiotoxicity was assessed by γH2AX assay.  
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The results are presented as “fold over the control levels” of the ƴH2AX response (percentage of 
activated cells) as a function of incubation time or as a function of “approximate” absorbed dose 
(Figure  4.19). As the HeLa cells were not 100 % confluent in this experiment (which is an assumption 
in the SC-values used) the stated absorbed doses are only an approximation. The real absorbed doses 
might be a bit less, for all samples.  Based on the intensities of the fluorescent antibodies, indicating 
the amount (and size) of the DNA DSBs in a cell, the cell is grouped as either activated or inactivated. 
The amount of activated over inactivated cells are calculated (ƴH2AX response) and normalised to 
controls to give fold over control levels. (For further elaboration see section 3.1.1 p. 59). 
HeLa cells incubated with 131Cs in the absent of ouabain show a steady increase in the ƴH2AX 
response with incubation time, and reached a 3.5 fold increase (compared to controls) after 480 min. 
In contrast, cells incubated with 131Cs in the presence of ouabain did not show any significant increase 
in their ƴH2AX response after 380 min and 480 min incubation, even though the 131Cs activity 
concentration in the medium was the same (Figure  4.19). 
 
 
A 
Figure text on next page 
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B 
Figure  4.19 ƴH2AX response in cells after exposure to intracellular or extracellular 
131
Cs decays 
Results are presented as ƴH2AX response plotted as fold over the control levels as a function of incubation time (A) or 
approximate absorbed dose (B). As the HeLa cells were not 100 % confluent in this experiment (which is an assumption in 
the SC-values used) the stated absorbed dose, is only an approximation. The real absorbed dose might be a bit less for all 
samples. HeLa cells were incubated with 
131
Cs in the present (green) or absent (blue) of ouabain, and so respectively, 
primarily exposed to intracellular or extracellular 
131
Cs decays. The ƴH2AX response increased with incubation time and 
absorbed dose in HeLa cells exposed to intracellular 
131
Cs decays, reaching a 3.5 fold increase after 480 min corresponding 
to ~5 Gy. However, HeLa cells incubated in the presence of ouabain, (mainly exposed to extracellular 
131
Cs) did not show 
any significant increase in their ƴH2AX response, neither with increasing incubation time or absorbed dose. Data is 
presented average ± s.d. of 3 independent experiments. The data points without any visible error bars only included one or 
two samples and a standard deviation could therefore not be calculated. 
 
The absorbed dose stated in Figure  4.19 was calculated (as shown in the example given in section 4.3 
p. 122) based on the measured activity concentration of 131Cs over time in these cells (Figure 4.20). As 
can be seen in Figure 4.20, the “uptake” of 131Cs (represented as intracellular 131Cs activity 
concentration) over time, is much lower when cells are incubation with ouabain, than when no 
ouabain is present. However, still some 131Cs is taken up by the cells in the presence of ouabain, 
resulting in the absorbed dose shown in Figure  4.19.  
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Figure 4.20 Uptake of 
131
Cs in HeLa cells incubated with or without ouabain 
The uptake of 
131
Cs in HeLa cells over time is presented as intracellular 
131
Cs activity concentration (Bq/pL) as a function of 
incubation time. The uptake of 
131
Cs in HeLa cells incubated in the presence of 8.45 µM ouabain was significantly less 
compared to cells incubated in the absence of ouabain. These data is the same that were used to calculate the absorbed 
doses on Figure  4.19. Data is presented as average ± s.d. of 3 independent experiments. The data points without any 
visible error bars only included one or two samples and a standard deviation could therefore not be calculated.   
 
Cells incubated in the absent of ouabain showed an increase in their ƴH2AX response and reach a 3.5 
fold increase (compared to control levels) after 5 Gy, whereas cells incubated with ouabain, showed 
no significant increase after receiving ~2 Gy. It is however interesting, that the ƴH2AX response at ~2 
Gy, appear to be lower in the cells incubated in the presence of ouabain, than those incubated in the 
absence. A possible reason for this will be discussed in the section 5.3.1 p. 161.      
In summary, the results demonstrate that the cellular localisation of 131Cs is important for its 
radiotoxicity. 131Cs located extracellular did not seem to cause any significant increase in the ƴH2AX 
response compared to control levels, whereas 131Cs located intracellularly showed significant increase 
in their ƴH2AX response.     
 
Results 
 132 
 Relative biological effectiveness of intracellular 131Cs 4.4.2
decay 
The RBE of 131Cs was investigated in HeLa and V79 cells using the γH2AX assay and clonogenic cell 
survival. As it is known that the dose rate can have a significant effect on the biological outcome, it 
was highly prioritized to use similar dose rate profiles for the 131Cs exposed cells and the cells exposed 
to the reference radiation (external γ-rays).  
 
 RBE of intracellular 131Cs exposure evaluated by γH2AX assay  4.4.2.1
The RBE of intracellular 131Cs decay in HeLa cells was investigated using yH2AX as endpoint. The data 
from the γH2AX assay of cells exposed to intracellular 131Cs (without ouabain) used in the above 
section (4.4.1 p.128) are the same data set that is used in this section (4.4.2.1). Again, as the HeLa 
cells were not 100% confluent in the experiment (which is an assumption in the SC-values used), the 
stated absorbed doses, are only an approximation. The real absorbed doses might be a bit less for the 
131Cs exposed cells        
 
 Experimental dose rate profiles 4.4.2.1.1.
As the dose rate of the intracellular 131Cs exposure was dependent on the 131Cs uptake kinetics in the 
cells and as this uptake could vary, dependent on the “quality” of the 131CsCl solution, the dose rate 
profile was first calculated for these 131Cs-exposed cells (as shown in the example given in section 4.3 
p. 122) The obtained dose rate profile was then used to plan the external γ-ray exposure, where the 
dose rate was much easier to control. A representation of the experimental dose rates profiles and 
absorbed dose over time for the 131Cs exposed cells (blue) and the externally γ-rays exposed cells 
(red) is pictured in Figure 4.21. To match the continuously increase in dose rate of the 131Cs exposed 
cells, the γ-ray exposed cells were moved in steps closer to the γ-ray source. During this time in which 
the incubator was moved the cells were not exposed. This is the reason the area under the (step-wise) 
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curve in the Figure 4.21 A, appears to be somewhat larger for the γ-ray exposed cells, than the 131Cs 
exposed cells, even though the absorbed dose in Figure 4.21 B shows that this difference between the 
absorbed doses is quite small. The very similar (time) course of the two curves showing the absorbed 
dose over time, confirms that both the dose rates and absorbed dose for the two exposures were 
nicely matched.   
 
 
A 
Figure text on next page 
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B 
Figure 4.21 Representation of the dose rate profiles and absorbed doses for HeLa cells exposed to internal 
131
Cs or 
external γ-rays for the γH2AX assay  
The experimental dose rate profiles presented as dose rate over time (A) and absorbed dose over time (B) for the 
131
Cs and 
γ-ray exposed cells are shown. To continuously get a comparable dose rate to the constantly increasing one of the 
131
Cs 
exposed cells (blue), the incubator with the γ-ray exposed cells (red) were moved in steps closer to the γ-ray source. The 
small breaks in the red curve (blue arrow) represent the short time in which the incubator was moved and the exposure 
was interrupted. Therefore the areas under the curve(s) appear to be larger for the γ-ray exposed cells, than the 
131
Cs 
exposed cells, even though the difference in absorbed dose is small. The curve of absorbed dose over time (B) of the 
131
Cs  
(blue) and γ-ray (red) exposed cells, are very similar, confirming that both the dose rates and the absorbed dose of the two 
exposures were nicely match.   
 
 γH2AX 4.4.2.1.2.
The biological effect was assessed by the γH2AX assay. The γH2AX  response (the percentage of 
activated cells in a giving sample) is compared to a control sample (unexposed cells) to give the “fold 
over control level” value (for more information on the γH2AX assay see section 3.1.1 p. 59). The 
results are presented as γH2AX response of the two exposures (intracellular 131Cs and external γ-ray) 
over absorbed dose (Figure 4.22). The γH2AX response in cells exposed to either intracellular 131Cs 
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decay (blue) or to external γ-rays (red), increases with increasing absorbed dose and reach a 3.5 fold 
increase (compared to control levels) at ~5 Gy. The γH2AX response at the different absorbed doses is 
very similar for the two exposures showing no indication of an increased radiobiological response for 
the 131Cs exposed cells. No increased radiotoxicity of 131Cs compared to y-rays at similar absorbed 
dose and dose rates could be observed and a RBE of 1 was therefore obtained. As this was evident 
from the standard deviations, no statistical test was performed. 
 
Figure 4.22 γH2AX response after exposure to intracellular 
131
Cs decays or external γ-rays 
Results are presented as γH2AX response plotted as fold over the control levels as a function of absorbed dose.  As the HeLa 
cells were not 100% confluent in the experiment (which is an assumption in the SC-values used) the stated absorbed doses 
for the 
131
Cs exposed cells are only approximate. Cells were exposed to either intracellular 
131
Cs decays (blue) or external γ-
rays (red) at similar dose rate profiles. The γH2AX response increased with the absorbed dose, reaching a 3.5 fold increase 
(compared to control levels) after receiving ~5-6 Gy. The ƴH2AX response at the different absorbed doses was similar for 
the two exposures and no difference in the radiotoxicity was observed. This corresponds to a RBE of 1. Data are presented 
as average ± s.d. of 3 independent experiments. The data points without any visible error bars only included one or two 
samples and a standard deviation could therefore not be calculated. As it was evident from the standard deviations, that 
there was no significant difference between biological effect of the two radiation exposures, no statistical test was 
performed. 
137
Cs ƴ-rays was used as reference radiation. 
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 RBE of intracellular 131Cs exposures evaluated by 4.4.3
clonogenic cell survival  
The RBE of intracellular 131Cs decays in HeLa and V79 cells was investigated using clonogenic cell 
survival as an endpoint.  
 
 Experimental dose rate profiles 4.4.3.1
As the dose rate of the intracellular 131Cs exposure was again dependent on the 131Cs uptake kinetics 
in the cells and as this uptake could vary, dependent on the “quality” of the 131CsCl solution, the dose 
rate profile was first calculated for these 131Cs-exposed cells (as shown above in the example in 
section 4.3 p.122). The obtained dose rate profile was then used to plan the external γ-ray exposures 
(as these were much easier to control) so that they would resemble as closely as possible the dose 
rate profile of the cells incubated with 131Cs. Given the restriction of our calibration facility, a dose 
rate above 492 mGy/h for these experiments (clonogenic cell survival) could not be achieved for the 
external γ-ray exposures. It was therefore prioritized (if needed) to reach the same absorbed dose (for 
131Cs and γ-ray exposed cells) after 24 hours, even though it compromised the dose rate match. Due 
to the number and size of samples (T25 flasks) placed in the incubator, it was necessary to increase 
the distance from the ƴ-ray source, to get a radiation field big enough to equally exposure all the 
flasks. Therefore a significant lower dose rate could be used in these experiments, compared to the 
dose rate used in the above “ƴH2AX” experiments (Figure 4.21 p. 134) (in which only a couple of 48-
well plates were placed in the incubator).   
Figure 4.23 and Figure 4.24 shows a representation of the experimental dose rates profiles (A) and 
the absorbed dose (B) for HeLa and V79 cells. The dose rate for the externally γ-ray exposed cells (red) 
changes in steps as the incubator is moved (closer to or further away from the ƴ-ray source), while 
the dose rate for the internal 131Cs exposed cells (blue) changes continuously. During the time in 
which the incubator was moved the cells were not exposed. This is the reason the area or under the 
(step-wise) curve in Figure 4.23 A and Figure 4.24 A, appears to be larger for the γ-ray exposed cells, 
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than the 131Cs exposed cells, even though the absorbed doses in Figure 4.23 B and Figure 4.24 B 
shows that the total absorbed doses for the two exposures were very similar. 
 
 
A 
 
Figure text on next page 
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      B                                                                           
Figure 4.23 Representation of the dose rate profiles and absorbed dose over time for HeLa cells exposed to internal 
131
Cs or external γ-rays (protracted) for clonogenic cell survival. 
 The experimental dose rate profiles presented as dose rate (A) and absorbed dose (B) over time for the 
131
Cs (blue) and γ-
ray exposed (red) cells are shown. To match the continuously increase in dose rate for the 
131
Cs exposed cells, the incubator 
with the γ-ray exposed cells were moved in steps closer to the γ-ray source. The small breaks in the red curve represent 
(blue arrows) the short time in which the incubator was moved and the exposure was interrupted. The green arrows (and 
the purple line on the blue curve) indicate the time where the cells were handled for seeding for clonogenic cell survival 
curves.  As the 
131
Cs was located intracellularly, the exposure of these cells continued during the seeding, while the γ-ray 
exposed cells were not exposed during this seeding process The absorbed dose over time (B) of the 
131
Cs  (blue) and γ-ray 
(red) exposed cells, are very similar, confirming that both the dose rates and the absorbed dose for the two exposures were 
nicely match.   
 
As the dose rate for the 131Cs exposed cells did not exceed the limit of 492 mGy/h it was easily 
matched and so was the absorbed dose over time. At the time point where the cells were seeded for 
clonogenic cell survival (green arrows on Figure 4.23) the γ-ray exposed cells had received the same 
absorbed dose as the 131Cs exposed cells.     
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Figure 4.24 Representation of the dose rate profiles and absorbed dose for V79 cells exposed to internal 
131
Cs or 
external γ-rays (protracted) for clonogenic cell survival. 
 The experimental dose rate profiles presented as dose rate (A) and absorbed dose (B) over time for the 
131
Cs (purple) and 
γ-ray exposed (red) cells are shown. To match the continuously increase in dose rate of the 
131
Cs exposed cells, the 
incubator with the γ-ray exposed cells were moved in steps closer to the γ-ray source. The small breaks (blue arrows) in the 
red curve represent the short time in which the incubator was moved and the exposure was interrupted. The green arrows 
(and the blue line on the purple curve) indicate the time where the cells were handled for seeding for clonogenic cell 
survival curves.  As the 
131
Cs was located intracellularly, the exposure of these cells continued during the seeding, while the 
γ-ray exposed cells were not exposed during this seeding process. At the time of seeding, the γ-ray exposed cells had 
received a smaller absorbed dose, than the 
131
Cs exposed cells, due to the dose rate limit in the calibration facility. This 
“lack” of absorbed dose was afterwards corrected for by continuing the exposure at the highest possible dose rate.  The 
absorbed dose over time (B) of the 
131
Cs (purple) and γ-ray (red) exposed cells deviate some due to the lower dose rate of 
the γ-ray exposed cells. However, as can be seen, at the end of the experiment (time point ~1440 min) the same absorbed 
dose was reach for the two exposures. 
 
For the V79 cells the dose rates could not be matched as nicely as for the HeLa cells. As can be seen in 
Figure 4.24, the dose rate for the 131Cs exposed cells exceeded the limit of 492 mGy/h (the highest 
dose rate possible for these experiments (clonogenic cell survival) in our calibration facility). As a 
consequence the γ-rays exposed cells had received a smaller absorbed dose than the 131Cs exposed 
cells when they were seeded for clonogenic cell survival. It was prioritized that the cells would receive 
the same absorbed dose after 24 hours (the end of the exposure), and so the “lack of absorbed dose” 
was corrected for afterwards, by continuing the exposure at the highest possible dose rate. As can be 
seen in Figure 4.24 B the y-ray exposed cells reached the same total absorbed dose after 24 hours as 
the 131Cs exposed cells.  
 
 Cellular and colony morphology of HeLa and V79 cells  4.4.3.2
 HeLa cells 4.4.3.2.1.
The morphology of the individual HeLa cells and the size and cell morphology of the colonies formed, 
in the clonogenic cell survival assay, varied within and between the samples exposed to intracellular 
131Cs decays and external γ-rays. This is of interest as it might elucidate possible mechanisms behind 
the different biological responses observed after exposure to different radiation qualities.  
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The two most common cell morphologies observed are showed in Figure 4.25 A B. These cells were 
normal in size, (~ 50-70 µm in diameter) and looked healthy (Figure 4.25 A) whereas those seen in 
Figure 4.25 B were much bigger than the normal cells (120-290 µm in diameter) and had a highly 
enlarge and flat cytoplasm. This (latter) morphology resembles that of senescence cells [117].  A small 
amount of the HeLa cells displayed the morphology showed in Figure 4.25 C. These cells were also 
highly enlarged and very elongated (~200 µm long). 
The colonies formed by the external γ-ray exposed cells displayed a high variation in their size and 
both big and small colonies plus aborted colonies were observed. Most of the colonies, consisted only 
of normal looking cells as seen in Figure 4.25-A. However, some colonies made up of cells presenting 
a senescence like morphology (Figure 4.25 B), or a mixture of these and normal sized cells were also 
present. A few colonies containing the very elongated cells (Figure 4.25 C) were also observed.     
Almost no colonies were formed by cells exposed to 131Cs , resulting in a very low survival fraction.  
However, many single cells were still present in some of the samples (cultures), while other samples 
contained significantly fewer cells and some samples contained almost no cells. The cells that were 
present in the 131Cs exposed samples either looked healthy and normal (Figure 4.25 A) or displayed a 
senescence-like morphology (Figure 4.25 B). 
Most of the colonies formed in the control samples (for both the 131Cs and the γ-rays exposed cells) 
looked healthy and contained many normal sized cells (Figure 4.25 A).  
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C 
Figure 4.25 Representative pictures of the different cell and colony morphologies displayed by HeLa cells. (~60X 
magnificantion 
All pictures were acquired by the light microscopy (Axiovert 200M from Zeiss) using a 5x objective and Axiovision SE 64 
software.  As the cells were seeded in T25-falsk the images of the colonies had to be acquired through the thick layer of 
plastic (of the T25- flaks), which compromised the quality of the pictures. Still the difference in size and morphology is 
obvious. The morphology of the HeLa cells and the colonies formed, varied within and between samples. A colony 
containing mainly healthy and normal sized (~ 50-70µm in diameter) cells are pictured in A.  A colony containing mainly 
cells with a senescence like morphology are pictured in B. These cells were much bigger than “normal” cells (120-290 µm 
in diameter) and had an enlarged and flat cytoplasm. The colony pictured in C, contained cells that were very elongated 
and much bigger (~200µm in length) than the “normal “cells.  Scale bar: 500 µm. 
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 V79 cells 4.4.3.2.2.
The morphology of the V79 cells and the colonies formed did not vary between the samples exposed 
to 131Cs, external ƴ-ray or the controls. Most of the colonies formed were big and consisted of much 
more than 50 cells (Figure 4.26). The cells in the colonies looked heathy, and had a size of around 20 
µm x 10 µm, which is the normal size for these V79 cells.  
 
Figure 4.26 Representative picture of the cell and colony morphology displayed by V79 cells (~60X magnificantion 
The picture was acquired by the light microscopy (Axiovert 200M from Zeiss) using a 5x objective and Axiovision SE64 
software. As the cells were seeded in T25-falsk the image had to be acquired through the thick layer of plastic (of the T25- 
flaks), which compromised the quality of the picture. Still the size and morphology is obvious. The picture shows a colony 
with many normal and healthy looking cells with sizes around 20 µm x 10 µm. Scale bar: 500µm 
 
 Clonogenic cell survival  4.4.3.3
HeLa and V79 cells were exposed to either intracellular 131Cs decays, or external γ-rays using similar 
dose rate profiles.  Absorbed doses between 4.7 Gy and 6.1 Gy were used in the HeLa cell exposures, 
while absorbed doses around 3 Gy, 7 Gy and 10 Gy were used in the V79 cell exposures. The absorbed 
dose and dose rate profiles for the 131Cs exposed cells were calculated as shown in the example in 
section 4.3 p. 122. A representation of how the dose rate profiles of the internal 131Cs exposures and 
the external γ-ray exposures were match were shown above in section 4.4.3.1 p. 136. HeLa cells and 
V79 cells were also exposed to external y-rays using a dose rate of 1.5 Gy/min (in this context “acute 
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exposure”). These cells were however exposed under different conditions (low cell density) and so 
care should be taken in drawing conclusion from these survival curves. However they still give a good 
estimate of the influence of the dose rate on the biological response. For convenience these external 
γ-ray exposures will be referred to as acute exposures, while the other external γ-rays exposure, using 
matched dose rate profiles, will be referred to as protracted exposures.     
 
 HeLa cells 4.4.3.3.1.
The clonogenic cell survival curves for HeLa cells can be seen in Figure 4.27. The experimentally 
obtained data points and their estimated uncertainties (see section 4.4.4 p. 149) for the 131Cs exposed 
cells are shown along with the fitted survival curves. The data points with estimated uncertainties for 
the γ-rays exposed cells (protracted & acute), are presented in appendix 8.4 p. 206. As only a limited 
range of absorbed doses were received by the 131Cs exposed and the protracted γ-ray exposed HeLa 
cells, it was not possible to deduce the presence of a potential shoulder on the survival curves. The 
survival curves were accordingly fitted to the linear model (𝑦 = 𝑒−∝𝑥), as this model uses fewest 
parameters. A greater range in absorbed dose was however received by the HeLa cells exposed 
acutely to external γ-rays, and as the survival curve showed a clear shoulder, it was fitted to the linear 
quadratic model ( y = e−(αx+βx
2)) (which is also the model most often used to fit survival curves for 
low LET radiation exposures [39]). α values (and β values) plus the D37 values for the different 
exposures were found to be 1.71 (α) and 0.58 Gy (D37) for the 
131Cs exposed cells, 0.38 (α) and 2.6 Gy 
(D37) for the protracted γ-ray exposed cells, and  0.136 (α), 0.0786 (β) and 2.8 Gy (D37) for the acutely 
γ-rays exposed cells. 
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Figure 4.27 Clonogenic cell survival curves for HeLa cells exposed to 
131
Cs or external γ-ray (protracted & acute) 
Survival fraction as a function of absorbed dose for HeLa cells exposed to internal 
131
Cs (blue) or external γ-ray at similar 
dose rate profiles (red) or external y-ray delivered acutely (black) are shown. The survival curves were fitted to either the 
linear model ((𝑦 = 𝑒−1.71𝑥, 131Cs exposed cells), (𝑦 = 𝑒−0.384𝑥, (protracted γ-ray exposed cells)), or the linear quadratic 
model (𝑦 = 𝑒−(0.136𝑥+0.0786𝑥
2),  acute γ-ray exposed cells). The experimentally obtained data points (average of 3 
replicates) for the 
131
Cs exposed cells are presented. The vertical error bars reflect the observed standard deviation in 
survival fraction, while the horizontal error bars reflect the estimated uncertainty in absorbed dose. To simplify the figure 
the obtained data points and estimated uncertainties for the γ-ray exposed cells (protracted and acute) are only presented 
in appendix 8.4.1 p. 206. The difference in slope of the survival curves for the 
131
Cs exposed and γ-ray (protracted) exposed 
cells gives a RBE of 4.5. (
137
Cs ƴ-rays were used as reference radiation). 
 
 
As can be seen on the survival curves (Figure 4.27), cells exposed to intracellular 131Cs decay had the 
lowest survival fraction, while the cells exposed to external ƴ-rays (protracted) had a substantially 
higher survival fraction, and the cells exposed to acute γ-rays had a survival fraction a bit lower than 
these. The presence of a possible dose rate effect was difficult to interpret due to the limited 
absorbed dose range used in the protracted γ-ray exposures. However, the survival fraction at 5-6 Gy, 
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(where survival fractions for the two γ-ray exposures (protracted and acute) were experimentally 
obtained), suggest that the dose rate effect was not pronounced. 
  
As it is known that the RBE-value can dependent on the chosen endpoint, and will tend to increase 
with decreasing absorbed dose [13], the RBE for a survival fraction of 10 % is often stated. However, 
as the linear model was used to fit both the 131Cs exposed and protracted γ-ray exposed cells, the 
calculated RBE-value will be independent on the endpoint (% survival fraction) and is simply the ratio 
between the slopes of the linear fits.  Accordingly, the RBE will be dependent on the chosen model 
used to fit the survival curves. Using the linear model a RBE value of 4.5 ± 0.5 was obtained using 137Cs 
γ-rays as reference radiation. 
However, it might make more sense to compare the survival fraction after exposure of 5 Gy, where 
survival fractions for all the different exposures, had been obtained. At this absorbed dose, a survival 
fraction of only ~4*10-4 was found for the 131Cs exposed cells, while a survival fraction of ~1.5*10-1  
and ~1*10-1 were found for the protracted and acutely y-ray exposed cells, respectively. 
 
 V79 cells 4.4.3.3.2.
The clonogenic cell survival curves for V79 cells can be seen in Figure 4.28. The experimentally 
obtained data points and their uncertainties (see section 4.4.4 p. 138) for the 131Cs exposed cells are 
shown along with the fitted survival curves. The data points and estimated uncertainties for the γ-rays 
exposed cells (protracted & acute), are presented in appendix  8.4 p. 206. Similar to the experiments 
with HeLa cells, the protacted γ-rays exposed cells were only exposed to a narrow range of absorbed 
doses (~6-10 Gy), and the course of the survival curve and the presence of a possible shoulder was 
difficult to interpret. However, the one data point around 10 Gy does indicate that a shoulder was not 
present. The survival curve was therefore fitted to the linear model (𝑦 = 𝑒−∝𝑥). In contrast, a broader 
range in absorbed doses were received by the 131Cs exposed V79 cells, and so the absence of a 
shoulder was evident and the survival curve was therefore also fitted to the linear model (𝑦 = 𝑒−∝𝑥).   
As for the HeLa cells, a greater range in absorbed doses were received by the acute γ-rays exposed 
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cells. The survival curve showed a clear shoulder and was fitted to the linear quadratic model ( 
y = e−(αx+βx
2)). α values (and β values) plus D37 values for the different exposures were found to be 
0.379 (α) and  2.6 Gy (D37) for the 
131Cs exposed cells, 0.0994 (α) and 10.0 Gy (D37) for the protracted 
γ-ray exposed cells, and 0.0983 (α),0.0266 (β) and 4.5 Gy (D37) for the acutely γ-rays exposed cells. 
As the survival curves reveal, cells exposed to protracted γ-rays showed the highest survival fractions, 
while cells exposed to 131Cs or acute γ-rays showed a similar, but much lower survival fraction. At 10 
Gy the survival curve for cell exposed acutely to external ƴ-ray, accidentally coincide with the survival 
curve for the 131Cs exposed cells.  In contrast to HeLa cells, a dose rate effect was here evident and 
had a great influence on the survival fraction and hence RBE.   
Again the RBE was not dependent on the chosen endpoint, as the linear model was used to fit both 
the 131Cs exposed and the cells exposed to protracted γ-ray. Still, as before, as no data was obtained 
(for the protracted ƴ-ray exposed cells) at 10 % survival (the endpoint normally used to obtain RBE 
values), the RBE will depend strongly on the model used to fit the survival curve. Nevertheless, a RBE 
of 3.8 ± 0.8 was found using 137Cs ƴ-rays as reference radiation. However, it might make more sense 
to compare the survival fraction after an exposure of 7 Gy, where the survival fraction, was 
experimentally obtained for both exposures. At this absorbed dose a survival fraction around 8*10-2 
was found for the 131Cs exposed cells, while a survival fraction around 5*10-1 and 1*10-1 was found for 
the protracted and acutely y-ray exposed cells respectively. In contrasts to the HeLa cells, the dose 
rate for the V79 cells had a big effect on the survival fraction. If the RBE had been calculated using the 
acutely γ-ray exposed data set instead of the protracted γ-ray exposed ones, the RBE-value at 10% 
survival fraction would have been 1.3.  
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Figure 4.28 Clonogenic cell survival curves for V79 cells exposed to 
131
Cs or external γ-ray (protracted & acute) 
Survival fraction as a function of absorbed dose for V79 cells exposed to 
131
Cs (purple) or external γ-ray at similar dose rate 
profiles (red) or external y-ray delivered acutely (black) are shown. The survival curves were fitted to either the linear model 
((𝑦 = 𝑒−0.379𝑥, 131Cs exposed cells), (𝑦 = 𝑒−0.0994𝑥, (protracted γ-ray exposed cells)), or the linear quadratic model 
(𝑦 = 𝑒−(0.0983𝑥+0.0266𝑥
2), acute γ-ray exposed cells). The experimentally obtained data points (average of 3 replicates) for 
the 
131
Cs exposed cells are presented. The vertical error bars reflect the observed standard deviation in survival fraction, 
while the horizontal error bars reflect the estimated uncertainty in absorbed dose. To simplify the figure the obtained data 
points and estimated uncertainties for the γ-ray exposed cells (protracted and acute) are only presented in appendix 
8.4.2p. 207.  The difference in slope of the survival curves for the 
131
Cs exposed and γ-ray (protracted) exposed cells gives a 
RBE of 3.8. (
137
Cs ƴ-rays were used as reference radiation). 
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 Uncertainty 4.4.4
The RBE-values were found by comparing the absorbed doses needed, to obtain an equal biological 
effect for a test and reference radiation and the uncertainties of the obtained RBE values are 
therefore related to the uncertainties in the dose-response curves of both the test and reference 
radiation. These uncertainties are again related to the uncertainties in the absorbed dose calculations 
and in observed biological effect. 
 
-γH2AX 
The RBE for internal 131Cs exposure was investigated using the ƴH2Ax as endpoint. To analyse the 
result, a graph showing the ƴH2AX response relative to the control levels over the absorbed dose, was 
made. Results were presented as average of ± s.d. (for data points obtained by 3 independent 
experiments). As could clearly be seen on the graph no significant difference in the ƴH2AX response 
for the two irradiations (internal 131Cs and external ƴ-rays) could be observed. As this was evident due 
to the standard deviations, no statistical test was performed.  
 
-Clonogenic cell survival  
The uncertainty in the RBE –values obtained by clonogenic cell survival comes from: 
- Uncertainty in the fitted survival curve for the 131Cs exposed cells. This is reflected in the 
uncertainty in the α-values; 1.1709 (1.83, 1.587; 95% confidence bounds for HeLa cells) and 
0.3792 (0.3432, 0.4153; 95% confidence bounds for V79 cells). The uncertainty is related to;  
o Uncertainty in the absorbed dose calculations. The uncertainty in the absorbed dose 
calculations were estimated to be 22 % of HeLa cells and 23 % in V79 cells (as explained 
in section 4.3.1 p. 126) 
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o Uncertainty in the survival fraction.  The uncertainty was dominated by the Poisson 
counting statistics (due to the low number of colonies counted especially for HeLa 
cells) and the total error was therefore assumed to be reflected by the observed 
variation. All clonogenic survival fractions were obtained by triplicates. The observed 
standard deviation in these triplicates is believed to reflect all the errors, and these 
standard deviations are used in the final data analysis.  
 
- Uncertainty in the fitted survival curve for the externally protracted γ-ray exposed cells. This is 
reflected in the uncertainty of the α-values; 0.3838 (0.3633, 0.4043; 95% confidence bounds 
for HeLa cells) and 0.09936 (0.08016, 0.1186 95% confidence bounds for V79 cells). The 
uncertainty is related to;  
o Uncertainty in the absorbed dose calculations. The uncertainty in the absorbed dose 
calculations were estimated to be 2.12 % (for both cell lines) dominated by uncertainty 
in the distance between the cells and the γ-ray source. 
o Uncertainty in the survival fraction.  The uncertainty in the survival fraction was 
dominated by the Poisson counting statistics. As for the internal exposure experiments, 
the observed standard deviations from the triplicate experiments are used in final data 
analysis.  
The total uncertainty in the obtained RBE values can be expressed as the compounded uncertainty for 
a ratio, where the uncertainty of each term is known (the slopes).  Using the stated uncertainty on 
alpha values the standard deviation for the RBE-value for Hela cells of 4.5 becomes 0.5 and the 
standard deviation for the RBE-value for V79 cells of 3.8 becomes 0.8, or in conclusion: 
RBE (Internal 131Cs, HeLa) = 4.5 ± 0.5 
RBE (Internal 131Cs, V79) = 3.8 ± 0.8 
137Cs ƴ-rays were used as reference radiation. 
For further elaboration on the calculation and estimations of the uncertainties see appendix 8.3 p. 
198. 
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5. Discussion 
In the previous section, the RBE values for the two investigated cell types were obtained. From the 
outset, this was the main objective for the study. Due to the choice of experimental methods, and 
because the dosimetric model proves reasonably independent of cell geometry variations and target 
size, the measured dose-survival curves include uncertainties on the absorbed dose from internal 131Cs. 
This allows me to state not only the RBE, but also its uncertainty. This in turn makes it evident that the 
RBE in my case is significantly different from 1. The surprisingly high RBE values found, necessarily 
demands a thorough discussion of the assumptions and methods applied with a critical comparison 
with literature. This is the intention in the following section.   
 
5.1 131Cs biokinetics 
As we saw in the result section (section 4.1 p. 95), the bio-kinetics of 131Cs was important for both the 
geometrical assumptions in the SC-value model and for the calculation of absorbed dose and dose 
rates. Especially the homogeneous intracellular distribution of 131Cs was of importance, as it laid the 
ground for the use of SC-values. Knowing the mechanism of the 
131Cs uptake, will help the 
understanding of the parameters for the uptake and release kinetics. Therefore, I will like to start the 
discussion with the experiment that investigated the uptake mechanism of 131Cs and supported the 
hypotheses of its homogenous intracellular distribution. 
 
 Blocking of 131Cs uptake by Ouabain 5.1.1
By this experiment the mechanism of 131Cs uptake in HeLa and V79 cells was investigated. The main 
aim was to confirm that the 131Cs was transported into the cell, and not just bound to the cell surface. 
In addition, the uptake mechanism strongly supported the hypothesis of a homogenous intracellular 
distribution of 131Cs.  
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-the mechanism of 131Cs uptake & its homogenous intracellular dis tribution 
The HeLa and V79 cells were incubated with 131Cs and different concentrations of ouabain. Ouabain is 
a well-known inhibitor of the Na+/K+-ATPase, a ubiquitous pump located in the plasma membrane of 
all mammalian cells. The pump normally transports  three Na+ ions out of the cell in exchange for two 
K+ under the hydrolyses of one ATP-molecule [118]. The 131Cs uptake by HeLa and V79 cells were 
significantly decreased in the presence of ouabain in the 131Cs -containing medium. The maximum 
achievable inhibition (“bottom”) was estimated to be ~11 % for HeLa cells and ~7 % for V79 cells. This 
strongly suggests that most of the 131Cs, taken up by the cells is pumped by the Na+/K+-ATPase, and 
accordingly delivered into the cell as caesium ions. Whether the “remaining” 131Cs was also 
transported by the Na+/K+-ATPase or other channels also contribute to the 131Cs transport was not 
investigated. Several other channels in the plasma membrane (e.g. NKCC), are known to transport K+ 
into the cell, and could be responsible for the uptake of the “remaining” 131Cs [88]. As explained 
earlier (see section 2.4 p. 53), caesium (like potassium) is an alkali metal and therefore not likely to 
form complexes with other ions. As caesium seems to mimic K+ in biological settings and potassium is 
known to only form weak bindings to biomolecules and exert its biological function primary as a 
charge carrier, it is reasonable to assume that intracellular ionic caesium, will behave similar to K+ and 
will remain unbound and freely moveable inside the cell [88] [91][99][100]. 
The main compartments in a cell are the cytoplasm and the nucleus. These two compartments are 
separated by the nuclear envelope which is a double lipid bilayer much like the plasma membrane. 
However, in contrast to the plasma membrane, the nuclear envelope contains nuclear pores that 
allow free diffusion of smaller proteins and ions [88]. Cs+ located intracellular will therefore be able to 
diffuse freely between the cytoplasm and the nucleus. No organelles are known to considerably 
accumulate K+ and so, it is a fair assumption that Cs+ will not either be accumulated in any cellular 
organelles [88]. This means that 131Cs transported into the cell, will be freely moveable and therefore 
homogenously distributed throughout the cell, including the nucleus.    
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-IC50, the ouabain concentration needed for half maximum inhibition of 
131Cs uptake. The 
differences between HeLa cells and V79 cells 
In this study the ouabain concentration needed to inhibit the 131Cs uptake by 50 % (IC50) was found to 
be 2.6*10-8 M and 2.77*10-4 M for HeLa and V79 cells respectively, differing by a factor of ~10000. 
Similar IC50(40) values of ~3*10
-8 M and  ~1*10-4 M ouabain  have been reported for HeLa and Chinese 
hamster cells respectively using  86Rb, an alkali metal also transported by the Na+/K+-ATPase  [119]. 
The big difference in the obtained IC50 values, between the HeLa and V79 cells, does therefore not 
reflect an experimental error. Rather this huge difference in cell sensitivity to ouabain is thought to be 
related to the animal species from which the cells are coming from. Similarly, a 2000 fold difference in 
the sensitivity to ouabain between cells originating from humans and monkeys versus hamsters and 
mice have been reported before, with the two latter, showing the highest tolerance. The mechanism 
is thought to involve differences in the binding and dissociation ability of ouabain to the α-subunit of 
the Na+/K+-ATPase [119][120][121].  
 
 Uptake and release of 131Cs from HeLa and V79 cells. 5.1.2
-The rate constants k in, kout & kc and their independence of the 
131Cs activity concentration  
As said, the two main compartments in a cell are the cytoplasm and the nucleus. Because of the free 
diffusion of 131Cs between these two compartments, the cell can be defined as one compartment. 
Therfore, my bio-kinetic model for 131Cs (uptake and release) has only two compartments, -the 
cellular compartment (intracellular) and the medium (extracellular) (Figure 5.1). kin and kout represent 
the microscopic rate constants in which 131Cs is transported into and out of the cell respectively. kc 
represents the resulting exponential constant, describing the change in intracellular 131Cs 
concentration. As shown in the results section (section 4.1 p. 95) the time course of 131Cs release and 
the change in intracellular 131Cs activity concentration were both fitted to the exponential equations 
(A = A0*(1 − e−t∗kc)) and (A = A0*∗ e−t∗kout) and kc and kout were respectively found to be 1/283 min
-1 
and 1/339 min-1 in HeLa cells and 1/204 min-1 and 1/256 min-1 in V79 cells. 
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Figure 5.1 Representation of the two compartments and the constants relevant for the bio- kinetics of 
131
Cs 
Due to the free diffusion of intracellular 
131
Cs between the cytoplasm and the nucleus, the 
131
Cs bio-kinetics can be 
described by a two compartment system; an intracellular compartment and an extracellular compartment. The change in 
intracellular activity concentration of 
131
Cs described by kc, is determined by the two rate constants; kin & kout 
 
The kc and kout values were obtained from experiments in which the 
131Cs activity concentration used 
was much lower (~1/500 (HeLa cells) and 1/250 (V79)) than the activity concentration used to study 
the radiotoxicity and RBE. As these rate constants were directly used in the absorbed dose 
calculations in the latter experiments, it was important to consider if the obtained rate constants (kin 
& kout) were dependent on the 
131Cs activity concentration, and if they would significantly change 
when the activity concentration was increased. Such a change could be due regulations of the 
“transitions rate” of the Na+/K+-ATPase or to saturations in 131Cs uptake or release.   
The transition rate of the Na+/K+-ATPase is mainly regulated by the intracellular Na+ concentration 
[122] and since this concentration do not change with the increase in 131Cs activity concentration, it 
seems reasonable to assume that the transition rate of this pump will not be affected. The highest 
131Cs activity concentration used was 17 MBq/ml which correspond to a chemical caesium 
concentrating of ~35 nM. (for calculations see appendix 8.1 p. 194). Due to the way 131Cs was 
produced and the subsequent chemical separation, the specific activity of the 131Cs solution added the 
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medium was close to the theoretical maximum. As the potassium concentration in the normal growth 
medium is 4-5 mM [123] the addition of  131Cs will not change the combined concentration (in the 
medium) of the two alkali metals, K+ and Cs+. Accordingly, 131Cs will only constitutes a very small 
fraction (10-5) of the ions pumped into the cell by the Na+/K+-ATPase and the transport of 131Cs should  
not become saturated as this concentration. It therefore seems reasonable to assume that the rate 
constant for 131Cs uptake (kin) does not change with the increase in 
131Cs activity concentration used. 
The precise mechanism resulting in 131Cs release from the cells was not investigated. However, 
measurements showed an exponential decrease in intracellular 131Cs activity concentration (after 
removal of 131Cs from the medium) indicating that a constant fraction of the intracellular 131Cs was 
released from the cells per unit time. The maximum intracellular  caesium concentration was only 1-2 
µM (for calculations see appendix 8.1 p. 194), whereas the normal intracellular K+ concentration is 
140 mM [88]. A “release mechanism” for 131Cs similar to that of potassium, should therefore not 
become saturated at this concentration.  Together, this suggest that the rate of 131Cs release from the 
cells, is directly proportional to the probability of a 131Cs ion reaching the plasmamembrane, which 
again, for a homogenous distributed ion, is directly proportional to the intracellular 131Cs 
concentration. It therefore seems reasonable to assume that the rate constant for 131Cs release (kout) 
does not change with the increase in 131Cs activity concentration. 
Since the rate constants, kin and kout, were not influenced by the increase in 
131Cs activity 
concentration and since kc only depends on these two constants, the measured kc and kout values 
could be safely applied to the experiments investigated the radiotoxicity of 131Cs. These kc and kout 
values were there used to calculate the absorbed dose by modelling the total time curve of uptake 
and release (and thus the cumulative activity) using only a single point of observation.  
 
 
Discussion 
 156 
 Chemical cytotoxicity of caesium 5.1.3
As 131Cs was used to investigate the radiotoxicity and RBE of Auger emitters, it is of course essential 
that the cytotoxicity observed is due to the radiation and not direct chemical effects. Caesium is 
known to be cytotoxic [92]and an experimental control for this chemical cytotoxicity could have been 
made using stable ordinary caesium. However, the highest caesium concentration used was ~35 nM 
and caesium toxicity has only been reported at a much higher concentrations (119 µM) [124]. 
Moreover, the caesium concentrations applied in my experiments were at the level of the natural 
caesium concentration in seawater [125]. At this level the chemical toxicity is excluded as a 
confounding factor. 
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5.2 SC-values 
One of the purposes of this work was an effort to reduce the uncertainty in the absorbed dose 
calculations. By using an Auger emitter (131Cs), which is homogeneously distributed throughout the 
cell, and by applying this to a confluent cellular monolayer, it was possible to use my so called SC-
values. The shift from a model with isolated cells to a confluent cell layer and the use of an even 
activity distribution throughout the cell layer made the calculated absorbed dose become almost 
independent of cell and nuclear sizes. It significantly reduces the uncertainty in absorbed dose 
calculated related to the use of the MIRD cellular S-values.  
 
 Calculation of the 131Cs SC-values, SC(N←CM) for HeLa 5.2.1
and V79 cells in confluent cellular monolayers 
The geometry used for the SC-value calculations was a 100 % confluent cellular monolayer, in which 
the ellipsoid nuclei were located. The source compartment was the whole cellular monolayer, and the 
target compartment, the nucleus. 
The SC-values used for this work differ from the MIRD cellular S-values by two important features;  
1. The geometry used in the SC-value calculations is an infinite ( in x and y direction) confluent 
cellular monolayer, and not two concentric spheres in isolation (the geometry used in the 
MIRD calculations) 
2. The unit of the SC-values; being Gy/(Bq*Sec)/pL, and not Gy/(Bq*Sec),which is the unit used by 
MIRD. 
 
The important parameters for the SC-value calculations using this geometry and unit turns out to be; 
o The confluency of the cells 
o The height of the cell layer and  
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o The size (volume), shape and orientation of the nucleus (to a lesser degree).  
 
-Confluency (denseness) of the cell cultures 
The geometry used in the SC-value calculations assumes a 100% confluent cellular monolayer. This 
confluence/denseness was verified by confocal microscopy. 
As could be in Figure 4.7 (p. 108) and Figure 4.8 (p. 109) the cells lie so close together that no space is 
left in between. This degree of confluency was confirmed by direct microscopy of the cell layer before 
all of the internal irradiation experiments. As the 131Cs is equally distributed between cells and 
between the nucleus and the cytoplasm, it becomes irrelevant where one cell ends and the next one 
begin. Instead the geometry can be thought of as a continuous “sea” of cytoplasm in which the nuclei 
are positioned (Figure 5.2). In this way the geometry and size of the individually cells can be ignored. 
In addition, the dose deposition becomes constant in all x and y planes with only a small axial (z-
direction) variation. As the nuclei are necessarily near the middle of the cell layer the Sc –values 
approaches the theoretical maximum value of 9.41*10-4 Gy/(Bq*Sec)/pL . 
 
   
                                        
Figure 5.2 Simplification of the cell culture due to the confluency 
As the cells are 100 % confluent and the 
131
Cs is homogenously distributed throughout this cell layer, the distinction 
between one cell and the next becomes irrelevant.  Instead the cell culture geometry can be simplified to a continuous 
“sea” of cytoplasm in which the nuclei are positioned. The size and shape of the individual cells can thereby be ignored. 
 
-Height of the cellular monolayer 
Inevitably, some of the Auger electrons manage to escape either the top or the bottom of the cell 
monolayer. Accordingly the axial (z direction) dose profile is not completely constant (Figure 4.12 p. 
114). The axial dose distribution depends on the height of the cellular monolayers. These heights 
were measured to be 10 µm and 8 µm for HeLa and V79 cells respectively, using the Z-stack images 
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obtained by confocal microscopy (Figure 4.7 p. 108 and Figure 4.8 p. 109). As was shown in the results 
section (Figure 4.12 p. 114) the axial distribution of dose to any small voxel changes less than 10% 
over most of the cell layer height. The axial dose distribution for the HeLa and V79 monolayers were 
quite similar. The only difference between the calculations of the two axial dose distributions (HeLa 
and V79), were the heights of the monolayers. These heights however were not easy to measure 
precisely due to the fundamental limitation of resolution in the confocal microscope used. The values 
may have been a 1-2 µm lower or higher. However, an increase in the HeLa monolayer height from 10 
µm to 12 um only increase the mid layer dose by 3  %. (found by convolution using a 12 µm high 
cellular monolayer). Decreasing the HeLa cellular monolayer height by 2 µm from 10 µm to 8 µm just 
brings us to the V79 situation and leads to a 4 % decrease of mid layer dose. Finally a reduction of V79 
monolayer height by 2 µm leads to about a 5 % absorbed dose drop. When averaged over many cells 
and many nuclei with varying axial lengths, the total effect on the resulting SC values is believed to be 
smaller than 3-5 %. In the uncertainty budget for the delivered internal doses, this has been 
accounted for as a 3% (HeLa), respectively 7 % (V79) uncertainty in SC value.  
 
-Size, shape and orientation of the cellular nuclei 
The size and shape of the HeLa and V79 nuclei were also found using the Z-stack images obtained by 
confocal microscopy. In general the nuclei displayed an ellipsoid shape rotated at different angles in 
respect to the x-y plane. This rotation resulted in a difference in the distance to the “top” and 
“bottom” of the cellular monolayer and as the axial dose distribution was not constant this had a 
small effect on the cellular SC -values (Figure 5.3).  This rotation effect on SC -values is actually 
contained in the variation of calculated SC -values for the actual nuclei dimensions measured (see 
Figure 4.14 and Figure 4.15 page 118). 
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Figure 5.3 Representation of different orientations of nuclei in the cellular monolayer 
Illustration of different orientations of the nuclei. The nucleus furthest to the left has sub-volumes closer to the surfaces of 
the monolayer and will receive a smaller dose than the nucleus to the right.  
 
The nuclear volume for both HeLa cells and V79 cells showed large variation, ranging from below 0.1 
pL to above 1.0 pL. The average nucleus volume for HeLa and V79 cells was determined to be 0.84 pL 
and 0.53 pL respectively. These values fit well with previously reported values of around 0.2 pL to 0.7 
pL for HeLa cells [126][127][128] and around 0.5 pL and 0.8 pL for V79 cells [129][130]. The SC-values 
for the 29 HeLa nuclei and the 50 V79 nuclei were calculated (Figure 4.14 p. 118 and Figure 4.15 p. 
119) based on their measured axis lengths. Despite the big variation in the nuclei volumes, the SC-
values changes by less than 1% for HeLa and less than 2.5 % for V79 .This “constancy” of the SC-values 
with nuclei of very different sizes is a beneficial consequence of the unit of the SC-values.  
As seen above, the SC-values calculated turn out to be “robust”. By this I mean that the final absorbed 
dose from internal exposure becomes relatively independent of a lot of biological variation in size, 
shape and volumes of cells and nuclei. In contrast, the geometry used by MIRD (two concentric 
spheres), makes their cellular S-values very  geometry dependent and sensitive to small changes in 
cellular and nuclear size [17].  It can be illustrated by applying the reported variation in HeLa nuclear 
volumes ranging from around 0.2 pL to 0.7pL to the MIRD formalism. This will give a variation of the 
MIRD cellular S values by around a factor 2 (S(N←C) for 131Cs (see values in appendix 8.2.1 p. 196), 
directly introducing a similar factor 2 variation in absorbed dose. Such an unnecessary variation could 
easily confound the determination of RBE by biasing the calculated internal absorbed dose.    
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5.3 Radiotoxicity and relative biological effectiveness of 
131Cs 
To investigate the radiotoxicity and the relative biological effectiveness of 131Cs in HeLa and V79 cells, 
both the γH2AX and the clonogenic cell survival assay were used. As we saw in the results section, the 
estimated RBE-values obtained by these two assay differed by a factor of 4, from a RBE of 1 using the 
γH2AX assay, to a RBE of 4.5 (HeLa cells) and 3.8 (V79 cells) using the clonogenic cell survival assay. 
 
 Radiotoxicity of intracellular and extracellular 131Cs 5.3.1
decays 
-The importance of auger emitter location and dose rate  
In this experiment the importance of the location (extracellular & intracellular) of the 131Cs was 
investigated. The HeLa cells were incubated with 131Cs either in the presence or absence of ouabain. 
As we saw in the results section (Figure 4.4 p. 102), ouabain significantly inhibited the 131Cs uptake, 
and so in the cells incubated with ouabain, the uptake and consequently the intracellular 131Cs activty 
concentration were considerably decreased. This decrease was also evident from Figure 4.20 (p.131). 
However, as the HeLa cells incubated with ouabain did take up a small amount of 131Cs, they were 
also exposed to intracellular 131Cs decays.  The extracellular 131Cs activity concentration and the 
incubation time were however the same for the two exposures.The radiotoxicity was evaluated by 
γH2AX and the results given ƴH2AX response over controls levels. (For further elaboration on the data 
presentation of this specific γH2AX assay see section 3.1 p. 59).  
As was seen in Figure  4.19 (p. 130) HeLa cells in which 131Cs uptake was partly blocked showed almost 
no increase in their ƴH2AX response after 380 min and 480 min of incubation with 131Cs. In contrast, 
cells in which the 131Cs uptake was not blocked showed an increase in their ƴH2AX response with 
incubation time and reached a 3.5 fold increase over control levels after 480 min. This showed that 
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the radiotoxicity of 131Cs is very dependent on its cellular localization, having almost no effect when it 
is located outside the cell.  
This result is in good agreement with what has previously been reported by others and with the 
current understanding of the underlying mechanism of the radiotoxicity of Auger emitter decays [28]. 
Several authors have reported a much lower radiotoxicity of various Auger emitters (125I, 111In, 201Ti), 
when these are located extracellular instead of intracellular (either distributed throughout the cell or 
bound to the DNA) [131][132][133][134]. Due to the short range of (most of) the Auger electrons, 
when the decays happens extracellularly only the K-and L-Auger electrons, will be able to reach the 
nucleus, leaving the possibly most harmful Auger electrons (MXY, CK & SCK) to deposit their energy 
outside the nucleus [82] [86].  
Cells incubated in the presence of ouabain were however still able to take up some 131Cs (Figure 4.20 
p. 131). The absorbed dose to the cells, received from this intracellular 131Cs, was calculated and their 
ƴH2AX response at the different absorbed doses was shown in Figure  4.19 (p. 130). In contrast to 
what might be expected, these cells did not show an equivalent increase in ƴH2AX response 
(equivalent to the level shown by the cells incubated in the absent of ouabain (”non-ouabain 
incubated cells”)), even though they received up to 2 Gy (from intracellular 131Cs decays). This “lack” 
in ƴH2AX response, might be explained by the dose rate effect. As the “non-ouabain” incubated cells 
received an absorbed dose of 1-2 Gy over 2-4 hours, the ouabain incubated cells received a similar 
absorbed dose but over 6-8 hours. The dose rate for the ouabain incubated cells (~0.2 Gy/h) was 
therefore 2-3 times lower than for the “non-ouabain” incubated cells. The dose rate effect is related 
to the repair of sublethal DNA damage [20].  It is not implausible that cells receiving a dose of 1-2 Gy 
with a dose rate of ~0.2 Gy/h, would be able to repair all the sublethal DNA damage and therefore not 
show any increase in ƴH2AX response level. However, the increased radiotoxicity of auger emitters 
are thought to be a consequence of exactly these more harmful DNA DSBs (LMDS, complex DNA 
damage) and therefore an inability of cells to repair these DNA DSB is also plausible. This ability (or 
inability) to repair DNA damage caused by Auger emitters is still open for debate[6] [28] [52]. The 
shoulder on clonogenic cell survival curves, characterize the repair of sublethal damage, and both 
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survival curves with and without shoulders (after exposure to Auger emitters) have been reported 
[62][20] [63][22]. The clonogenic cell survival curves (for the 131Cs exposed cells) in this work (Figure 
4.27 p. 145 and Figure 4.28 p. 148) did not show any shoulder, thus indicating that the repair of 
sublethal DNA damage was not pronounced.   
Another reason for the “low” γH2AX response of the ouabain incubated cells, could be related to an 
interplay between a potential effect of ouabain on DNA damage repair, and the biological assay used 
(γH2AX). Ouabain is believed to affect the cellular sensitivity to ionising radiation. The mechanism is 
not yet known, but is thought to be related to the activation of DNA damage response (DDR), 
including cell cycle blockage and inhibition of sublethal DNA damage repair [121] [135]. The repair of 
sublethal DNA damage and especially the fast repair has been reported to significantly decrease in 
HeLa cells exposed to 10-100 nM of ouabain (8.45 µM ouabain were used in this experiment) [135]. 
Depending on the underlying mechanism of this inhibition of sublethal DNA damage repair, it could 
explain the “low” γH2AX response observed.  
 
 Relative biological effectiveness of 131Cs 5.3.2
The RBE of the 131Cs was investigated using two different assays; yH2AX and clonogenic cell survival 
assay. 
 RBE of intracellular 131Cs evaluated using γH2AX assay  5.3.2.1
In this experiment the relative biological effectiveness of 131Cs was investigated in HeLa cells using the 
γH2AX assay. HeLa cells were either exposed to intracellular 131Cs decays or external γ-rays. The 
increasing dose rate, resulting from the increasing uptake of 131Cs was mimicked in the external γ-rays 
exposure (as explained in section 4.4.2.1.1 p. 132). In order to eliminate any dose rate effects in the 
obtained RBE it was highly prioritized to use the same dose rate profiles for the two exposures.     
As was presented in the results section (Figure 4.22 p. 135), both the 131Cs exposed and the γ-ray 
exposed cells showed a similar increase in their ƴH2AX response with increasing dose. In both cases 
the exposed cells reached a 3.5 fold increase over the control levels after receiving 5-6 Gy. No 
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significant difference in radiotoxicity of intracellular 131Cs decays and external y-rays was observed 
using the γH2AX assay and a RBE of 1 for 131Cs was found.  
The increase in the percentage of activated cells only reached a 3.5 fold increase over control levels 
after receiving 5 Gy (from either 131Cs or γ-rays exposures). This increase was lower than expected. 
However, a ~4.5 fold increase in the γH2AX response compared to controls after 5 Gy acute exposure 
(using a dose rate of 1.5 Gy/min) to external γ-rays was also observed (data obtained from positive 
controls and therefore not shown) and so, this 3.5 fold increase seemed reasonable, considering the 
lower dose rate used. However it is noteworthy that this positive control (5 Gy external acute γ-ray 
exposure) did indicate that a RBE below 1 might be found if the dose rate was not considered. 
The proportion of H2AX (histones) of the total H2A histones, is only 2% in HeLa cells. This is quite low 
compared to other cell lines in which H2AX constitute between 2-20% of their total H2A histones 
[136]. This could explain the relatively low increase in the level of ƴH2AX response observed with 
increasing absorbed dose. HeLa cells might therefore not be the most suitable cell line, for this DNA 
damage assay and using a cell line with a higher proportion of H2AX (histones), might increase the 
validity of the obtained result. 
 
The obtained RBE-value of 1 is in the range of what has previously been reported, when the Auger 
emitter is located outside the cell or in the cytoplasm [28]. Hofer et al found that radiotoxicity of 67Ga 
located in the cytoplasm was comparable to the radiotoxicity of 3H bound to the DNA [137].  However 
as the 131Cs was homogenously distributed throughout the cell, and therefore also located in the 
nucleus a higher RBE value than 1 was expected. Even RBE-values of 1.4 and 1.9 for 125I and 103Pd 
respectively, were found by Ling et al when these Auger emitters were located extracellularly [138].  
However, it is well known, that the RBE is an experimentally obtained value that often differs 
between studies using different biological assays, endpoints, cell lines etc [13]. Therefore, the “lower 
than expected and otherwise reported” RBE-value obtained here, could be explained by the different 
biological assay used. Surely, as will be seen below the γH2AX assay might not be the most suitable 
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for investigating the radiotoxicity of Auger emitters, and the biological assay used can have a great 
influence on the obtained RBE.   
It is believed that the DNA damage produced by high LET radiation and Auger electrons, can be more 
complex and induce LMDS and so is more difficult for a cell to repair. This can result in an increase in 
the size of the γH2AX foci, which might also stay phosphorylated for a longer time. However, this 
increase in foci size and “existence” time might be difficult to identify [6][48] [52]. As explained earlier 
(section 3.1.1 p. 59) the γH2AX assay used in this work, measures the total intensity (per cell) of a 
fluorescent antibody bound specifically to phosphorylated serine 139 on histone 2AX (γH2AX). 
Therefore, this assay should (in theory) be able to reflect, an increase in γH2AX foci size by an 
increased fluorescence signal. However, due to the “grouping” of the cells in two (three) categories, 
any possible differences in γH2AX foci size would not be evident. The γH2AX assay still presents the 
overall increase in number of γH2AX foci present in a cell. However, the number of DNA DSBs (and so 
γH2AX foci), is not necessarily a good indicator for the severity of the DNA damage produced. This is 
especially evident when comparing the more detrimental complex and clustered DNA damage 
produced by high LET radiation, with the simple DNA damage produced by low LET radiation[52].  The 
γH2AX assay shows the number of the DNA DSBs produced, but tells little about the severity of the 
produced DNA damage and about the further fate of the cell. This assay may therefore not be the 
most suitable assay when investigating radiotoxicity of high LET radiation and Auger emitters, and 
especially not when comparing the detrimental effects of different radiation qualities.   
 
 RBE of intracellular 131Cs evaluated using clonogenic cell survival   5.3.2.2
In this experiment the relative biological effectiveness of 131Cs was investigated in HeLa and V79 cells 
using clonogenic cell survival. The HeLa or V79 cells were either incubated with 131Cs or exposed to 
external γ-rays. The increasing dose rate, resulting from the increasing uptake of 131Cs was mimicked 
in the external γ-ray exposures (as explained in section 4.4.3.1 p. 136). Using the same dose rate 
profiles was highly prioritized, in order to eliminate any dose rate effect in the obtained RBE. In 
addition, to see a potential effect of the dose rate, cells were also exposed to external acute γ-rays 
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using a dose rate of 1.5 Gy/min. However, these cells were exposed under different conditions and so 
care should be taken when drawing conclusions from these survival curves. Still, the data can give a 
good estimate for the relative importance of the dose-rate effect. To minimise confusion these 
external γ-ray exposure will be referred to as acute exposures, while the external γ-ray exposures 
using the matched dose rate profile, will be referred to as protracted exposures.           
 
 HeLa cells 5.3.2.2.1.
As was shown in the results section (Figure 4.27 p. 145), there was a big difference in the survival 
fraction between the intracellular 131Cs exposed cells and the protracted external γ-ray exposed cells. 
Due to the limited range of absorbed doses used for these exposures, it was difficult to interpret the 
shapes (shoulder or no shoulder) of the survival curves and they were therefore fitted to the linear 
model. Consequently, the RBE is not dependent on which endpoint (% survival fraction) is used and a 
RBE of 4.5 was found. The survival curve for the acutely exposed HeLa cells, show the expected 
shoulder and was fitted to the linear quadratic model. No pronounced dose rate effect was found, 
and so using the acute exposed cells as a reference radiation, would give a similar RBE. 
The obtained RBE of 4.5 is a lot higher than expected. Normally, a RBE of approximate 4 is expected 
for Auger emitters intercalated or otherwise bound but not incorporated into the DNA 
[62][23][139][24]. This high RBE could not be explained by an unreasonable low survival fraction of 
the cells exposed to the reference radiation (protracted external γ-ray exposure), as these cells had a 
D37 of 2.6 and a 10 % survival fractions at 6 Gy. This is around the normal values seen when using an 
average dose rate of ~4 mGy/min for low LET exposures [20]. Furthermore, the acute (1.5 Gy/min) γ-
ray exposed cells, had a similar survival fraction at 10% after receiving ~5 Gy and so, the dose rate did 
not seem to have any impact on the survival fraction in that absorbed dose range. The high RBE-value 
obtained must therefore be a consequent of the very low survival fraction of the 131Cs exposed cells. 
This was also confirmed by the very low D37 of 0.58 found. A D37 of 0.58 is in the range of what would 
be expected for Auger emitters bound or incorporated into the DNA and not when the Auger emitter 
is distributed throughout the cell (as in this work)[22][23][140]. However, due to the narrow range of 
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absorbed doses used, the “D37” was found by extrapolation, and are therefore sensitive to small 
changes in the slope of the survival curve.  
Because of the low plating efficiency of the HeLa cells (3-6*10-1) and their radiation sensitivity, the 
amount of cells seeded (for the clonogenic cell survival assay) was very high. This sometimes made it 
difficult to separate the colonies from each other, and two sub-colonies (less than 50 cells each), lying 
close to each other, could have been mistaken as one colony, and therefore included in the survival 
fraction. Furthermore, the high amount of dead cells, and the lack of a midway medium change, could 
have affected the cells and their ability to form colonies. Yet, a similar amount of cells was seeded 
after the different exposures and so if these conditions had an influence on the number of colonies 
formed, they should have affected the survival fraction of both the 131Cs and the γ-ray (protracted) 
exposed cells.  
However, it is noteworthy that the clonogenic cell survival assay only scores the fraction of cells able 
to form colonies. Cells that have survived, but lost their ability to divide continuously e.g. cells in 
senescence, are thereby not contributing to the survival fraction. Almost no colonies were observed 
in the 131Cs exposed samples, but many single cells, which displayed a senescence-like morphology 
were still present (Figure 4.25 p. 142). These senescence-like cells were also present (however fewer) 
in the samples exposed to the reference radiation (protracted external y-ray exposure), but were 
almost missing in both controls. If these cells were indeed cells in senescence, the very low  
clonogenic survival fraction observed (for the 131Cs exposed cells) and the high RBE obtained, could be 
a cause of an increased ability of 131Cs over y-rays, to drive cells into senescence.  
 
 V79 cells 5.3.2.2.2.
As was shown in the results section (Figure 4.28 p. 148), there was a big difference in the clonogenic 
cell survival of the intracellular 131Cs exposed and protracted external γ-rays exposed cells.  As three 
different absorbed doses around 3 Gy, 7 Gy and 10 Gy were used in the intracellular 131Cs exposure it 
was possible to deduce the shape of the survival curve, being a straight line (on a semi-log plot) with 
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no shoulder. It was therefore fitted to the linear model. In contrast, a narrower range of absorbed 
doses were used for the protracted external γ-ray exposures (reference radiation), and so the shape 
of this survival curve was less clear. However, as the few data points do suggest a linear curve with no 
shoulder, and as this model uses the fewest parameters, the survival curve was also fitted to the 
linear model. Again, the obtained RBE-value is not dependent on which endpoint (% survival fraction) 
is used and a RBE-value of 3.8 was calculated. The survival curve for the acutely exposed V79 cells, 
showed the expected shoulder and was fitted to the linear quadratic model. Using the acutely 
exposed cells as reference radiation, would give a RBE-value of 1.3 at 10 % survival fraction. 
Again, the obtained RBE-value of 3.8 is a lot higher than expected. A RBE-value of 3.8 is in the order of 
what has previously been reported for Auger emitters bound (but not incorporated) to the DNA 
[62][23][139][24]. This high RBE-value could again not be explained by an exceptionally high survival 
fraction of the protracted γ-ray exposed cells (reference radiation). These cells had a survival fraction 
of 60 % after 5 Gy and a D37 of 10 Gy which seems reasonable giving the average dose rate of ~ 5 
mGy/min [141][142]. However, the cells exposed to acute (1.5 Gy/min) y-rays had a much lower 
survival fraction of only 30 % after 5 Gy and a D37 of 4.5 Gy,  showing a significant dose rate effect in 
V79 cells. As so, if the dose rate effect had not been considered and the acute γ-ray exposures with a 
dose rate of 1.5 Gy/min would have been used for comparison, the obtained RBE value would have 
been only 1.3. These results demonstrate the importance of using similar dose rates for the test and 
reference radiation when studying the RBE.     
Unfortunately the y-ray exposed (protracted) cells were allowed to from colonies for 8-9 days, 
whereas the 131Cs exposed cells were incubated for 7 days, which could have had an influence on the 
obtained survival fraction. However, as the cell cycle time of V79 cells is  ~12 hours [114], the 131Cs 
exposed cells would still have had time to produce a colony of 50 cells, even if they had experience an 
extensively cell cycle delay. Moreover, most of the colonies produced by V79 cells, consisted of 
significantly more than 50 cells (the minimum amount of cells in a colony to be considered a survivor), 
and so a “extended” incubation time of 1-2 more days was not thought to influence the result 
significantly. 
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 The difference between HeLa cells and V79 cells and the results 5.3.2.3
obtained. 
The RBE-values obtained for HeLa and V79 cells using clonogenic cell survival were very similar, being 
3.8 and 4.5 respectively.  Yet, comparing the data from the two different cell lines, several differences 
were observed. The HeLa cells generally displayed a much lower survival fraction than the V79 cells, 
while the V79 cells show a significant dose rate effect, which was not observes in HeLa cells. In 
addition, the senescence like morphology, which was seen in the HeLa cell samples, was not present 
in the V79 cell samples. 
 
 Colony and cellular morphology 5.3.2.2.3.
Many of the HeLa cells showed a senescence like morphology, which was not seen in V79 cells. The 
induction of senescence in HeLa cells, but not in V79 cells might be due to difference in their cell cycle 
check points and response to DNA damage [143][144].  In response to DNA damage, the DNA damage 
response mechanism (DDR) will be activated in both cell lines. This will in turn activate p53, an 
important effector that is involved in cell cycle arrest and induction of senescence. However both cell 
lines lack a well-functioning p53 protein. Other proteins are however also involved in cell cycle 
checkpoints, cells cycle arrest and induction of senescence. The protein Retinoblastoma (pRb) plays 
an important role in the restriction point present in the G1 cell cycle phase and may also be a 
downstream effector in the DNA damage response [69]. Studies have shown that human cell lines and 
cell lines from mice differ in their ability to surpass senescence upon DNA damage. This difference 
may lie in a difference in activation of two different pathways, one involving p53 and one involving 
pRb. Human cell lines, have shown to still undergo senescence after DNA damage, if just one of these 
two proteins (p53 or pRb are present). In contrast, if not both proteins are functional, murine cells 
line are able to surpass senescence [143][144].  As murine cells and hamster cells are quite similar, it 
is likely that this mechanism is also present in V79 cells. This could explain why we observe 
senescence cells in the HeLa cell samples but not in V79 cell samples.    
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 Dose rate effect 5.3.2.2.4.
Another difference between the two cell lines was the effect of dose rate on clonogenic survival. For 
HeLa cells no significant difference in survival fraction between the cells exposed to ƴ-rays, acutely or 
protracted were observed. However, if a broader absorbed dose range had been applied in the 
protracted γ-ray exposure, a dose rate effect might have been observed). In contrast, the survival 
fraction of V79 cells decreased dramatically, when the dose rate was increased. It has been shown 
that a dose rate of 0.372 Gy/h is needed to arrest to HeLa cells while a dose rate of 2.7 Gy/h was 
needed to arrest V79 cells [142]. This might explain the difference in dose rate effect between the 
two cell lines. The highest dose rate used for the protracted y-ray exposure was 0.492 Gy/h. This dose 
rate is above the one needed to arrest HeLa cells, and so both the HeLa cells exposed to the lower 
(protracted) and the higher (acute) dose rate, could be arrested. In contrast, the dose rate needed to 
arrest V79 cell was much higher than the 0.492 mGy/h used in the protracted ƴ-ray exposures (and in 
the 131Cs exposed cells, (~0.8 Gy/h)), and so these V79 cells would not become arrested. In contrast 
the acute γ-ray exposed cells received a much higher dose rate (1.5 Gy/min or 90 Gy/h), which could 
arrest the cells and significantly decrease their clonogenic cell survival fraction.       
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5.4 Relative Biological Effectiveness of Auger emitters 
The RBE for 131Cs homogenously distributed throughout the cell were found to be 1 when using the 
γH2AX assay and around 4 (4.5 for HeLa cells and 3.8 for V79 cells), when using the clonogenic cell 
survival assay. Based on earlier reported RBE values for Auger emitters located intracellularly, a RBE-
value around 2 had been expected. The RBE-value of 1 was therefore lower than expected, while the 
value around 4 was much higher than expected. Due to the distinct qualities of the two biological 
assays used, the RBE-values obtained by clonogenic cell survival assay were considered to most 
accurately reflect the radiotoxicity of intracellular Auger decays.  These RBE-values are even 
conservative, as a 17 % higher (compared to NuDat 2.7) total energy per decay was used in the 
absorbed dose calculations. If this normalisation had not been applied, the calculated absorbed dose 
would have been 17 % lower and accordingly the obtained RBE- values 17 % higher.   
Unfortunately, not many (if any) have investigated the RBE for Auger emitters distributed 
homogenously throughout the cell and no one has used 131Cs. It is therefore a bit difficult to compare 
the RBE-values obtained in this work, with previously reported ones. In addition, the dependency of 
the RBE on the biological assay and endpoint used, makes the comparison (of RBE values) only more 
complicated. A big difference in obtained RBE-values for seemingly similar experiments, using 
different biological assays have also been reported before, and is an inherent property of the RBE 
concept [145][24]. Nonetheless, the RBE value of 1 (found in this work) is in the range of what would 
be expected (and has previously been reported), for Auger emitters located either extracellularly or 
purely in the cytoplasm [28][137][138].  As the 131Cs in this work was also located in the nucleus and 
not only in the cytoplasm, a RBE value above 1 had been expected.  In contrast the RBE-values around 
(3.8 & 4.5), also obtained in this study, were much higher than expected as these are in the range of 
what have previously been reported for Auger emitters bound to (but not incorporated into) the DNA 
[21] [62][24] [23]. Together with RBE-values for Auger emitter located throughout a cell (however not 
homogenously) [146][147][148], a RBE-value around 2 had been expected in this work.  
As the RBE is dependent on several parameters, the cause of the difference in the obtained RBE-
values in this work, and the ones reported in the literature can be many. However, one clear possible 
Discussion 
 172 
cause could lie in the absorbed dose calculations. For Auger emitters the absorbed dose is difficult to 
estimate, and so a big uncertainty these calculation must be incorporated into the obtained RBE-
values. Often the tabulated MIRD cellular S-values are used for the absorbed dose calculations and 
several combinations of source and target compartments are calculated and listed for several 
radioisotopes [17]. However, the MIRD cellular S-values are especially sensitive to changes in the 
cellular or nuclear size. Unfortunately, as also showed in this work, the size of a nucleus in a cell 
population varies greatly, which raises a problem in deciding which nucleus size and consequently 
cellular S-value to use, for the absorbed dose calculation. The volume of the nuclei measured in this 
work, varied from below 0.1 pL to above 1 pL. The corresponding tabulated MIRD cellular S-values for 
this range in nucleus size differs by several factors (1.3-6,5)  (for 131Cs, S(N←C), (for these cellular S-
values see appendix  8.2.1 p. 196)), which will result in a similar variation in the calculated absorbed 
doses. The cellular S-values as tabulated by MIRD might thereby give a very big uncertainty in the 
absorbed dose calculations and hence the obtained RBE-value. This could also be an explanation for 
the diverse RBE-values reported in the literature and might be one of the reasons why we obtained a 
higher than expected RBE-value. 
In relation to the absorbed dose, the dose rate is known to influence the biological response and 
hence the RBE.  When using radiochemicals the bio kinetics (uptake and release of the radiochemical), 
often results in a chronic or protracted exposure of the cells, and the dose rate between the test and 
reference radiation can be very different (if not matched). As pointed out by Howel et al [149] and 
Rao et al [150], this difference in dose rate and especially acute versus chronic (protracted) exposures, 
can have a big influence on the obtained RBE. A RBE-value of ~20 for DNA incorporated 125I, were for 
example reported by Howel et al, when matching the dose rate with chronic exposure, in contrast to 
the RBE-value of ~9 he obtanied, when acute exposure was used (as the reference radiation) [149]. 
Rao et al though, found the reverse effect, in which the radiotoxicity increased by a factor 3, when the 
dose rate decreased [150]. Both results illustrates that the dose rate can have a big influence on the 
RBE-value obtained. Likewise, this work also showed a difference in the radiotoxicity obtained when 
acute exposures instead of protracted exposures were used (as the reference radiation). A RBE-value 
of ~4 were found when the dose rates were matched (protracted exposure), in contrast to the RBE-
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value of 1.3 when acute exposure was used. The effect was visible for V79 cells, but not for HeLa cells, 
which most likely is due to the chosen dose rates and the inherent differences between the cell types, 
as explained in section 5.3.2.2.4 (p. 170). Interestingly, the “RBE-value” of 1.3 obtained in this work, 
when using acute exposure as the reference radiation, is closer to what I initially expected based on 
previous reported RBE-values.  Unfortunately, matching the dose rate or at least using a chronic 
exposure as the reference radiation, when investigating the RBE of Auger emitters is often not applied 
[22] [23][24] [151]. This, feature could also be an explanation for the higher than expected RBE-value 
obtained in this study. In addition, it might also explain some of the seemingly paradoxical RBE-values 
below 1, that has been obtained in some studies [151][148].       
However, more interesting is it that Auger emitters are often referred to as a homogenous group, 
even though their decay characteristics are very different [13][25]. Paradoxically, it is the very low 
energy electrons (MXY Auger and higher shell branches, plus CK  and SCK ), which can safely be 
ignored in conventional absorbed dose calculations , that are believed to be responsible for the 
severe DNA damage and high biological effectiveness of Auger emitter decays [15]. The number of 
electrons emitted and their energy distribution will have a great impact on the obtained RBE-value. 
Most experiments have investigated the RBE of 125I, 111In and 99mTc, which on average emits 24.9, 14.7 
and 4.0 electrons per decay with average energies of 849 eV, 2215 eV and 3159 eV respectively 
[86][152]. The great range in number of electrons released and their average energies (or rather 
energy distribution), might also explain some of the variations in the reported RBE-values. In 
comparison, 131Cs releases on average 10.1 electrons with an energy average of 613eV (Personal 
communication with Boon Q. Lee). The combination of a high number of electrons released per decay 
and low average electron energy, is believed to cause the most severe DNA damage. Hence 125I is 
thought to be the most potent Auger emitter of the four [152]. This also corresponds with studies 
showing a lower radiotoxicity of 99mTc compared to the 111In [153],and the general lower radiotoxicity 
obtained for 99mTc [150][154]. However, in order to better understand this complexity and biological 
response following Auger emitter decays, there is a need for microdosimetry. The use of 
microdosismetry is also the official recommendation from ICRP in assessing risk estimation from 
Auger emitters [13]. Unfortunately, there are several factors needed for proper microdosimetric 
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calculations/simulations, for which the details are not known. These include the distribution of the 
actual number of electrons and their energies emitted per individual decay, along with the angular 
correlations in which these electrons are emitted. In addition, the size of the “true” biological target 
needed to convert energy deposition into dose is unknown, and might even dependent on cell type 
[87].  Before these questions have been answered, microdosimetry might not be able to precisely 
calculate the energy deposition distribution and predict the biological effect of from Auger emitter 
decays. However, even if all these factors were known, the biological response would still dependent 
on several factors (just like the RBE), including cell type, dose rate, endpoint etc. As also showed in 
this work, the biological response was very dependent on the cell type and the biological assay used. 
Even though almost the same RBE-value were obtained for HeLa and V79 cells, using the clonogenic 
cell survival assays, their respective survival fractions (at similar absorbed doses) differed by a factor 
103. The biological response, showed a huge dependency on cell type (here sought to be explained by 
differences in pathway activations, see section 5.3.2.3 p. 169) which could never be explained purely 
by microdosimetry.  
The biological response can be evaluated using different biological assays each showing a different 
“aspect” of the biological response. Dependent on the purpose of the study, the chosen biological 
endpoint can be more or less relevant. If wishing to ascertain Auger emitters as a future cancer 
therapy, the fate of a cell after irradiation is of highest importance. The clonogenic cell survival assays 
tells exactly the information that is relevant; is the cancer cell still able to continuously divide or not. 
However, if the issue is radiation protection, the risk of stochastics effects, e.g. cancer, will be related 
to the mutagenic and carcinogenic properties of the radiation, and biological assays with focus on 
this, e.g. in vitro mammalian gene mutation test or fluorescence in situ hybridizations, ((FISH), which 
looks at translocations and deletions) might give more useful information.  
In retrospect, the RBE concept might be dependent on too many parameters, which precise effect is 
unclear, and the obtained RBE-values (for Auger emitters) will therefore become too complicated to 
extract the relevant information. Especially, the high uncertainty in calculated absorbed doses, 
resulting from big variations in the MIRD cellular S-values, makes the obtained RBE-value so 
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dependent on the chosen cellular and nuclear size, that they can “change” the obtained RBE 
considerable.  In addition, as showed by microdosimetry, the energy deposition density and “track 
structure” of different Auger emitters vary so much that they should not be considered as equally 
potent or harmful. Microdosimetry could elucidate these differences, but the calculated dose will still 
be dependent on the chosen target volume, resulting in a similar issue with high dependency and 
uncertainty in the target size, as confronted with, when the MIRD cellular S-values are used in the 
absorbed dose calculations.  To obtain reliable results of the radiotoxicity of Auger emitters, it might 
be better to disregard the absorbed dose all together and just use the activity of the Auger emitter 
instead. In this way ones effort could be concentrated on investigating the delivery of the individual 
Auger emitters and their respective potentials in cancer therapy or detrimental effects for radiation 
protection. In addition, the classical way of calculating equivalent dose using radiation weighting 
factors, based on RBE-values (not using microdosimetry), does not make much sense for Auger 
emitters, since a higher absorbed dose of one Auger emitters will not necessarily result in a greater 
biological effect than a lower absorbed dose from another Auger emitter. As so, a higher absorbed 
dose from 99mTc will not necessarily result in a greater biological effect compared to a lower absorbed 
dose from 125I.  
A few studies have already been carried out in humans studying the pharmacokinetics, toxicity profile 
and therapeutic potential of various  111In-radiopharmaceuticals [155][156][157][158], that were 
originally approved for diagnostic use (except [155]). Due to the complex nature of the energy 
deposition distribution after Auger emitter decays, and the even more complex nature of the 
following biological response, a pragmatic approach investigating the potential of various 
radiopharmaceutical candidates, using a steady increase in the administered activity, might be the 
most effective methodology. This suggests that animal experiment might be the most reasonable 
choice in assessing the potential of a radiopharmaceutical. If this approached is chosen, the 
differences between human cells and the cells from the chosen animal, should be highly considered, 
especially if using human xenograft. As showed in this work (and also supported by the literature 
[20][119][141][142]), several difference between the human (HeLa) and hamster (V79) hamster cells 
Discussion 
 176 
were found, including a factor 103 difference in their sensitivity to radiation. Such a difference would 
be of vital importance in assessing the radiation response using animal models.  
However if one still wish to investigate the RBE of Auger emitters, certain aspect of the experimental 
setup should be highly prioritized. First, a reliable method to calculate absorbed dose should be used. 
Using the MIRD cellular S-values for these calculations, will most likely result in an uncertainty of the 
absorbed dose and hence RBE, that is too big to draw any conclusions.  In this work, I have developed 
and showed one possible method to calculate the absorbed dose (for homogeneously distributed 
Auger emitters), which are very robust and almost independent on the cellular and nuclear sizes. 
Second, using comparable dose rates for the test and reference radiation should also be highly 
prioritized. As also showed in this work, the dose rate effect can significantly change the RBE-value. 
Ignoring this dose rate effect, can again influence the obtained RBE so much, that it losses its validity. 
A lot of effort has been put into the investigation of the radiotoxicity and RBE of Auger emitters, and it 
is unfortunately that the validity of many of these RBE-values are compromised due to unfortunate 
mistakes in the experimental setup and the absorbed dose calculations.  
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5.5 Summary 
In the present study the radiotoxicity and relative biological effectiveness of Auger emitters were 
investigated. For this purpose the pure Auger emitter 131Cs was chosen, as it had some beneficial bio-
chemical characteristic. The cellular experiments were carried out using two cell lines; HeLa and V79 
cells. By investigating the bio-kinetics of 131Cs in these two cell lines, it was found that at least ~80 % 
of the 131Cs, taken up by the cells, was transported across the plasmamembrane through the Na+/K+-
ATPase. The uptake of 131Cs resulted in an accumulation of intracellular 131Cs compared to the 
external cell culture medium, of at least a factor 30. 131Cs was also found to be released from the cells 
again, although this mechanism was not further studied. The increase in intracellular 131Cs activity 
concentration and the release of 131Cs from the cells over time could both be described by 
exponential functions. The bio-kinetics of 131Cs plus its chemical characteristics, as an alkali metal, 
leads us to strongly believe that 131Cs was not intracellularly chemically bound , but  freely diffusible 
and homogeneously distributed throughout the cell. 
The intracellular homogeneous distribution of 131Cs, allowed us to establish an experimental setup 
and develop new cellular S-values, denoted SC-values. The geometry applied for these SC-values was a 
confluent cellular monolayer, in which ellipsoidal nuclei were located. The source compartment for 
these SC-values was the whole cellular monolayer and the nucleus the target (SC(N←CM)). The SC-
values were dependent on the height of the cellular monolayer, which was estimated using confocal 
microscopy to be 10 µm and 8 µm respectively, for the two cell lines used (HeLa & V79). Using the 
experimental setup, the SC-values turned out to be very robust, and almost independent of the 
nuclear size. The SC-value changed with less than 2.5 % for nuclear sizes ranging from below 0.1 pL to 
above 1.1 pL.  
The SC-values were expressed as Gy/(Bq*Sec)/pL, and so the intracellular 
131Cs activity concentration 
over time was used in the absorbed dose calculations. As the bio-kinetics of 131Cs had been 
elucidated, the activity concentration of 131Cs at only one time point was needed, in order to calculate 
the absorbed dose and dose rates over time. This was a huge advantage as the total amount of 131Cs 
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available to us was spares. In addition, the intracellular accumulation of 131Cs, allowed us to ignore 
the dose contribution from the cell culture medium.  
In the end the radiotoxicity and RBE of 131Cs was investigated. Using the obtained knowledge of the 
131Cs transport across the plasmamembrane, we were able to block most of this uptake using 
ouabain, which is known to inhibit the Na+/K+-ATPase. This allowed me to study the radiotoxicity of 
intracellular and extracellular located 131Cs. In line with the belief, the radiotoxicity of 131Cs was 
markedly reduced, when it was located extracellularly compared to intracellularly. The RBE of 
intracellular 131Cs was investigated using two different biological assays; the γH2AX assay and the 
clonogenic cell survival assay. As several factors are known to influence the biological response to 
radiation, it was highly prioritized to apply similar experimental conditions for the cells exposed to 
intracellular 131Cs (test radiation) and external γ-rays (reference radiation). A special focus was on the 
dose rate effect and the dose rate profiles for the two exposures were therefore matched as closely 
as possible. A RBE-value of 1 was obtained for HeLa cells, using the γH2AX assay. In contrast much 
higher RBE-values of 4.5 ± 0.5 and 3.8 ±0.8 respectively, were obtained for HeLa and V79 cells using 
the clonogenic cell survival assay and 137Cs ƴ-rays as reference radiation. In addition, a “RBE”-value 
using acute exposure for the reference radiation instead of the matched dose rate profiles was also 
obtained. Here, a significant dose rate effect was found for V79 cells (but not for HeLa cells) 
decreasing the obtained “RBE”-value from 3.8 to 1.3. Nevertheless, due to the distinct qualities of the 
two biological assays used (γH2AX & clonogenic cell survival) the RBE-values obtained by clonogenic 
cell survival assay were considered to more accurate. These RBE-values (4.5 & 3.8) were higher than 
would be expected for Auger decays located intracellularly, as long as it is not intercalated or bound 
to the DNA. However, our robust SC-value, the simple homogeneous intracellular distribution of 
131Cs, 
the elucidated 131Cs bio-kinetics and especially the matched dose rate profiles, make our obtained 
RBE-values reliable. It is very unlikely that our absorbed dose calculations would be are so incorrect as 
to account for this high RBE-value. In addition, we know that the obtained RBE-values are 
conservative, as a 17 % higher (compared to NuDat 2.7) total energy per decay was used in the 
absorbed dose calculations. If this normalisation had not been applied the calculated absorbed dose 
would have been 17 % lower and accordingly the obtained RBE-values would be 17 % higher.   
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 A possible explanation for the high RBE-values obtained, could be related to a dose rate effect, which 
in this study, when ignored, decreased the obtained “RBE- value from 3.8 to 1.3. All in all, this study 
have established an experimental setup and developed new cellular S-values, named SC-values, which 
are very robust and almost independent of nuclear volumes. Using this setup, RBE-values of 1 (HeLa 
cells) and 4.5 ± 0.5 (HeLa cells) and 3.8 ± 0.8 (V79 cells) for intracellular 131Cs decays, were obtained 
using the γH2AX and clonogenic cell survival respectively.   
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6. Conclusions and Outlook 
The outcome of this study is twofold. The first outcome relates to the RBE values found, while the 
second relates to the experimental model and SC-values that were developed. 
RBE-values of 1 (HeLa) and 4.5 ± 0.5 (HeLa) and 3.8 ± 0.8 (V79) were found for intracellular 131Cs 
decays, using the γH2AX and clonogenic cell survival assay respectively and 137Cs ƴ-rays as reference 
radiation. Due to the distinct qualities of the two biological assays used, the RBE-values obtained by 
clonogenic cell survival assay were considered to most accurately reflect the radiotoxicity of 
intracellular Auger decays. Due to the experimental model, the very robust SC-values and the matched 
dose rates profiles, these obtained RBE-values are seen as very reliable.  The high RBE-values 
obtained, raise both hope and concerns. One of the struggles in developing Auger therapy is related 
to getting the radioisotope close enough to the DNA to achieve a high radiotoxicity. With the RBE-
values obtained in this study, it may be enough to get the radioisotope into the nucleus, not being 
forced to bind it to the DNA. On the other hand, these RBE-values of ~4, should raise concerns in the 
way Auger emitters are treated in radiation protection and especially in the risk assessment of 
diagnostic procedures. At the moment Auger electrons release by the Auger emitters e.g.  111In, 99mTc, 
which are extensively used in everyday diagnostic procedures are treated as “regular electrons”, 
having a radiation weighting factor of 1. This might have been justified by the belief that Auger 
emitters should bind to the DNA to be highly radiotoxic.  However, the RBE-values of ~4 obtained in 
this study, show that the radiotoxicity of intracellularly located Auger decays (when not bound to the 
DNA), are significantly higher than otherwise thought, and should not be ignored. Even though the 
precise radiotoxicity of 99mTc, 111In and other Auger electron emitting radioisotopes is most likely not 
identical to 131Cs, due to their individual energy deposition density, the high RBE-value obtained in 
this study should be taken very serious. Luckily, studies have indicated that 99mTc might not be as 
radiotoxic as 111In and 125I, which correspond to their lower number of electrons released per decay.  
However, as the average number of electrons released per decay and their energy average for 131Cs 
are not that different from 111In, it could be feared that the RBE-values obtained in this study reflect 
that of 111In. If this is true, we could be severely miscalculating the risk posed by Auger electron 
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emitting radioisotopes. The risk associated with diagnostic procedures, could therefore very well, be 
significantly underestimated, affecting a substantial amount of people.  
This leads to the second outcome of this study: The radiotoxicity of Auger emitter decay clearly needs 
to be further investigated. I believe that the experimental model and the SC-values developed and 
applied in this study, is highly suitable for this purpose. The cell culture geometry, the homogenous 
distribution of 131Cs and the use of intracellular activity concentration, makes our SC-values very 
robust. This along with the known bio-kinetics of 131Cs, makes the calculated absorbed doses and dose 
rates very reliable. The high uncertainty in dosimetric calculations often inherent in other 
experimental setups can thereby be overcome. In addition, the matching the dose rate profiles, 
overcomes the dose rate effect, which is known to greatly impact the biological response and hence 
the RBE. Other endpoints (e.g. micronuclei formation) or other cellular responses to Auger decays, 
including changes in gene expression and DNA damage repair pathways can also be studied using this 
model and could help to further elucidate the biological differences between Auger emitter decay 
exposures and exposure from other types of ionising radiation.  
Importantly, this experimental model and calculation of the SC-values can if wished to also be applied 
to other radioisotopes, as long as they are homogeneously distributed in the cells.  
Lastly, as 131Cs is transported into the cells by the Na+/K+-ATPase, which is a ubiquitous pump present 
in all mammalian cells, the experimental model can be applied to all cell types. Differences in 
sensitivity to Auger emitter decays between cells originating from different tissues (e.g. cancerous or 
normal) can be investigated. In addition, because of the resemblance of caesium to potassium this 
can be expanded to include investigation the radiotoxicity of Auger emitter decays in cells of non-
mammalian origin, including microorganism such as bacteria and fungi. 
However, most importantly, this study unequivocally demonstrates a high RBE for Auger emitter 
decays located intracellular, but not bound to the DNA. This high radiotoxicity of Auger emitters 
shows that Auger electrons released by radioisotopes should not be ignored, but rather taken very 
seriously. The detrimental effects and risks associated with Auger emitter decays should be further 
investigated, regardless of the experimental model used. 
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8. Appendix 
 
8.1 Calculations of chemical caesium concentrations in 
the medium and intracellular  
Chemical caesium concentration in the medium 
The number of 131Cs nuclei present can be calculated if the activity is known, by the formula below: 
Number of nuclei/Bq =
𝑻(
𝟏
𝟐
)
𝐥𝐧(𝟐)
               (Eq. 39) 
 
Number of nuclei/Bq =
9.689∗24∗3600
ln(2)
= 1,21 ∗ 106 𝑛𝑢𝑐𝑙𝑒𝑖/𝐵𝑞           (Eq. 40) 
 
Because of the production of 131Cs and the subsequent chemical separation, the specific 
concentration is very high and close to 100%.  The highest activity concentration of 131Cs used was 
17MBq/ml and assuming a specific activity of 100%, maximum chemical concentration of caesium in 
the medium was found to be: 
         chemical concentration of Cs131 =
number of nuclei per beqaurel∗ activity cocentration  
avogadro constant
            (Eq. 41) 
 
chemical concentration of Cs131 =
1.21∗106nuclei
Bq
∗
17∗109Bq
L
6.022∗1023
                          (Eq. 42) 
≈ 35nM 
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-Intracellular chemical caesium concentration  
Given a maximum caesium concentration in the medium of ~35nM, as obtained above, the maximum 
intracellular 131Cs concentration was calculated using the accumulation factor. The accumulation 
factor of caesium in the HeLa and V79 cells were found to be around 30 and 70 respectively. This 
gives a maximum caesium concentration inside the HeLa and V79 cells of 1µM and 2µM respectively. 
As the highest 131Cs activity concentration in the medium used in experiments with V79 cells was 
significantly lower, the maximum intracellular 131Cs concentration in these cells, will also be lower, 
however a more precise estimate was not necessary. For comparison the normal concentration of 
potassium inside mammalian cells is around 140mM [88] , a factor 105 higher. 
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8.2 Cellular S-values 
 MIRD Cellular S-values for 131Cs 8.2.1
The published MIRD cellular S-values for 131Cs are show in the table below [17]. In addition, the 
cellular S-value with the whole cell as source and nucleus as target, (which have not been tabulated 
by MIRD), have been calculated and is shown in the last column (blue column) in the table. These 
cellular S-values have been calculated using only the already given cellular S-values. As can be seen by 
below equation (Eq. 43) given by MIRD for calculation of absorbed dose when the radionuclide is 
located in one or more of the source compartment [17], the cellular S-value for source and target 
combination S(N←C) is easily calculated using equation (Eq 45). 
 
D̅N =  ÃC [fN S(N ← N) +  fCy S(N ← Cy)]                   (Eq. 44) 
 
S(N ← C) =  
S(N←N) ∗ nuclear volume + S(N←Cy) ∗ cytoplams volume 
volume of the whole cell
           (Eq. 45) 
 
Each S(N←C) for the different cellular geometries (cytoplasm and nuclear size), shall of course be 
calculated using the S(N←N) and S(N←Cy) for those respective geometries.  
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Radionuclide: 
131
Cs                             Half-Life: 9,69 d                          Decay Mode: EC
Cell radius 
(µm)
Nucleus 
radius (µm)
S(C←C)
(Gy / Bq s)
S(C←CS)
(Gy / Bq s)
S(N←N)
(Gy / Bq s)
S(N←Cy)
(Gy/ Bq s)
S(N←CS)
(Gy/ Bq s)   
                 
S(N←C)
(Gy/ Bq s)
                1,71E-02
1,07E-01
5,47E-03
1,66E-02
2,42E-03
5,31E-03
1,61E-02
1,29E-03
2,35E-03
5,16E-03
7,69E-04
1,25E-03
2,28E-03
5,02E-03
5,00E-04
7,44E-04
1,21E-03
2,21E-03
3,45E-04
4,83E-04
7,20E-04
1,17E-03
2,50E-04
3,34E-04
4,68E-04
6,97E-04
1,13E-03
3 2
1,42E-03 1,60E-04
4 3 2,59E-03 1,35E-03 5,94E-03 4,00E-04 1,04E-04
5 3 1,37E-03 7,15E-04 5,94E-03 2,02E-04 6,62E-05
5 2 1,37E-03 7,15E-04 1,91E-02 2,44E-04 6,35E-05
2,80E-04 2,59E-03 8,43E-05 3,79E-05
6 3 8,13E-04 4,29E-04 5,94E-03 1,31E-04 4,74E-05
7 6 5,26E-04 2,80E-04 8,13E-04 8,83E-05 4,31E-05
7 4 5,26E-04
1,94E-04 1,37E-03 6,08E-05 3,28E-05
7 3 5,26E-04 2,80E-04 5,94E-03 9,51E-05 3,67E-05
8 7 3,62E-04 1,94E-04 5,26E-04 6,50E-05 3,51E-05
8 6 3,62E-04 1,94E-04 8,13E-04 5,95E-05
8 4 3,62E-04 1,94E-04 2,59E-03 6,54E-05 3,13E-05
9 8 2,61E-04 1,40E-04 3,62E-04 4,91E-05 2,83E-05
2,77E-05
10 9 1,95E-04 1,04E-04 2,61E-04 3,80E-05 2,29E-05
1,40E-04 8,13E-04 4,72E-05 2,75E-059 6 2,61E-04
10 5 1,95E-04 1,04E-04 1,37E-03 4,22E-05 2,33E-05
10 7 1,95E-04 1,04E-04 5,26E-04 3,71E-05 2,24E-05
10 6 1,95E-04 1,04E-04 8,13E-04 3,94E-05 2,27E-05
5,94E-03
4 2 2,59E-03 1,35E-03 1,91E-02 4,25E-04 9,64E-05
5 4 1,37E-03
3,09E-03 1,91E-02 1,01E-03 1,72E-04
7,15E-04 2,59E-03 2,09E-04 7,14E-05
3 1 5,94E-03 3,09E-03 1,36E-01
5,33E-05
6 4 8,13E-04
7 5 5,26E-04 2,80E-04 1,37E-03 8,01E-05 3,99E-05
4,29E-04 2,59E-03 1,19E-04 4,96E-05
6 5 8,13E-04 4,29E-04 1,37E-03 1,28E-04
1,95E-04 1,04E-04 3,62E-04 3,55E-05
3,38E-05
8 5 3,62E-04
9 7 2,61E-04 1,40E-04 5,26E-04 4,58E-05 2,75E-05
2,24E-0510 8
9 5 2,61E-04 1,40E-04 1,37E-03 4,97E-05
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8.3 Uncertainties 
 
-Clonogenic cell survival 
The aim of this experimental study was to compare the survival fraction as function of the absorbed 
dose for the two different exposures (intracellular131Cs and external γ-rays), while keeping all other 
experimental conditions as similar as possible (e.g. cell density, dose rates). Each of the two exposures 
has its own sources of experimental errors that generate an inherent uncertainty in the actual doses 
delivered. This means that each data point (absorbed dose versus survival fraction) in each of the two 
data sets from the two exposures will have an uncertainty in the calculated absorbed dose.  In 
addition there are important sources of uncertainty in the observed survival fraction. Not only from 
the normal liquid handling and pipetting error sources, but also, more fundamentally from the 
inherent Poisson statistical nature of the cell colony counting. This was especially pronounced in the 
internal 131Cs exposures, for HeLa cells, due to the very low number of colonies formed. It is a 
combination of all errors in the survival fraction that gives rise to the uncertainty in the calculated 
survival fraction. 
In the sections below, the different error sources will be treated individually, and then later 
combined.However, from the starting point it should be made clear, that the aim is to compare the 
two clonogenic cell survival curves, each having their statistics and confidence limits.  
 
-External γ-ray exposure (protracted)  
The integrated external absorbed doses contain the following error terms: 
- Uncertainty in calibrated dose rate at fixed distance from the γ-ray source (137Cs), (0.63 %).  
- Uncertainty in dose rate decrement due to the decay of the 137Cs source since time of 
calibration caused by uncertainties in the half-life of 137Cs (0.29 %). 
- Uncertainty and experimental errors in the distance adjustments between the cells and the γ-
ray source (2 %) 
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- Uncertainty in timing of the individual exposures (small).  
- Dose rate effects (deviation from attempted curve) (neglected) 
 
When these errors are combined in quadrature (because they are independent) the total uncertainty 
in external absorbed dose becomes: 2.12 % 
 
-Intracellular 131Cs exposures  
The integrated internal absorbed doses contain the following error terms: 
- Calibration of LSC efficiency for 131Cs (6%), (Uncertainty mainly coming from the Ge-
detector) 
- Counting statistics in LSC (small) 
- Average cell volume determination by the Scepter (Estiamted to be 15%) 
- Cell concentration (cell number/uL) (20 %) 
- Exposure time (2%) 
- LSC counting sample pipetting (5%) 
- Error in intracellular cumulative activity due to exponential fit of uptake and release curves 
(small, further elaborations can be seen below. Less than 4% and ignored compared to the 
other, larger uncertainties. 
- Error in SC-values from geometry variations ( cell layer Height)  HELA  3%  
- Error in SC-values from geometry variations (cellular monolayer height)  V79  7%  
Cummulative internal absorbed dose error: 22 % HeLa cells 
Cummulative internal absorbed dose error: 23 % V79 cells 
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-Survival fraction for both exposures 
The survival fraction calculations contain the following sources of error terms: 
- Cell concentration counting (5 %) observed 
- Number of cells seeded in the controls samples (pipetting, (5 %) systematic) 
- Number of cells seeded in the test samples (pipetting, (5 %) observed) 
- Counting statistics in the  control experiment : (small, is ignored)  
- Counting statistics in the exposed arm of the experiments. The uncertainty in the number of 
counted colonies N is √N, and the relative error then √N / N. 
 
The only “unobserved, systematic” error source is the pipetting (number of cell seeded) of the control 
samples. However, these seedings are done in triplicates, and the resulting number of colonies 
counted is used to define the plating efficiency. Therefore, this error is seen as “small” compared to 
the cell colony number errors. The relative standard deviation of the observed survival fraction varies 
between 5 % and 21 %. The largest Poisson statistical error for a single observation is in each of the 
internal dose experiments leading to high absorbed dose for HeLa. Here only 9-10 survivors are 
counted, giving a Poisson error close to 30 %. However, when all survivors in the triplicate are 
counted, the sum of survivors is 29 and the Poisson error then 19 %. 
 
The observed error in the survival fractions seem to be in accordance with the error sources listed, as 
the cumulative relative survival fraction error becomes dominated by the Poisson counting statistics. 
The total error is therefore assumed to be reflected in the observed variation.2  
 
 
 
 
 
 
                                                     
2
 The statistical analysis of the survival fraction from clonogenic cell survival is done by supervisor Mikael Jensen.  
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 The influence of time constant uncertainty for 8.3.1
cumulative activity concentration  
The cumulative activity concentration (𝐴∗) of intracellular 131Cs could be calculated by equation 48;  
 
𝐴∗ =  ∫ 𝐴𝑢𝑝
480
0
∗ 𝑑𝑡 +  ∫ 𝐴𝑜𝑢𝑡 ∗ 𝑑𝑡
1440
480
                         (Eq. 46) 
 
Where 𝐴𝑢𝑝and 𝐴𝑜𝑢𝑡 are calculated by equation…; 
 
Aup = A480 ∗ (1 − e
−480 min∗ kc  )
−1
∗ (1 − e−t∗kc)for t ≤ 480 min 
Aout = A480 ∗ e
−(t−480 min)∗kout  𝑓𝑜𝑟 𝑡 > 480 𝑚𝑖𝑛                          (Eq. 47) 
 
Using an arbitrary activity concentration of 1 Bq/pL at 480 min, the resulting difference in cumulative 
activity concentration after 1440 min for the different combinations of kc and kout, could be 
calculated.  
 
 
 HeLa 8.3.1.1
kc and kout were found to be; 
kc:  1/283 min
-1 (with 95% conf. limits 1/251 min-1 to 1/325 min-1,R2 = 0.922)  
kout:  1/337 min
-1 (with 95% conf. limits 1/304 min-1 to 1/381 min-1, R2 = 0.958)  
1/339 min-1 (using solver) 
 
 
 
 
Appendix 
 202 
Worst case (2 s.d.): 
The biggest impact of errors in the kc and kout arises from a situation when one of them is determined 
too short and the other too long, or vice versa. 
Having an error exceeding 2 standard deviations on both kc and kout at the same time is very unlikely 
(p=0.05*0.05 = 0.0025), but it can used to graphically illustrate the impact as shown in the curves 
below (Figure 8.1). This “unlikely” combination leads to an error in A* of 6.5% for HeLa. 
 
  
Figure 8.1 Uncertainty in cumulative activity concentration due to variations in kc & kout 
The graph shows the cumulative activity concentration (𝑨∗) for three scenarios; the blue line represent the the case used 
in the dose calculations in which kc and kout have the values obtanied by the fit. The yellow and red lines represent the 
case in with the constants (kc & kout) are 2 standard deviations shorter or longer in opposite directions, resulting in the 
biggest difference in the cumulative activity. The cumulative activity using an arbitrary activity concentration of 1 Bq/pL at 
480 min, calculated for the three situations are shown.  
 
 
Below are given the change in the cumulated activity concentration (A*) for different errors in kc and 
kout, calculated as shown above 
 
Appendix 
 203 
 
Worst case at 1 s.d.: 
Looking at the 1.s.d. limit , I get : 
3.3 % increase in A*if kc is 1 s.d. shorter, and kout is 1 s.d. longer 
2.8 % decrease in A* if kc is 1 s.d. longer and kout is 1 s.d. shorter  
 
Less than worst case: 1 s.d. change in kc and kout in the same direction 
1.5% decrease in A* if time constants are 1 s.d. shorter  
2.1% increase in A* if times constant are 1 s.d. longer 
 
  V79 cells 8.3.1.2
Kc and Kout were found to be; 
kc:  1/204 min
-1 (with 95% conf. limits 1/154 min-1 to 1/303 min-1, R2 = 0.841)  
kout:  1/256 min
-1 (with 95% conf. limits 1/237 min-1 to 1/280 min-1, R2 = 0.9768)  
 
Worst case (2 s.d.): 
7.0 % decrease in A* if kc is 2 s.d. longer, and kout is 2 s.d. shorter   
7.5 % increase in A*  if kc is 2 s.d. shorter, and kout is 2 s.d. longer   
 
Worst case (1 s.d.): 
4.0 % decrease in A* if kc is 1 s.d. longer, and kout is 1 s.d. shorter   
3.5 % increase in A*  if kc is 1 s.d. shorter, and kout is 1 s.d. longer  
 
Less than worst case : 1 s.d. change in kc and kout in the same direction 
0.23 % increase in A* if time constants are 1 s.d. shorter 
0.75 % decrease in A*  if time constants are 1 s.d.longer 
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 Normalization of the dose kernel.  8.3.2
The dose kernel used to calculate the absorbed dose to cell nuclei was based on known electron 
emission energies and rates. The dose kernel was computed using the Cole stopping power 
approximation, which may be slightly incorrect [82]. However, under all circumstances should the 
total energy released in the dose kernel be equal to the sum of energies of the intensity weighted 
electron emissions. 
When only using NuDat 2.7 data, this sum is 5.02 keV. However, NuDat 2.7 lists only K- and L- Auger 
electrons [25]. We know that more electrons are emitted (MXY-Auger, CK-, SCK-electrons).  
Bambynek et al (1972) discusses in depth the emission rates of Auger electrons, and compare with 
experiments available at the time of writing. Bambynek argues for a high emission probability (more 
than 1 per decay) for CK and M shell Auger electrons for Z around 50, but he has no relevant 
experimental data for 131Cs [159].  
Babenkov (1975) show significant deviation between calculated and measured KMM emission 
probabilities for 131Cs [160].  
Finally, Boon Q. Lee in ref. [93] and in private communication has done a detailed Monte-Carlo 
calculation of the 131Cs Auger yields. When using his data, the total Auger electron energy released 
per decay is around 6.20 keV (20-24 % higher than NuDat 2.7). The main differences are slightly higher 
total K-Auger yields (because KMX are taken into consideration) and higher L-Auger yields. Finally, the 
inclusion of CK and SCK branches adds a few percent to the total energy release. 
We cannot decide if Boons data are the most correct, but the use of Boons total Auger energy release 
as normalization gives the highest total absorbed dose in our confluent cellular monolayer model, 
irrespectively of the detailed shape of the dose kernel. 
As such a higher absorbed dose will lead to a conservative measurement of the RBE values (by a 
possible overestimation the absorbed dose) we have chosen to use a normalization of 5.87 keV per 
decay throughout the SC-value calculations in this study. This is 17% higher than NuDat 2.7, but 
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slightly below the value given by Boon. This normalization gives total KMM rates consistent with the 
experimental measurement given by Babenkov [160].  
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8.4 Clonogenic cell survival curves 
 HeLa cells 8.4.1
 
A 
 
B 
Figure 8.2 Clonogenic cell survival curves for HeLa cells external γ-ray (protracted & acute) 
Survival fraction as a function of absorbed dose for HeLa cells exposed external γ-ray at similar dose rate profiles (A) or 
external y-ray delivered acutely (B) are shown. These survival curves are the same survival curves that are shown in Figure 
4.27p. 145. The survival curve for the protracted ƴ-rays exposed cell were fitted the linear model, (𝑦 = 𝑒−0.384𝑥 ), while the 
survival curve for the acutely ƴ-exposed cells were fitted to the linear quadratic model (𝑦 = 𝑒−(0.136𝑥+0.0786𝑥
2
). The 
experimentally obtained data points (average of 3 replicates) for the two exposures are shown. The vertical error bars 
reflect the observed standard deviation in survival fraction, while the horizontal error bars reflect the estimated 
uncertainty in absorbed dose.  
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 V79 cells 8.4.2
 
A 
 
B 
Figure 8.3 Clonogenic cell survival curves for V79 cells external γ-ray (protracted & acute) 
Survival fraction as a function of absorbed dose for V79 cells exposed external γ-ray at similar dose rate profiles (A) or 
external y-ray delivered acutely (B) are shown. These survival curves are the same survival curves that are shown in Figure 
4.28 p. 148. The survival curve for the protracted ƴ-rays exposed cell were fitted the linear model, (𝑦 = 𝑒−0.0994𝑥 ),while 
the survival curve for the acutely ƴ-exposed cells were fitted to the linear quadratic model (𝑦 = 𝑒−(0.0983𝑥+0.0266𝑥
2). The 
experimentally obtained data points (average of 3 replicates) for the two exposures are shown. The vertical error bars 
reflect the observed standard deviation in survival fraction, while the horizontal error bars reflect the estimated 
uncertainty in absorbed dose. 
